University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
2021

Empirical Investigations Into The Impact Of Step-Down Unit
Admission And Health Information Technology On Patient
Outcomes
Suparerk Lekwijit
University of Pennsylvania

Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Databases and Information Systems Commons, Health and Medical Administration
Commons, and the Operational Research Commons

Recommended Citation
Lekwijit, Suparerk, "Empirical Investigations Into The Impact Of Step-Down Unit Admission And Health
Information Technology On Patient Outcomes" (2021). Publicly Accessible Penn Dissertations. 4016.
https://repository.upenn.edu/edissertations/4016

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/4016
For more information, please contact repository@pobox.upenn.edu.

Empirical Investigations Into The Impact Of Step-Down Unit Admission And
Health Information Technology On Patient Outcomes
Abstract
This dissertation in operations management studies healthcare operations using large-scale data sets
and econometric methods. In chapter one, we examine the benefits of step-down units (SDU), which
provide an intermediate level of care for semi-critically ill patients. Using data from 10 hospitals, we
estimate the clinical and operational impact of SDU care and find that SDU care significantly improves
health outcomes among post-intensive care unit patients. However, its benefits are less certain for
patients admitted from the emergency department. In chapter two, we utilize data from a field experiment
and examine the efficacy of a connected health system that aimed to reduce readmissions through
improved medication adherence. Patients in our study received electronic pill bottles that tracked
medication adherence and received different types of feedback when they were non-adherent. We find
that patients were more likely to become adherent when receiving high levels of intervention involving
personalized feedback and when the intervention is escalated quickly and consistently. We also find that
long-term adherence to two crucial heart medications reduces readmission risk. Additionally, we develop
a dynamic readmission risk-scoring model and use simulation to show that, when using an intervention
strategy that prioritizes high-risk patients, we can significantly reduce readmissions while using the same
effort level. In chapter three, we investigate the impact of video visit availability at a large academic
medical center on in-system care utilization. Through difference-in-differences, we find that video visit
availability is associated with increases in overall care utilization and in-person care utilization within the
system. As a whole, this dissertation provides healthcare providers and managers with data-driven insight
towards how to maximize effectiveness and efficiency in healthcare delivery through changes in the care
structure and health technology adoption.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Operations & Information Management

First Advisor
Christian Terwiesch

Keywords
Empirical Operations Management, Health Information Technology, Healthcare Operations Management,
Telehealth

Subject Categories
Databases and Information Systems | Health and Medical Administration | Operational Research

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/4016

EMPIRICAL INVESTIGATIONS INTO THE IMPACT OF STEP-DOWN UNIT ADMISSION
AND HEALTH INFORMATION TECHNOLOGY ON PATIENT OUTCOMES
Suparerk Lekwijit
A DISSERTATION
in
Operations, Information and Decisions
For the Graduate Group in Managerial Science and Applied Economics
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2021

Supervisor of Dissertation

Christian Terwiesch, Andrew M. Heller Professor; Professor of Operations, Information and Decisions
Graduate Group Chairperson

Nancy R. Zhang, Ge Li and Ning Zhao Professor of Statistics

Dissertation Committee
Hummy Song, Assistant Professor of Operations, Information and Decisions
Carri W. Chan, Associate Professor of Business, Columbia Business School

EMPIRICAL INVESTIGATIONS INTO THE IMPACT OF STEP-DOWN UNIT ADMISSION
AND HEALTH INFORMATION TECHNOLOGY ON PATIENT OUTCOMES
c COPYRIGHT
2021
Suparerk Lekwijit

This work is licensed under the
Creative Commons Attribution
NonCommercial-ShareAlike 4.0
License
To view a copy of this license, visit
https://creativecommons.org/licenses/by-nc-sa/4.0/us/

Dedicated to Mom and Dad

iii

ACKNOWLEDGMENT
First of all, I would like to thank my PhD advisor, Professor Christian Terwiesch, who has given
me tremendous support and guidance throughout my PhD career. You made my PhD experience
memorable (in the best possible way), enjoyable (a word that almost no one uses to describe their
PhD experience), and rewarding (not only did I learn a lot but I also got a degree and a job!). Without
you, this would not have been possible. Thank you, Christian, for always looking out for me and
wanting the best for me. I am fortunate to have you as my advisor.
I would like to thank the rest of my dissertation committee, Professor Hummy Song and Professor
Carri Chan. Professor Hummy Song has been a mentor, a teacher, and a friend who has inspired and
motivated me to be the best teacher and researcher I can be. I would like to thank Professor Carri
Chan for being my early mentor, introducing me to healthcare operations, and paving me the path
to PhD. Thank you, Hummy and Carri! I am grateful to have both of you as my mentors.
My warm thanks to everyone in the OID Department, including all past and present PhD
coordinators, Professor Noah Gans, Professor Serguei Netessine, and Professor Xuanming Su. Most
importantly, my PhD experience would not be complete without my PhD friends, especially those
in my cohort—Aman, Canberk, Park, and Sam. You guys are amazing! I would also like to thank
Arielle, Chloe, Dawson, Edward, Erika, Joseph, Kaps, Jiding, Lesley, Ozge, Pia, and Rowena. You
all made coming to work each day a joy (and gave me distractions from work that I needed).
On the clinical front of my research, I would like to thank Professor Kevin Volpp, Professor David
Asch, and Professor Krisda Chiyachati for supporting me and making our research possible.
There are so many other people that have inspired, motivated, and supported me directly and
indirectly throughout the years—family, friends, and other important people in my life. I would
name all of you here if I could, but this would be longer than the rest of my dissertation.
Lastly, to my future self who may be reading this, be proud of yourself. Do you remember that you
wrote this during a pandemic? What a weird time, but you made it through!

iv

ABSTRACT
EMPIRICAL INVESTIGATIONS INTO THE IMPACT OF STEP-DOWN UNIT ADMISSION
AND HEALTH INFORMATION TECHNOLOGY ON PATIENT OUTCOMES
Suparerk Lekwijit
Christian Terwiesch
This dissertation in operations management studies healthcare operations using large-scale data sets
and econometric methods. In chapter one, we examine the benefits of step-down units (SDU), which
provide an intermediate level of care for semi-critically ill patients. Using data from 10 hospitals,
we estimate the clinical and operational impact of SDU care and find that SDU care significantly
improves health outcomes among post-intensive care unit patients. However, its benefits are less
certain for patients admitted from the emergency department. In chapter two, we utilize data from
a field experiment and examine the efficacy of a connected health system that aimed to reduce
readmissions through improved medication adherence. Patients in our study received electronic
pill bottles that tracked medication adherence and received different types of feedback when they
were non-adherent. We find that patients were more likely to become adherent when receiving
high levels of intervention involving personalized feedback and when the intervention is escalated
quickly and consistently. We also find that long-term adherence to two crucial heart medications
reduces readmission risk. Additionally, we develop a dynamic readmission risk-scoring model and
use simulation to show that, when using an intervention strategy that prioritizes high-risk patients,
we can significantly reduce readmissions while using the same effort level. In chapter three, we
investigate the impact of video visit availability at a large academic medical center on in-system care
utilization. Through difference-in-differences, we find that video visit availability is associated with
increases in overall care utilization and in-person care utilization within the system. As a whole,
this dissertation provides healthcare providers and managers with data-driven insight towards how
to maximize effectiveness and efficiency in healthcare delivery through changes in the care structure
and health technology adoption.
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PREFACE
The broad goals of this dissertation are to understand how healthcare providers and managers can
make operational improvements to achieve better health and operational outcomes and to provide
actionable, data-driven insight towards how to maximize effectiveness and efficiency in healthcare
delivery. This dissertation focuses on two broad research areas within the healthcare operations
literature. First, in chapter one, we study inpatient operations and examine the impact of step-down
unit care on patient outcomes. Second, in chapters two and three, we seek to understand the impact
of health information technology on outpatient operations and ways providers provide care and
connect with patients, as well as determine how providers can effectively adopt such technologies.
In chapter one, ”Assessing the Impact of Service Intensity on Customers: An Empirical Investigation
of Hospital Step-Down Units”, we study a service setting where servers have different capabilities
and customers have varying needs. One common way this occurs is when servers are hierarchical
in their skills or in the level of service they can provide. Much of the literature studying such
systems relies on an understanding of the relative costs and benefits associated with serving different
customer types by the different levels of service. In this chapter, we focus on estimating these costs
and benefits in a complex healthcare setting where the major differentiation among server types is
the intensity of service provided. Step-down units (SDUs) were initially introduced in hospitals
to provide an intermediate level of care for semi-critically ill patients who are not sick enough to
require intensive care but not stable enough to be treated in the general medical/surgical ward. One
complicating factor is that the needs of customers is sometimes uncertain—specifically, it is difficult
to know a priori which level of care a particular patient needs. Using data from 10 hospitals from
a single hospital network, we take a data-driven approach to classify patients based on severity and
empirically estimate the clinical and operational outcomes associated with routing these patients to
the SDU.
In chapter two, ”Evaluating the Efficacy of Connected Healthcare: An Empirical Examination
of Patient Engagement Systems and Their Impact on Readmission”, we study a provider-initiated

xiii

connected healthcare model, which is a form of health delivery that connects patients and providers
through connected health devices and allow providers to monitor patient behavior and proactively
intervene before an adverse event occurs. Unlike the costs, the benefits of connected healthcare in
improving patient behavior and health outcomes are usually difficult to determine. In this chapter,
we examine the efficacy of a connected health system that aimed to reduce readmissions through
improved medication adherence. Specifically, we study 1,000 patients with heart disease who
received electronic pill bottles that tracked medication adherence. Patients who were non-adherent
received active social support that involved different types of feedback such as text messages
and calls.

By integrating data on adherence, intervention, and readmission, we aim to (1)

investigate the efficacy of connected healthcare in promoting medication adherence, (2) examine
the relationship between medication adherence and readmission, and (3) develop a dynamic
readmission risk-scoring model that considers medication adherence and use the model to better
target non-adherent patients.
In chapter three, ”The Impact of Video Visit Availability on Care Utilization”, we study a
patient-initiated connected healthcare model known as video visits or tele-visits. Video visits allow
patients to remotely connect at any time of day or night with their providers through a computer,
smart phone, or tablet. This chapter investigates the impact of video visit availability at a large
academic medical center on in-system care utilization using difference-in-differences and discusses
the next steps in our work towards understanding how video visit availability impacts the choices
that patients make when they are sick.

xiv

CHAPTER 1 : Assessing the Impact of Service Level when Customer Needs are
Uncertain: An Empirical Investigation of Hospital Step-Down Units
Joint work with Carri W. Chan, Linda V. Green, Lijian Lu, and Gabriel Escobar

1.1. Introduction
Hospitals are responsible for the largest component of national health care expenditures and are
therefore under pressure from government and private payers to become more cost efficient (Centers
for Medicare & Medicaid Services 2016). Traditionally, inpatient care at hospitals had been defined
by two levels of care: Intensive care units (ICUs) and general medical/surgical wards (wards). With
one nurse per one or two patients, ICUs provide the highest level of care and are very costly to
operate, with annual costs in the U.S. between $121 and $263 billion (i.e., 17.4%-39% of total
hospital costs; Coopersmith et al. 2012). In an effort to mitigate critical care costs, Step-down units
(SDUs), sometimes called transitional care or intermediate care units, have been used to provide an
intermediate, third level of care for semi-critically ill patients who are not severe enough to require
intensive care but not stable enough to be treated in the ward. SDUs typically have one nurse per
three to four patients and are generally less expensive to operate than ICUs primarily due to lower
nurse-to-patient ratios. On the other hand, SDUs are more expensive than general wards where
there are, generally, about 6 patients per nurse. With the use of SDUs becoming more widespread,
it is of growing importance for hospital administrators and healthcare providers to have a better
understanding of the benefits and best practices associated with using this intermediate level of
care.
At a conceptual level, the hospital and ICU/SDU/ward system can be thought of as a general service
system with three levels of service and heterogenous customers. The levels are nested, in the sense
that the lowest level (ward) has the least capabilities and can only provide service to a subset of
customers (patients); the second level (SDU) can provide service to the lowest level customers
plus additional customers with greater needs; and the highest level (ICU) can provide service

1

(theoretically) to all customers. Due to higher staffing levels as well as specialized equipment,
higher levels of care are more costly to provide. It is of interest to understand whether such a
structure is beneficial and, if so, how to best utilize the different levels of service. This is more
challenging when there is uncertainty concerning which customers are best served at each level,
making it very difficult to evaluate the cost-benefit tradeoffs. The ultimate goal is to understand
effective management of such a service system, including capacity management of each level of
service, when and how to route customers, as well as how to classify customers and identify their
needs for the different levels of service.
There has been a considerable amount of research into capacity management of service systems and
the development of routing policies to different service types (e.g., Wallace and Whitt 2005, Gurvich
et al. 2008). Such issues have been studied in various service settings including call-centers (e.g.,
Gans et al. 2003), hospitals (e.g., Armony et al. 2018, Best et al. 2015), cloud-computing (e.g.,
Maguluri et al. 2012), among many others. A common assumption in these works is a general
understanding of the relative costs and benefits associated with different customer groups receiving
service from the various server types. Yet, in some contexts these relative costs and benefits may
not be known. Specifically, the needs of customers may be uncertain prior to starting service. In
this work, our goal is to gain an understanding of how best to use different levels of service to
serve customers with uncertain needs by empirically examining how different customer groups are
impacted by being served at differing levels. We examine this question in a healthcare context–the
SDU.
There is a lack of consensus in the medical community surrounding the use of SDUs as well as a lack
of substantive evidence concerning their effectiveness. Still, many hospitals have SDUs and others
are considering introducing these units. Even within a single hospital, the use of SDUs is generally
not standardized. Therefore, it is very important to understand their value and how they can best be
used. This paper examines whether or not SDUs are associated with improved operational and/or
clinical outcomes for different types of patients. In this context, the aforementioned costs and
benefits are not necessarily financial in nature. For instance, they can correspond to deteriorations
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or improvements in patient outcomes. Such analysis can provide insights into how the nested
levels of care structure could be used to treat patients with differentiated service requirements and
potentially lower hospital operating costs without sacrificing patient outcomes. Given the increasing
pressures for hospitals to reduce costs and improve quality, such insights can be very valuable to
hospital administrators. More broadly, this analysis may also provide insights into the analysis and
management of other service systems with different levels of care (e.g., call centers).
To the best of our knowledge, our work is the first to conduct a multi-hospital study to empirically
examine the role of an SDU for patients who are discharged from the ICU as well as those who are
admitted from the Emergency Department (ED). Our analyses are based on recent data from Kaiser
Permanente Northern California, an integrated health care delivery system serving 3.6 million
members that operates 21 hospitals, some of which do and some of which do not have SDUs. The
cohort and type of data we employ have been described in previous studies (see Escobar et al. 2013
and Kim et al. 2015, among others). Our data source is based on nearly 170,000 hospitalizations in
a total of 10 hospitals over a course of one and half years. Each of the 10 hospitals in our study has
an ICU and SDU, though the number of beds in each of the units varies across hospitals.
There are a number of challenges which arise when trying to understand the impact of SDU care
on patient outcomes. One challenge is that there are limited studies regarding its efficacy and, more
specifically, which patients can be safely admitted to the SDU (Nasraway et al. 1998). While there
is some evidence that some ICU patients who are at low risk of needing life support could be given
less intensive care in an SDU with no impact on outcomes (e.g., Zimmerman et al. 1995), there is
also evidence that some critical care patients who are treated in SDUs or general wards instead of
the ICU are worse off (e.g., Simchen et al. 2004). As such, it seems that there are patients who may
benefit from being cared for in an SDU rather than in a general ward, while others who are treated in
an SDU rather than an ICU may suffer adverse consequences. An important empirical challenge is
to be able to classify patients in order to accurately assess the impact of SDU admission on patient
outcomes. To that end, we initially segregate patients who are candidates for SDU care into two
broad groups: those who are discharged from the ICU and those who are admitted to an inpatient
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unit from the ED. Taking a data-driven approach, we then stratify patients from the ED into highand low-severity groups.
In developing an understanding of SDUs, we face an important estimation challenge. The SDU
admission decision may be affected by health factors which are known to the physician at the time
of the decision, but are unobservable in the data. For instance, a patient’s physical appearance (i.e.,
whether he/she appears ashen or pale) may provide evidence of early shock. Thus, a physician
may determine that, despite relatively stable vital signs and lab scores, a patient who is pale and
sweating will benefit from SDU care relative to being sent to the general medical ward. But because
the patient is more critical than the average ward patient, he/she is also more likely to have worse
outcomes. Similarly, it may be more appropriate to admit a patient to the ICU if he is cognitively
impaired and not lucid. Thus, patients who are admitted to the SDU instead of the ICU may be
healthier by unobservable measures. Ignoring this potential endogeneity could result in biased
estimates. To address this challenge, we utilize an instrumental variable approach to identify the
desired effects.
Our empirical findings suggest that SDU care is associated with substantial improvements in various
patient outcomes for patients discharged from the ICU as well as low-severity patients being
admitted from the ED. However, we find that SDU admission is associated with worse outcomes
for high-severity patients coming from the ED. Our results suggest that when SDUs are used as
originally intended, as intermediary units for post-ICU care, they may result in improved outcomes
relative to ward care. However, if hospital administrators wish to expand the use of SDUs beyond
post-ICU care, it is important to be able to classify which patients should or should not be treated
in the SDU. More generally, our findings highlight the importance of being able to accurately
classify customers and to quantify the (dis)utility associated with different service capabilities when
considering routing decisions.
The rest of the paper is organized as follows. We conclude this section with a brief summary of
related papers in the literature. In Section 1.2, we introduce our study setting and describe our data,
including the two patient cohorts we study. In Section 1.3, we describe our econometric model for
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our first cohort of patients–those being discharged from the ICU. The estimation results for this
cohort is provided in Section 1.4. Section 1.5 describes how we partition patients who are admitted
from the ED into high and low-severity patients and then discusses the econometric model we use
for these patients. Results for these patient types are provided in Section 1.6. Section 1.7 provides
concluding remarks as well as discussions for future research.
1.1.1. Literature Review
Our work is related to existing literature in both the operations management and medical
communities. Within the operations literature, our work is related to three streams of research: 1)
management of general service systems, 2) management of healthcare operations, and 3) empirical
analysis of healthcare operations.
There has been a large body of literature examining how to route customers to servers with different
skill sets (see the survey article Gans et al. (2003) and the references therein). Research in this area
has considered customer prioritization (e.g., Mandelbaum and Stolyar 2004, Gurvich and Whitt
2009), customer routing (e.g., Bell and Williams 2001, Tezcan and Dai 2010), and staffing (e.g.,
Wallace and Whitt 2005, Gurvich and Whitt 2010). Additionally, there have been a number of works
studying service settings with different levels of service. In call-centers, one can consider human
servers as providing more intense and costly service than chat-room or automated response systems
(e.g., Gans et al. 2003, Tezcan and Behzad 2012, Luo and Zhang 2013, Tezcan and Zhang 2014).
Maglaras and Zeevi (2005) considers pricing, admission control, and the design of a mechanism to
relay congestion information in a system where servers can provide either a guaranteed service rate
or a best-effort service rate. In call center settings, VIP customers often require a higher level of
service than the typical customer, raising questions on how to route customers to various servers
(e.g., Gans et al. 2003). Such features also arise in healthcare settings including the SDU we study
in this paper. Chan et al. (2013) considers how to prioritize burn-injured patients for treatment
in hospitals with burn-units which provide the specialized, intense therapies (e.g., skin grafting
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surgeries) required for severely burned patients versus other hospitals with less intense treatment
capabilities.
The nested structure of the different levels of care we examine in the hospital setting bears
similarities to the gate-keeper literature (e.g., Shumsky and Pinker 2003, Hasija et al. 2005, Lee
et al. 2012) where the specialist is able to provide services the gate-keeper is not able to. However,
in contrast to this literature, in our setting, the lowest level of service does not make the decision to
route customers to higher levels of service as in the gate-keeper literature. The nested structure is
also related to the classic toll-booth problem considered in Edie (1954) as certain lanes can serve
all types of vehicles, while others can only serve a subset of them (e.g., Green 1985). Rather than
having a central planner making routing decisions for customers whose needs may be unknown to
him/her, in the toll-booth problem, the customers know their needs and self-direct to servers.
There are a number of papers which utilize stochastic modeling and queueing approaches to study
resource allocation in hospital settings (e.g., Mandelbaum et al. 2012, Shi et al. 2016, Huang et al.
2015, Huh et al. 2013, Barz and Rajaram 2015). In all of these works, the focus is on admitting
patients with heterogeneous needs to different units within the same level of care. That is, servers
are interchangeable. In contrast, our work considers the impact of admitting patients to different
levels of care. In doing so, we are able to capture heterogeneous service requirements of customers
(patients) as well as the various levels of service (care).
There has been a growing body of work in healthcare operations management using mathematical
models to manage heterogeneous patients in systems with differentiated server types. Best et al.
(2015) examines how to determine the amount of flexibility allowed in hospital wings in order to
minimize costs associated with lack of access to care. Dai and Shi (2017) uses an approximate
dynamic programming approach to determine how to allocate patients to primary and non-primary
units. Armony et al. (2018) uses fluid and diffusion models to determine allocation among expensive
resources (ICU beds) that can be used to treat all patient types rather than cheaper resources (SDU
beds) that can only treat a subset of patients. An underlying assumption in all of these works is that,
in addition to a patient’s type, the relative costs (i.e., degradation of patient outcomes) to treat that
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patient in different types of units are known. Our aim is to provide a framework to classify patients
as well as to provide rigorous, quantitative estimates of the outcomes for patients treated in an SDU.
As we take an empirical approach to quantify the costs/benefits of treating patients in the SDU,
our work is closely related to papers in the empirical operations management literature, especially
those focused on healthcare settings. Jerath et al. (2015) empirically estimates how customers’
service needs impact their preferences to use different types of service channels when interacting
with a health insurance call center. In hospital settings, Stowell et al. (2013), Kim et al. (2015),
and Kuntz et al. (2019) take an empirical approach to explore the impact of admitting patients to
different types of hospital units on patient outcomes. While these works highlight the undesirability
of ‘off-placement’, Wang et al. (2019b) explicitly considers how information on hospital (server)
quality needs to be patient-specific. As such, while hospitals are capable of treating all different
types of patients, which is similar to the SDU, the costs/benefits associated with being treated at
a specific hospital are quite varied. Unfortunately, it is not always possible to treat patients at the
most appropriate hospital or hospital unit. Congestion is a common reason for this lack of access to
care. There have been a number of studies examining the impact of congestion and lack of access to
care on patient outcomes (e.g., Kc and Terwiesch 2012, Kuntz et al. 2015, Berry Jaeker and Tucker
2017). Batt and Terwiesch (2017) and Freeman et al. (2016) empirically examine how less or more
skilled servers can be used to treat some patients during congested periods. In a similar vein, we
examine how treating different patient types in an SDU, which is a higher level of care than the
ward, but lower than the ICU, impacts their outcomes.
There is a lack of consensus within the medical community about the role of the SDU. Those
who advocate the use of SDUs see them as an alternative to either maintaining larger ICUs or
jeopardizing patient care due to premature, demand-driven, discharge of patients from ICUs to
general care units. As the name suggests, the initial role of SDUs was to serve as a transition
for patients after being discharged from the ICU. In practice, SDUs are often used to treat other
patients, for example, those who might have gone to an ICU but were blocked because the ICU was
full. In general, the use of SDUs has evolved without substantial evidence as to their benefits and
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what their role should be. On one hand, some studies argue that SDUs are a cost-effective approach
to treat patients by providing a safe and less expensive environment for patients who are not quite
sick enough to require treatment in the ICU, but not quite stable enough to be treated in the ward.
Without an SDU, most of these patients end up being cared for in the ICU. Byrick et al. (1986)
suggests that the use of the SDU could alleviate ICU congestion by reducing ICU length-of-stay
(LOS) without increasing mortality rates. This reduction is possible because patients do not have to
reach as high a level of stability to be discharged to an SDU rather than to a general medical-surgical
ward. Other studies that have shown the cost-effectiveness of an SDU include Harding (2009), Stacy
(2011), and Tosteson et al. (1996). On the other hand, a survey of studies on SDUs raises doubts
about these benefits and argues that there is not enough evidence of cost-effectiveness (Keenan
et al. 1998). While we do not explicitly consider the cost-effectiveness of SDUs (due to lack of
detailed financial data), our study provides some insight into these questions by providing rigorous
and robust estimates to the effectiveness of SDUs for patients of varying types. At a high-level, one
can project ordinal cost estimates due to the lower (higher) staffing levels in the SDU versus the
ICU (ward). From a methodological standpoint, our study differentiates itself in that the majority
of these studies are conducted exclusively within a single hospital, whereas our study utilizes data
from 10 different hospitals. Additionally, rather than conducting a before-and-after study, which
may be limited by the inability to control for temporal changes such as staffing changes or closures
of nearby hospitals, we utilize an instrumental variable approach to identify the impact of different
care pathways (going to the SDU versus ward following ICU discharge as well as going to the
SDU versus ward or ICU upon hospital admission from the ED). Our multi-center study provides
compelling evidence that there are some patients for whom SDU care is associated with improved
clinical outcomes, while there are others for whom SDU care is associated with worse clinical
outcomes. As such, our results suggest that it would be of value for the medical community to focus
more attention on developing an understanding of which patients would or would not benefit from
SDU care at hospitals of varying patient mix and resource availability. More broadly, our results
suggest that one must be prudent when introducing multiple levels of service in service systems
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with highly heterogeneous customers as there can be substantial variation in the costs and benefits
associated with (incorrectly) routing customers to these servers.
Our estimation approach utilizes an instrumental variable which is based on an operational
measure–congestion in an inpatient unit–as has been done in Kim et al. (2015) and Kc and Terwiesch
(2012), among others. While the general methodology is similar, the question we are considering is
wholly different. The aforementioned works focus on the ICU, while our focus is on the SDU. From
an operational standpoint, it is of value to develop an understanding of how servers with lower costs
due to lower staffing levels (SDUs) may be used to serve heterogeneous customers. Additionally,
from the viewpoint of clinicians and hospital administrators, these units are fundamentally different
in their use and role. As a customer’s type and, subsequently, his service requirements are not
always observable to managers of the service system, it can be challenging to estimate the costs and
benefits associated with being served by particular server types. This challenge arises in the SDU
setting because they serve as the site of intermediate care between the ICU and the ward; that is,
there are risks of adverse consequences in admitting a patient to the SDU who actually needs ICU
care, as well as benefits to admitting patients who might be too sick for the ward. As such, we first
take a data-driven approach to help classify customers (patients) before estimating the impact of
SDU care on patient outcomes.

1.2. Setting and Data
We utilize patient data from 10 hospitals from Kaiser Permanente Northern California1 , containing
165,948 hospitalizations over a course of one and a half years. We note that even within the Kaiser
Permanente Northern California system, there is no consensus on how to use SDUs. Thus, some
hospitals have SDUs, while others do not.
Our data contains operational and patient level information. Operational level information includes
every unit to which a patient is admitted during his hospital stay along with the date and time
1
This project was approved by the Kaiser Permanente Northern California Institutional Review Board for the
Protection of Human Subjects, which has jurisdiction over all study hospitals, and the Columbia University Institutional
Review Board for the Protection of Human Subjects.
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of admission and discharge for each unit. Our objective in this work is to understand the impact
of service by flexible servers (SDU care) on heterogeneous customer (patient) types. Table 1
summarizes the distribution of where patients come from immediately preceding their SDU visit.
Over 78% of patients in the SDU come from the ED or ICU. As such, our analysis will focus on
these two patient cohorts. Specifically, we will focus on how transfer to the SDU impacts patients
who are admitted to an inpatient unit from the ED as well as patients who are discharged from the
ICU to lower levels of care. Figure 1 depicts these two transfer decisions that will be the heart of our
empirical investigation. Given the contrasting routes to the SDU of these patients, it is reasonable to
assume the impact of SDU care may differ substantially and our objective is to rigorously estimate
the treatment effect of SDU care for these heterogeneous patient types.
Table 1: Distribution of Units Preceding the SDU
Unit Preceding SDU
ED
ICU
Ward
Post-Anesthesia Recovery Unit (PAR)
Operating Room (OR)
Other/Unknown

Percentage
60.93%
17.11%
13.88%
4.25%
3.58%
0.25%

ICU

ED

SDU

Discharge from the ICU

Transfer from
the ED

Ward

Figure 1: Types of Admission Decisions
For each inpatient unit in each hospital, we use these patient flow data to derive hourly occupancy
levels and we define its capacity as the maximum occupancy level over the time horizon of our study.
Table 2 summarizes the capacity for each of the different levels of inpatient care in each hospital.
While each level of care may have further divisions based on specific services, e.g., medical versus
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surgical ICU, clinicians and administrators at the study hospitals indicate that it is widely accepted
practice at their hospitals to consider the boundaries as somewhat fluid in the sense that if a medical
service patient requires ICU care, but there are no medical ICU beds available, he will likely be
cared for in the surgical ICU. We observe substantial heterogeneity across these hospitals; the SDU
capacity varies from 11 to 32 beds and the number of ICU beds in a given hospital ranges from one
half to twice the number in the SDU.
Table 2: Capacity of Various Inpatient Units in Terms of Number of Beds
Hosp
1
2
3
4
5
6
7
8
9
10

ICU
11
11
16
16
16
23
24
26
31
32

SDU
24
25
14
19
24
19
20
27
11
32

Ward
61
76
77
76
78
124
145
110
188
100

Our dataset also contains information about patient characteristics such as age, gender, admitting
diagnosis and three different severity scores. One score (LAPS2) is based on lab results taken
72 hours preceding hospital admission and the second (COPS2) is based on comorbidities, such
as diabetes, that may complicate patient recovery. These severity scores are assigned at hospital
admission and are not updated during the hospital stay (more details on these scores can be found
in Escobar et al. 2008, 2013). The third severity score is the simplified acute physiology score 3
(SAPS3), which is a common severity score used exclusively for ICU patients (see, e.g., Strand and
Flaatte 2008, Mbongo et al. 2009, Christensen et al. 2011).
1.2.1. Data Selection
Since we study two different transfer decisions (from the ED and from the ICU), we form two
separate patient cohorts: an ICU Cohort and an ED Cohort. Our data selection process is depicted
in Figure 2. Because we use the patient flow data to determine the occupancy level (and capacity)
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for each unit, we first restrict both of our cohorts to the 12 months in the center of the 1.5 year
time period in order to avoid censored estimates. A patient’s admission category is defined as
a combination of whether or not they were admitted through the ED, and whether they were
admitted to a medical or surgical service resulting in 4 categories: ED-medical, ED-surgical,
non-ED-medical, or non-ED-surgical. We primarily focus on patients who are admitted via the ED
to a medical service for two major reasons. First, this group is the largest, consisting of about 60%
of the patients treated in these hospitals, and is similar to the cohort considered in Kim et al. (2015).
Second, the care pathways of surgical patients tend to be fairly standardized (e.g., Gustafsson et al.
2011, Lassen et al. 2013, Miller et al. 2014, Thiele et al. 2015), especially for non-ED-surgical
patients, which is the larger of the two surgical groups. In contrast, the care pathways of ED-medical
patients are more variable. It is this variability we will leverage in our identification strategy (see
Sections 1.3 and 1.5).

ICU Cohort
Many SDUs are designed as true ‘step-down units’, where patients can only be admitted following
ICU discharges (e.g., Eachempati et al. 2004). Moreover, the ICU is the second most frequent unit
from which SDU patients are transferred. Thus, our first cohort considers patients discharged from
the ICU to either the SDU or ward. To form the ICU Cohort, we consider patients who are admitted
to the ICU at least once during their hospital stay. For each patient, we focus on the initial ICU
admission within each hospitalization. We exclude patients who die in the ICU or are discharged
directly home from the ICU, since there is no decision about whether to route these patients to the
SDU or ward following ICU discharge2 .

ED Cohort
Over 60% of SDU patients are admitted from the ED. For these patients, we consider the ED to
inpatient unit admission decision. The three possible units a patient can be admitted to are the ICU,
2

We consider analysis including these patients in our robustness checks.
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Total hospitalizations:
165,948*

Admitted during the 1-year
period: 130,698

Never admitted to ICU:
62,422 (80.63%)

OutǦofǦhospital or nonǦ
Ward/SDU units :
3,938(26.26%)

Admitted outside the study
period: 35,250 (21.24%)

Admitted as Surgical or nonED patients: 53,280
(40.77%)

Admitted as ED-Medical:
77,418

Out-of-hospital or nonICU/SDU/Ward units:
3,333 (4.30%)

Admitted to
ICU/SDU/Ward after
1st ED: 74,085**

Admitted to ICU at
least once: 14,996

ED Cohort
Admitted to
Ward/SDU after
1st ICU : 11,058**
ICU Cohort
* to determine capacity and occupancy
** patient cohorts used in our econometric model

Figure 2: Data Selection
the SDU, or the Ward. We exclude the less than 5% of ED-medical patients who go directly to the
Operating Room (OR) or Post-Anesthesia Recovery unit (PAR) from the ED.
Table 3 provides some summary statistics of these two cohorts. The SDU introduces a third level
of care that, ideally, will be used to treat moderate to low-severity patients, but not high-severity
patients. Our goal is to understand how service in this unit impacts quality of service, as measured
by patient outcomes across different patient types. In doing so, we can gain a better understanding
of the costs and benefits associated with utilizing a three levels of care structure to provide service
to heterogenous customers.
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Table 3: Summary Statistics of Patient Demographics

Variable
Age
Male
LAPS2
COPS2
SAPS3
ED LOS (hrs)
Total LOS (hrs)
ICU LOS (hrs)
LOS before ICU (hrs)

Mean
67.68
0.47
74.70
46.18
1.46
108.89

ED Cohort
SD
Min
17.53
18
0.50
0
37.35
0
44.21
0
N/A
2.20
0.02
162.71 0.90
N/A
N/A

Max
111
1
272
290
118.68
13138.50

Mean
68.13
0.55
75.13
46.63
45.41
1.57
235.53
61.87
32.99

ICU Cohort
SD
Min
15.91
18
0.50
0
49.10
0
44.61
0
11.79
15
2.73
0.02
362.38 6.20
84.75 0.02
108.88
0

Max
105
1
262
267
100
118.68
13138.50
2279.17
4877.58

Notes: LAPS2 is a severity score based on lab results taken 72 hours preceding hospital admission.
COPS2 is a severity score based on comorbidities. SAPS3 is a severity score used for ICU patients.

1.2.2. Patient Outcomes
We consider four patient outcomes:

(1) in-hospital death (M ortality), (2) remaining

hospital length-of-stay (HospRemLOS), (3) hospital readmission (HospReadm), and (4) ICU
readmission (ICU Readm) for ICU patients.
The outcome HospRemLOS is defined as the remaining time spent in the hospital following the
transfer decision. Thus, for patients in the ED Cohort, this will be their total inpatient LOS; for
patients in the ICU Cohort, this will be the remaining time spent in the hospital following ICU
discharge.
HospReadm2w is defined as hospital readmission within two weeks after leaving the hospital (e.g.,
see Doran et al. (2013) and Ouanes et al. (2012) which use these durations). In calculating hospital
readmission rates, we exclude patients with in-hospital death. We also do robustness checks for
different time windows for hospital readmission.
Following Brown et al. (2013) which aims to define reasonable time windows for ICU readmission,
we consider ICU Readm2d (ICU Readm5d ) which indicate ICU readmission within two (five)
days following ICU discharge. This measure is studied only for the ICU Cohort. We also do
robustness checks for different time windows for ICU readmission.

14

Table 4 summarizes these patient outcomes for the two cohorts.
Table 4: Summary Statistics of Patient Outcomes: Mean (Number of Observations or Standard
Deviation for Continuous Variables)

Outcome
Mortality
HospRemLOS (days)
HospReadm - 2 weeks
ICUReadm - 2 days
ICUReadm - 5 days

ICU
Mean (N/SD)
0.12 (8,630)
6.67 (11.51)
0.12 (7,629)

ED Cohort
SDU
Mean (N/SD)
0.04 (14,832)
4.23 (5.89)
0.11 (14,269)
N/A
N/A

Ward
Mean (N/SD)
0.03 (50,623)
4.05 (5.79)
0.10 (49,206)

ICU Cohort
SDU
Ward
Mean (N/SD) Mean (N/SD)
0.06 (3,832)
0.07 (7,226)
7.24 (14.76)
5.13 (10.91)
0.14 (3,585)
0.13 (6,685)
0.04 (3,832)
0.05 (7,226)
0.08 (3,832)
0.06 (7,226)

1.2.3. Hypotheses
As there are various flows of patients into the SDU, we expect the impact of admission to the
SDU to vary across different patient types. In particular, there is evidence that SDU care may
improve or degrade patient outcomes (e.g., Zimmerman et al. 1995, Simchen et al. 2004). Thus, we
hypothesize that the SDU is beneficial or detrimental depending on patient type and severity–it will
help moderate- to low-severity patients, but hurt high-severity patients. More formally, we outline
our hypotheses below.
As SDUs were initially developed with the intent to provide a ‘step-down’ from the ICU, we expect
that ICU clinicians use SDUs appropriately:
Hypothesis 1 (ICU patients) Patients discharged from the ICU will have better outcomes (lower
mortality and readmission rates and shorter LOS) if admitted to the SDU rather than the ward.
For patients admitted from the ED, the impact of SDU care is likely to be more nuanced.
Specifically, this is a highly heterogenous group. We will describe how we partition patients into
low, medium, and high-severity groups in Section 1.5. The majority of patients admitted to the
hospital from the ED do not go to the ICU (Kim et al. 2015). Thus, we expect that for most patients
(i.e., low- and medium-severity patients), being treated in the SDU will either improve or have no
impact on their outcomes. On the other hand, the sickest patients should be admitted to the highest
level of care, so being admitted to the SDU is likely to result in worse outcomes. Note that in the
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following, we assume that low-severity patients are rarely admitted to the ICU while high-severity
patients are rarely admitted to the ward.
Hypothesis 2 (Low-Severity ED patients) Low-severity patients admitted from the ED will have
no worse, and possibly better outcomes (lower mortality and readmission rates and shorter LOS),
if admitted to the SDU rather than the ward.
Hypothesis 3 (Medium-Severity ED patients) Medium-severity patients admitted from the ED
will have no worse, and possibly better outcomes (lower mortality and readmission rates and shorter
LOS), if admitted to the SDU rather than the ward. On the other hand, they will have have no better,
and possibly worse outcomes, if admitted to the SDU rather than the ICU.
Hypothesis 4 (High-Severity ED patients) High-severity patients admitted from the ED will have
worse outcomes (higher mortality and readmission rates and long LOS) if admitted to the SDU
rather than the ICU.

1.3. ICU Cohort: Econometric Approach
We begin by explicitly stating our fundamental research question for the ICU cohort: Following ICU
discharge, is SDU care associated with better patient outcomes than those for patients receiving
ward care and, if so, what is the magnitude of the improvement? By exploring these questions,
we will develop some insight into the value of differentiated levels of service (i.e., SDU versus
ward) for one customer type (ICU patients). In Section 1.5, we expand our analysis to understand
the impact of this level of service on additional patient types, providing insights into the role of
customer differentiation.
1.3.1. Econometric Challenge: Endogeneity
Our objective is to utilize retrospective patient data to determine if ICU patients who are transferred
to the SDU have better outcomes than those transferred to the ward. Because we are using
retrospective data, an estimation challenge arises due to the fact that the routing decision following
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ICU discharge is likely correlated with patient outcomes. To highlight this challenge, we start with
the following reduced form model for hospital LOS:

log(HospRemLOSi ) = βXi + γADM IT SDUi + νh(i) + i

(1.1)

where Xi is a vector of control variables including patient characteristics (e.g., age) and seasonal
factors (e.g, admission time of day), ADM IT SDUi is an indicator variable that equals 1 if patient
i is transferred directly to the SDU following ICU discharge, h(i) is the hospital where patient i is
treated, νh(i) is the hospital fixed effect and i denotes the error term. See Table 14 in the Appendix
for more details on control variables. While we include controls for patient severity, unobservable
patient severity measures may be correlated with both HospRemLOS and ADM IT SDU . That
is, sicker patients are more likely to be transferred to the SDU than the ward, but are also more
likely to have bad outcomes. As such, our estimates for γ may be biased and we may erroneously
conclude that going to the SDU hurts patients. To overcome this potential endogeneity bias, we
utilize an identification strategy using Instrumental Variables (IVs).

Instrumental Variable
A valid instrument should be 1) correlated with the endogenous variable, ADM IT SDUi , and 2)
unrelated to the unobservable factors captured in i which affect patient outcomes. We propose to
use congestion in the SDU one hour before the ICU discharge as an IV. In particular, we define
SDU Busyi as an indicator variable that equals one when the number of available beds in the
SDU one hour prior to patient i’s discharge from the ICU is less than or equal to two, and zero
otherwise3 . On average, about 11% patients are discharged from the ICU when the SDU is busy
(SDU Busy = 1), though this varies quite a bit across hospitals (see Table 15).
When controlling for various patient characteristics in a Probit regression model, we also find at
the 0.1% significance level that when the SDU is busy, patients are less likely to go to the SDU.
In particular, we estimate that, on average, 21.14% percent of patients are routed to the SDU if
3

We also do a number of robustness checks by considering different specifications of SDU Busyi .
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SDU Busy = 1 and this percentage increases to 35.91% if SDU Busy = 0. Namely, a congested
SDU is predicted to result in a 47% reduction in the likelihood of the SDU admission. Hence,
condition 1 is satisfied.
We now consider Condition 2 and consider whether SDU Busyi is uncorrelated with unobservable
factors in patient outcomes captured in i . Since we cannot examine unobservable measures, we
use patient severity, SAP S3, as a proxy for those unobservable factors. In particular, we perform
a two-sample Kolmogorov-Smirnov test (see Gibbons and Chakraborti 2011 for details) to test
the hypothesis that the distribution of SAPS3 for patients who are discharged from ICU when
SDU Busy = 1 is not statistically different to that when SDU Busy = 0. The p-value for the
combined Kolmogorov-Smirnov test is 0.136. Thus, we cannot reject the null hypothesis and believe
that patients who are discharged from the ICU when SDU Busy = 1 are statistically similar to
patients who are discharged from the ICU when SDU Busy = 0. For completeness, we also check
this for the LAPS2 score, which is assigned at the time of hospital admission. The p-value of the
combined Kolmogorov-Smirnov test is 0.334.
Kc and Terwiesch 2012 demonstrates that ICU congestion could result in early discharge, which
could, in turn, affect the routing decision of ICU patients. While ICU congestion has been used as
an IV in a number of hospital studies (e.g., Kc and Terwiesch 2012, Kim et al. 2015), we find that
ICU congestion is not a valid IV. This is because the impact of ICU congestion does not exhibit a
consistent effect on routing post-ICU patients, i.e., a congested ICU could result in both a higher
and a lower percentage of patients being admitted to the SDU depending on a patient’s severity
score. Moreover, we find that the ICU congestion is correlated with a patient’s SAPS3 and LAPS2
score.
We also considered using a number of additional instrumental variables. Specifically, we considered
a measure of the average severity of other patients in the ICU, a measure of how the discharged
patient compares to the severity of other patients in the ICU, and a measure of severity for the most
recently discharged ICU patient. We find that all of these measures are correlated with the SAPS3
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and LAPS2 scores, suggesting they may also be correlated with unobservable measures of severity,
thereby invalidating these variables as potential instruments.
1.3.2. Econometric Model
Continuous outcome models
We now present our estimation model for our continuous outcome, HospRemLOS. Since the
ICU to SDU routing decision, ADM IT SDUi , is a binary variable, we model the ICU discharge
decision via a latent variable model.
ADM IT SDUi∗ = Xi θ + αSDU Busyi + ωh(i) + ξi ,
ADM IT SDUi = 1 {ADM IT SDUi∗ > 0} ,
log(HospRemLOSi ) = Xi β + γ · ADM IT SDUi + δ · AvgOccV isitedi + νh(i) + εi ,
(1.2)

where ADM IT SDUi∗ is a latent variable which represents the propensity towards SDU admission;
Xi is a vector of control variables for patient information; ωh(i) is the hospital fixed effect; and, ξi
represents unobservable factors that affect the routing at ICU discharge. For the outcome equation,
νh(i) is the hospital fixed effect; and εi captures unobservable factors that affect patient outcomes.
Because congestion during a patient’s hospital stay could impact the patient’s outcomes (see Kuntz
et al. 2015 and Kc and Terwiesch 2012), we also control for the daily average occupancy level,
denoted as AvgOccV isitedi , patient i experiences for all inpatient units s/he is admitted to after
leaving the ICU and before leaving hospital. We also conduct robustness checks for different
specifications of occupancy during the stay, as well as with such a control excluded. Kim et al.
(2015) provides additional discussion regarding the necessity of such a control.
The error terms (ξi , εi ) in (1.2) may be correlated to model the endogeneity between the routing
decision at ICU discharge and the patient outcome. We assume that (ξi , εi ) follows a Standard
Bivariate Normal distribution with correlation coefficient ρ. This model can be jointly estimated
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using a treatment effect model via Full Maximum Likelihood Estimation (FMLE) (Greene 2012).
A likelihood ratio test of null ρ = 0 can be used to test the presence of endogeneity.

Discrete outcome models
For the binary outcomes (M ortality, HospReadm, ICU Readm), we modify Equation (1.2) by
replacing the continuous patient outcome with a probit model. Specifically, we have:
ADM IT SDUi∗ = Xi θ + αSDU Busyi + ωh(i) + ξi ,
ADM IT SDUi = 1 {ADM IT SDUi∗ > 0} ,
yi∗ = Xi β + γ · ADM IT SDUi + δ · AvgOccV isitedi + νh(i) + εi ,
yi = 1 {yi∗ > 0}

(1.3)

where yi∗ is a latent variable which represents the propensity for the outcome. Similar to before,
we assume that (ξi , εi ) follows a Standard Bivariate Normal distribution with correlation coefficient
ρ. This Bivariate Probit model can be jointly estimated via FMLE (see Cameron and Trivedi 1998,
Greene 2012). The presence of endogeneity can be tested through a likelihood ratio test of null
ρ = 0.
For ICU readmission, we modified AvgOccV isitedi to be the daily average occupancy level
that patient i experiences in all inpatient units s/he is admitted to between two consecutive ICU
admissions.
1.3.3. Impact of Congestion on ICU LOS
Kc and Terwiesch (2012) found evidence that when ICUs are highly congested, current ICU patients
may be demand-driven discharged, in order to accommodate incoming demand of more severe
patients. Kim et al. (2015) found that patients admitted to a medical service from the ED do
not seem to be susceptible to such demand-driven discharges. While we look at a similar group
of patients to Kim et al. (2015), one potential concern is that we only consider patients treated in
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hospitals with SDUs, while Kim et al. (2015) includes hospitals with SDUs as well as those without.
Thus, it is possible that the presence of an SDU makes it more likely for medical patients who were
admitted to the hospital via the ED and are being treated in the ICU to be demand-driven discharged;
thus, making it possible that these types of discharges occur in our dataset. A patient who is
demand-driven discharged is by definition, discharged earlier than under ordinary circumstances
and therefore more critical than if he were discharged later at a more appropriate time. So such a
patient is more likely to be admitted to the SDU, but also more likely to have bad outcomes. If this
were the case, this could cause a downward bias of our results.
To check this, we estimated the following reduced form model:

log(ICU LOSi ) = ηXi + κICU Busyi + υi

(1.4)

to explore whether ICU LOS is reduced when the ICU is busy. We estimate κ to be −0.05 with
standard error 0.04. Thus, consistent with Keenan et al. (1998) and Kim et al. (2015), we do not find
evidence that patients are demand-driven discharged. To dig a little deeper, we examined whether
the SDU congestion had an impact on whether patients are demand-driven discharged. To do this,
we enhance our regression model to include a measure of SDU congestion:

log(ICU LOSi ) = ηXi + κICU Busyi + φSDU Busyi + ψ (ICU Busyi × SDU Busyi ) + υi
(1.5)
In particular, we would expect demand-driven discharges to be most common when the ICU is busy
and the SDU is not. Table 5 summarizes these results with the base case of both the ICU and SDU
not being busy (81.5% of time). We find that the coefficients have very large standard errors and are
not statistically significant. While it is possible that lack of statistical power is the reason we do not
find evidence to support the hypothesis that a busy ICU may result in demand-driven discharges, we
find that our sample size would need to be larger than 350,000 for the estimated coefficients to be
statistically significant when using the approach in Gelman and Hill (2006).
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Table 5: Effect of ICU Busy and SDU Busy on ICU LOS
Parameter
κ
φ
ψ

ICU Busy
1
0
1

SDU Busy
0
1
1

Estimate (SE)
-0.057 (0.040)
-0.039 (0.039)
-0.034 (0.096)

# Observations: Total = 11,058
855
1,056
136

Notes: Standard error in parentheses. + (p < 10%),∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).

Our IV analysis is based on the evidence that a busy SDU decreases the likelihood of SDU
admission. However, it is also possible that patients may stay longer in the ICU when the SDU
is busy, making them more stable upon discharge from the ICU and potentially biasing our results.
To test this hypothesis, we ran the reduced form model in Equation (1.4), but with SDU busyi as an
explanatory variable. We find the coefficient for SDU Busyi to be -0.02 with standard error 0.03.
This is consistent with the results in Table 5, which suggests that the relationship between a busy
SDU and ICU LOS is not statistically significant. As an additional check, we ran a hazard rate model
to examine the impact of SDU Busy after controlling for patient characteristics, seasonality, and
hospital fixed effects. Again, we see that a busy SDU does not have a statistically significant effect
on the likelihood of ICU discharge. Thus, we do not find evidence to support that the busy-ness of
the SDU impacts ICU LOS.

1.4. ICU Cohort: Results
We start by exploring the impact of SDU care on patients being discharged from the ICU. Because
we jointly estimate the SDU admission decision and patient outcomes, using FMLE, the impact of
SDU Busyi may vary slightly for different outcomes. That said, we observe that the differences
are very minor. For illustrative purposes, we note that the coefficient for the impact of SDU Busyi
in the Mortality model is −0.5110 with standard error 0.0503 and p-value < 0.1%.
As we are primarily interested in estimating the causal effects of SDU admission on patient
outcomes, we report only the coefficient of SDU admission on the patient outcomes, i.e., γ in (1.2)
and (1.3). Table 6 summarizes the relationship between SDU admission right after ICU discharge
and patient outcomes. The sign of SDU admission is negative and statistically significant in all
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Table 6: Estimated Effect of SDU Admission Following ICU Discharge (γ) on Patient Outcomes
and Correlation Between Error Terms (ρ) for the Admission Decision and Patient Outcomes: N =
11, 058

Outcome

γ (SE)

M ortality
log(HospRemLOS)
ICU Readm2d
ICU Readm5d
HospReadm2w

-0.60∗∗ (0.22)
-0.35∗∗∗ (0.10)
-0.51∗∗ (0.20)
-0.51∗∗ (0.18)
-0.43∗ (0.21)

With IV
Predicted Outcome
P̂SDU Busy=0 P̂SDU Busy=1
8.24%
9.93%
3.77
4.05
5.22%
6.38%
8.18%
9.83%
14.02%
15.26%

Without IV
ρ (SE)
0.26+ (0.14)
0.44∗∗∗ (0.05)
0.32∗ (0.12)
0.36∗∗ (0.11)
0.21+ (0.12)

Test
ρ=0
0.07
0.00
0.02
0.05
0.09

γ (SE)
-0.18∗∗∗ (0.05)
0.38∗∗∗ (0.02)
0.01 (0.05)
0.09∗ (0.04)
0.05 (0.04)

Notes: Standard error in parentheses. + (p < 10%),∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
Predicted outcome: P̂SDU Busy=0 - Average predicted outcome if the SDU was never busy
P̂SDU Busy=1 - Average predicted outcome if the SDU was always busy.
Predicted HospRemLOS (days) is shown instead of log(HospRemLOS)

outcome measures, suggesting that routing an ICU discharge to the SDU is associated with improved
patient outcomes. To get a rough estimate of the magnitude of the effects we have estimated, we
also use our estimation results to predict patient outcomes under two extreme scenarios: (i) the SDU
has ample capacity and is never busy (referred to as P̂SDU Busy=0 ) versus (ii) the SDU is always
busy (P̂SDU Busy=1 ). There are some patients who are stable enough that even if there were ample
capacity in the SDU, they would not be admitted to the SDU. Instead they would be sent to the
ward, irrespective of the SDU bed availability. Using the first stage of our models, we estimate
the likelihood of SDU admission depending on whether the SDU is busy or not, and then use our
second stage results to estimate the likely patient outcome. We find that, on average, availability of
SDU care is associated with significant improvements in patient outcomes: the relative reduction is
17% in the likelihood of in-hospital death, 0.28 fewer remaining hospital days, 18% (17%) in the
likelihood of ICU readmission within 2 (5) days, and 8% in the likelihood of hospital readmission
within 2 weeks. Based on the size of our cohort, we estimate eliminating SDU busy-ness would
translate into annual savings of 187 lives, 3,096 hospital days, 128 (182) ICU readmissions in 2 (5)
days, and 137 hospital readmissions in 2 weeks (weekly savings of 3.6 lives, 59.5 hospital days, 2.5
(3.5) ICU readmissions, and 2.6 hospital readmissions) aggregated across the 10 hospitals.
Our empirical findings also suggest strong evidence of an endogeneity bias between the routing
following ICU discharge and patient outcomes. The p-value of the likelihood ratio test with null
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hypothesis that the correlation between the two error terms in our model ρ = 0 is small, as seen in
Table 6, implying a strong correlation between the routing at ICU discharge and patient outcomes.
Ignoring this endogeneity tends to result in underestimates of the benefit of SDU care and could
result in a qualitatively different insight; see the column titled with “Without IV”.
1.4.1. Robustness Checks
We now describe a number of robustness checks for our main results. First, we tried different
specifications of control variables. Recall that, some of our control variables – age, severity scores
(LAPS2, COPS2, SAPS3), length-of-stay at ICU, and length-of-stay before ICU admission – are
modeled as spline variables to account for their possible non-linear effects on the ICU to SDU
routings and patient outcomes. We repeated the analysis with different specifications, including
changing the number of cutoffs and values of these cutoffs. Our results are qualitatively similar to
these changes.
The second robustness check we did is with respect to specifications for the congestion experienced
by a patient during the hospital visit (AvgOccV isited in Equations (1.2) and (1.3)). We considered
specifications which exclude this control as well as ones that examine the maximum occupancy in
any unit during a patient’s hospital stay. All specifications yield similar results to those reported in
Table 6.
Another factor which could be impacting our results is “do not resuscitate (DNR)” orders, which
are patients’ end-of life wishes not to undergo Cardiopulmonary resuscitation (CPR) or advanced
cardiac life support if their heart were to stop or they were to stop breathing. In speaking with
intensivists, we learned it is possible that patients with DNRs are more likely to be sent to the
ward, but also may be more likely to die, resulting in an overestimate of the effect of SDU care.
Unfortunately, we do not have access to patients’ DNR status, so cannot control for this. That said,
DNR orders only represent 9% of ICU patients (Jayes et al. 1993), so this is likely to affect only
a small percentage of patients. Additionally, there is evidence that DNR orders do not change the
quality of care (Baker et al. 2003). We do not expect DNR orders to impact our results for hospital
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readmission since we exclude patients who died in hospital in this model. For the LOS models, we
also considered the robustness of our results to including patients with in-hospital death. We find
that our results are very robust.
We also considered alternative specifications for the length of time window for readmission. For
ICU readmission, we varied the time window of the ICU readmission from time of ICU discharge
from 2 to 7 days and also during any time frame during the same hospital stay. Only the results for
ICU readmission within 2 days were statistically significant, though the sign of the coefficient was
negative in all models. For hospital readmission, we consider hospital readmission within 1 week,
2 weeks, and 30 days after a patient is discharged from the hospital. We found that while SDU
admission is associated with lower hospital readmission risk, the effect is weaker when the elapsed
time between two consecutive hospital stays is longer.

Definition of our IV
We also consider various definitions of a busy SDU. First, we considered different cutoffs for the
number of available beds, ranging from one bed to four. On average, the percentage of patients,
who are discharged from the ICU when the SDU is congested, varies from 34% to 3% when
the cutoff is decreased from four beds to one (Table 15). The capacity of the SDU was defined
as the maximum occupancy level over the 12-month time horizon in our study. While capacity
changes in the hospitals we study are very rare, we also allow for the bed capacity (defined as the
maximum occupancy level) to change over time. Specifically, we define a time-varying capacity
as the maximum occupancy level over three non-overlapping 4-month periods during the total
12-month time horizon.
Note that while we find our IV to be statistically significant based on various definitions of bed
capacity, it can be very challenging to accurately determine the number of beds available in a unit.
This is because capacity depends on multiple factors including the number of physical beds, but
also the number of nurses and physicians available to staff them. As such, we also considered
alternative measures of SDU congestion based on percentiles of the SDU occupancy level. We did
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this using a binary variable indicating whether the occupancy level exceeds a threshold percentile
as well as a piece-wise linear spline to potentially model non-linear effects of SDU congestion on
the SDU admission decision. Next, we considered different time lines for when SDU congestion
was measured: 1 hour (main specification), 2 hours and 6 hours before ICU discharge.
We find that the results for the mortality and LOS models to be very robust to the various
specifications with the coefficients all negative and all with the same order of magnitude. All
coefficient estimates have a p-value < 0.05, with most having a p-value p < 0.001. Interestingly,
the coefficient estimates for the ICU and hospital readmission models are all negative; however,
the statistical significance of the coefficient estimates varies substantially, with some specifications
indicating a p-value < 0.001 and others not being significant, even at the level of p-value < 0.1.
Thus, while our mortality and LOS results are quite robust, the readmission results do not seem to
be.

Patients discharged out of the hospital
In all of our analysis for the ICU cohort, we focused on patients who were discharged from the ICU
to the SDU or ward. While the majority of patients (83.82%) go to one of these units, a number
of patients are actually discharged directly out of the hospital from the ICU (see Table 16 in the
Appendix). Not surprisingly, patients who are discharged out of the hospital directly from the ICU
appear to be healthier (lower severity scores and younger) than those admitted to an inpatient unit
following ICU discharge. We find that if we include all patients who are discharged alive from
the ICU (to the SDU, ward or out of the hospital) instead of just those discharged to the SDU or
ward, the busy-ness of the SDU still has a statistically significant effect on the likelihood of SDU
admission following ICU discharge. In this analysis, we found evidence that patients are 1.77%
more likely to be discharged home alive when the SDU is busy (p < 0.05). As such, excluding
these patients from our analysis may bias our estimates to make the SDU seem more beneficial
than it is because the patients who end up staying in the hospital are sicker and SDU treatment
likely benefits them more. With this in mind, we re-ran our ICU and hospital readmission models
including patients discharged out of the hospital alive. Note that we do not examine our mortality
26

and LOS models as these are inpatient outcomes, and a patient who is discharged out of the hospital
alive will, by definition, have deathi = 0 and HospRemLOS = 0. We find that the coefficient
estimates for our readmission models are negative, but not statistically significant. This is consistent
with our other specifications which suggest that the readmission results are not very robust.

1.5. ED Cohort: Econometric Approach
In this section, we study the routing decision regarding the ED Cohort. We aim to empirically
estimate how SDU admission immediately following transfer from the ED affects patient outcomes,
comparing to ED patients who are transferred to the ICU or ward. Here, a similar estimation
challenge arises. Routing decisions are associated with patient severity and, thus, with patient
outcomes.
Kim et al. (2015) examined this problem in the context of admitting patients to the ICU from the ED.
In that paper, the goal was to estimate the impact of admitting a patient to the highest level of care,
i.e., the ICU versus elsewhere. In contrast, our objective is to understand the impact of admitting
patients to an intermediary level of care, the SDU. In contrast to the ICU case, it is possible that
the impact of SDU care could be positive, neutral or even negative. For instance, high-severity
patients who should be admitted to the ICU, but are instead admitted to the SDU may experience
worse outcomes as a result. On the other hand, SDU care may have no impact or even benefit
low-severity patients who would traditionally be cared for in the ward. There are limited objective
standards for who should be treated in the ICU (see Task Force of the American College of Critical
Care Medicine, Society of Critical Care Medicine 1999 and Kim et al. 2015), let alone for the SDU
(Nasraway et al. 1998). Thus, such categorizations of patients are likely to be highly varied across
different physicians. As such, we take a data-driven approach to stratifying patients by severity.
Such an approach could be useful in other service settings where precisely defining a customer’s
type is a challenging, but necessary, step toward determining the costs and benefits associated with
service by different server types.
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1.5.1. Severity Categorization
In order to estimate the impact of SDU care for patients admitted from the ED, we categorize
patients based on their severity and study each severity group separately. Specifically, we aim to
identify a ‘low-severity’ cohort, for which the decision is to admit patients to either the ward or
SDU, and a ‘high-severity’ cohort for which the decision is to admit to either the SDU or ICU. One
can also consider a ‘medium-severity’ cohort whose patients can be admitted to any one of the three
levels of care. Certainly, it seems reasonable to expect the decision to admit a patient to the SDU
will have a different impact on patients of varying severity.
We begin by considering how patient level characteristics influence whether a patient is admitted
to the ICU, SDU or ward from the ED. Specifically, we use our data to estimate an Ordered Probit
regression model using only patient characteristics.



W ard, if T x∗i 6 t1



T xi =
SDU, if t1 < T x∗i 6 t2




 ICU,
if t2 < T x∗i

and

T x∗i = Xi0 θ + ξi ,

(1.6)

where Xi0 is a vector of control variables for patient characteristics and ξi represents unobservable
factors.
∗
∗
We use the observed latent variable Tcxi = Xi0 θ to define each patient’s severity. Intuitively, Tcxi

is a linear transformation of patient characteristics into a single continuous variable which can be
∗
interpreted as a measure for the desired amount of care for the patient. The larger the value of Tcx ,

the more likely the patient will be routed to higher level units, e.g., the ICU; the lower the value, the
more likely a patient will be routed to the ward.
∗
We differentiate patient severity groups by partitioning the Tcxi space with thresholds. In theory, t1

and t2 from (1.6) partition the T x∗i space into patients who will be routed to the Ward, SDU, and
ICU, so that patients with T x∗i ≤ t1 could be classified as low-severity patients and patients with
T x∗i > t2 could be classified as high-severity patients. However, because we do not observe ξi ,
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∗

∗

we are only able to observe an estimate Tcxi , instead of T x∗i . Thus, some patients with Tcxi ≤ t1
∗
will be routed to the SDU, or even the ICU. Similarly, patients with Tcxi > t2 may be routed
∗

to the SDU or ward. Increasing t2 will increase the proportion of patients with Tcxi > t2 who are
routed to the ICU and simultaneously decrease the proportion who are routed to the ward. Similarly,
∗

decreasing t1 will increase the proportion of patients with Tcxi ≤ t1 being admitted to the ward and
decrease the proportion being admitted to the ICU. Of course, this also comes at the cost of reducing
the number of patients which satisfy these two criteria. Thus, we define the cutoffs to balance
increasing the proportion of patients in the high (low) severity group who are routed to the ICU
(ward) versus maintaining large enough patient cohorts to allow for meaningful statistical analysis.
The tradeoff we are concerned with is close thresholds lead to increases in patient spill-over into the
high or low-severity groups, resulting in patients who do not comply with our instrument, versus
far thresholds which reduce sample sizes, resulting in less statistical power. We use a data-driven
∗
approach and find that setting thresholds at the 95th and 60th percentiles of the distribution of Tcxi

seen in the data achieve this delicate balance. In Section 1.6, we discuss robustness checks using
different thresholds.
We expect that when the SDU is congested, patients will be less likely to be admitted (see Section
1.3). Thus, we examine where patients are admitted when the SDU is busy, defined as done in
Section 1.3. Figure 3 shows the proportion of high and low-severity patients admitted to each unit,
while Table 7 summarizes these results. Note that the ICU and SDU congestion have a correlation
coefficient of 0.08, so the busyness of the ICU does not factor substantially into these results.
Specifically, we ran t-tests comparing the proportion of patients admitted to each level of inpatient
unit when the SDU is busy versus not busy. As we can see, when the SDU is busy, low-severity
patients will be rerouted to the ward (p < 0.001), rather than the ICU (p = 0.327). Conversely,
when the SDU is busy, high-severity patients tend to be rerouted to the ICU (p = 0.002), rather than
the ward (p = 0.212). These results are suggestive that these severity categorizations are reasonable
for our purposes.
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∗
Note that one can also define a ‘medium severity’ group as patients with t2 ≤ Tcxi < t1 . While a

busy SDU does decrease the likelihood of SDU admission (Figure 3(b) and Table 7), the challenge
with this cohort is that some patients who are discouraged from being admitted to the SDU will be
admitted to the ICU, while others will be admitted to the general ward. Certainly, being bumped
to a higher versus lower level of care will have a substantial impact on patient outcomes. As
seen in Figure 3(b) and Table 7, there is a heterogenous effect of SDU Busy on these patients,
whereas high-severity patients are consistently bumped up to the ICU and low-severity patients are
consistently bumped to the ward. This suggests that within the medium-severity group a mix of
high- and low-severity patients are being admitted to the SDU, so SDU admission can be beneficial
or detrimental. By grouping these patients together into a medium severity classification, we cannot
tease out the true impact of SDU admission. Still, for completeness, we will include results for this
group of patients.
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Figure 3: Proportions of ED Patients Who Are Routed to the ICU, SDU, and Ward When
SDU Busy = 1 vs. SDU Busy = 0
As summarized in Table 8, for the high-severity group, 54.9% are admitted to the ICU, 20.76%
to the SDU, and 24.35% to the ward. For low-severity patients 4.65%, 14.73% and 80.62% are
admitted to the ICU, SDU, and ward, respectively. We can see that even with our classifications,
some high (low) severity patients will still be admitted to the ward (ICU). In order to focus on the
impact of SDU admissions on patient outcomes, we exclude high (low) severity patients who are
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Table 7: Proportions of ED Patients Who Are Routed to the ICU, SDU, and Ward When
SDU Busy = 1 vs. SDU Busy = 0 and Results of t-Tests That Compare the Difference in
Routing Proportions

Low Severity
Medium Severity
High Severity

SDU Busy = 0
ICU
SDU
Ward
4.62% 15.97% 79.14%
16.90% 31.05% 52.04%
53.60% 22.39% 24.01%

SDU Busy = 1
ICU
SDU
Ward
4.94%
5.23% 89.93%
21.84% 12.64% 65.51%
63.38% 10.06% 26.56%

ICU
0.327
0.013
0.002

p-value of t-test
SDU
Ward
< 0.001 < 0.001
< 0.001
0.001
< 0.001
0.212

∗

Notes: Severity thresholds, t1 and t2 , defined by 95th and 60th percentiles of Tcxi .

routed to the ward (ICU). For the medium-severity group, we consider patients admitted to all three
levels of care as it is not clear whether the ICU or ward is the ‘more desirable’ unit if the SDU is
not available. Tables 9 and 10 report summary statistics of patient demographics and outcomes for
each severity group.
Table 8: Routing Statistics of Patients for Different Severity Groups
Unit following the ED
ICU
SDU
Ward

Low Severity
Frequency Percentage
2,067
4.65
6,549
14.73
35,836
80.62

Medium Severity
Frequency Percentage
4,529
17.47
7,514
28.98
13,885
53.55

High Severity
Frequency Percentage
2,034
54.90
769
20.76
902
24.35

∗

Notes: Severity thresholds, t1 and t2 , defined by 95th and 60th percentiles of Tcxi .

Table 9: Summary Statistics of Patient Demographics for ED Cohort by Severity Classification
Variable
Age
Male
LAPS2
COPS2
ED LOS (hrs)

Mean
67.48
0.43
59.48
41.96
1.38

Low Severity
SD
Min Max
18.57 18
107
0.49
0
1
26.89
0
158
41.21
0
285
1.99 0.02 62.73

Mean
67.63
0.54
89.22
50.86
1.56

Medium Severity
SD
Min
Max
15.96 18
111
0.50
0
1
32.53
0
200
46.53
0
290
2.41 0.02 118.68

Mean
70.36
0.57
155.57
64.13
1.66

High Severity
SD
Min
Max
14.74 18
102
0.50
0
1
31.85 16
272
53.64
0
278
2.92 0.02 113.50

Notes: LAPS2 is a severity score based on lab results taken 72 hours preceding hospital admission.
COPS2 is a severity score based on comorbidities. SAPS3 is a severity score used for ICU patients.
∗
Severity thresholds, t1 and t2 , defined by 95th and 60th percentiles of Tcxi .

1.5.2. IV Justification
We are again faced with the econometric challenge of endogeneity bias. Our econometric model is
very similar to that of (1.2) and (1.3). The main difference is that for low (high) severity patients,
ADM IT SDUi is equal to 1 if the patient is admitted to the SDU and 0 if to the ward (ICU).
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Table 10: Summary Statistics of Patient Outcomes for ED Cohort by Severity Classification: Mean
(Number of Observations or Standard Deviation for Continuous Variables)

Outcome
Mortality
HospRemLOS (days)
HospReadm - 2 weeks

Low Severity
SDU
Ward
Mean (N/SD) Mean (N/SD)
0.02 (6,549) 0.02 (35,836)
3.97 (5.85)
3.95 (5.21)
0.10 (6,431) 0.10 (35,258)

Outcome
Mortality
HospRemLOS (days)
HospReadm - 2 weeks

SDU
mean (N/SD)
0.04 (7,514)
4.20 (5.15)
0.12 (7,202)

High Severity
SDU
ICU
Mean (N/SD) Mean (N/SD)
0.17 (769)
0.27 (2,034)
6.68 (10.54)
9.35 (14.22)
0.17 (636)
0.16 (1,483)

Medium Severity
Ward
Mean (N/SD)
0.04 (13,885)
4.22 (6.67)
0.11 (13,310)

ICU
Mean (N/SD)
0.08 (4,529)
6.11 (11.77)
0.12 (4,156)
∗

Notes: Severity thresholds, t1 and t2 , defined by 95th and 60th percentiles of Tcxi .

For medium-severity patients, ADM IT SDUi is equal to 1 if the patient is admitted to the SDU
and 0 if to the ward or ICU. Detailed descriptions of the covariates are shown in Table 14 in the
Appendix. Similarly, we also control for AvgOccV isitedi , i.e., the daily average occupancy level
patient i experiences for all inpatient units s/he is admitted to after leaving the ED and before leaving
hospital.
Similar to our models for the ICU Cohort, we consider using SDU Busyi as an instrumental
variable. Additionally, we consider using ICU Busyi as an instrument as Kim et al. (2015) found
that it is a good instrument when studying patients who are or are not admitted to the ICU, which is
similar to our high-severity group. Specifically, we define SDU Busyi (ICU Busyi ) as an indicator
variable that equals one when the number of available beds in the SDU (ICU) one hour prior to
patient i’s transfer from the ED is less than or equal to two, and zero otherwise. On average, the
proportions of patients who are transferred from the ED when the SDU is busy and the ICU is busy
are approximately 12% and 6%, respectively.
As discussed previously, in order for a variable to be a valid instrument, it has to be 1) correlated
with the endogenous variable, ADM IT SDUi , and 2) unrelated to the unobservable factors which
affect patient outcomes. As seen in Table 7, when the SDU is busy, patients are less likely to be
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admitted to the SDU. However, we find that ICU congestion does not appear to have a monotonic
effect on SDU admission for low- or medium-severity patients. Specifically, we observe in Figure
∗
4 that when we partition the (a) low- or (b) medium-severity patients into deciles of Tcxi , ICU

congestion increases the percentage of SDU admissions for some patients, while it has no effect or
even decreases the percentage of SDU admissions for other patients. Therefore, we conclude that
ICU Busyi is not a valid instrument for low- or medium-severity patients. We see these effects
more concretely when we analyze a Probit regression model, which controls for various patient
characteristics and operational controls. We find with 0.1% significance level that SDU congestion
reduces the likelihood of SDU admission for both low, medium and high-severity patients, and that
ICU congestion increases the chance of SDU admission for only high-severity patients. The impact
of ICU congestion for low- and medium-severity patients is not statistically significant.

(a) Low Severity

(b) Medium Severity

Figure 4: Percentage of (a) Low- or (b) Medium-Severity Patients Admitted to the SDU from the ED
When the ICU Is Busy (ICU Busy = 1) or Not (ICU Busy = 0) for Varying Levels of Severity as
∗
∗
Measured by Deciles of Tcxi , Given Patients Are Classified as Low Severity: Tcxi ≤ t1
We next examine whether our instruments are correlated with observable measures of severity. We
again perform a two-sample Kolmogorov-Smirnov test to test the hypothesis that the distribution
of LAPS2 is not statistically different when SDU Busy = 1 (ICU Busy = 1) from that
when SDU Busy = 0 (ICU Busy = 0).

For low-severity patients, the p-value for the

Kolmogorov-Smirnov test is 0.135, thus, we conclude that patients who leave the ED when
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SDU Busy = 1 are statistically similar to those who leave the ED when SDU Busy = 0. For
medium-severity patients, the p-value for the Kolmogorov-Smirnov test is 0.120. For high-severity
patients, the p-values are 0.141 and 0.358 for SDU Busy and ICU Busy, respectively. Therefore,
our models for low- and medium-severity patients use SDU Busyi as an instrument, while both
SDU Busyi and ICU Busyi are used in the models for high-severity patients.

Additional Instruments
Apart from the congestion in the ICU and the SDU, we also consider other potential behavioral
IVs discussed in Kim et al. (2015). The first factor is RecentDischargeSDU
, which accounts
i
for the number of all SDU discharges in the 3-hr window before patient i’s admission to
the first inpatient unit.

The second behavioral factor, RecentAdmissionSDU
, accounts for
i

the number of SDU admissions in the 3-hr window before patient i’s admission to the first
inpatient unit. To define RecentDischargeSDU
and RecentAdmissionSDU
, we normalize the
i
i
number of discharges or admissions by the SDU capacity of each hospital. The third factor,
LastAdmitSeverityiSDU , measures the severity of the last patient admitted to the SDU from the
ED. We also consider RecentDischargeICU
, RecentAdmissionICU
, LastAdmitSeverityiICU ,
i
i
which are defined the same way but instead involve the ICU. Most of these variables demonstrate a
heterogeneous impact on the SDU admission decision; for instance, amongst low-severity patients,
RecentAdmissionSDU
will increase the likelihood of SDU admission, while it will decrease
i
likelihood for other patients. We find that only RecentAdmissionICU
is a valid instrument and is
i
valid only for high-severity patients. However, we do not include this as a third IV for high-severity
patients in our main specifications because the results are similar.

1.6. ED Cohort: Results
We now present our main results for our ED cohort on the impact of SDU admission on patients
being admitted to an inpatient unit from the ED. We start with the two patient cohorts for which the
routing decision is more straight-forward (low- and high-severity patients). Then, for completeness,
we include the results for the medium-severity patients.
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1.6.1. Low Severity
For low-severity patients, a busy SDU is associated with a decrease in likelihood of SDU admission.
For the mortality model, the coefficient on SDU Busyi is −0.5117 with standard error 0.0376 and
p-value < 0.1%. The results are similar for the other patient outcome models.
Table 11 summarizes our results. We find that SDU care may benefit low-severity patients.
Specifically, we find that SDU care is associated with lower mortality rate and shorter hospital
remaining length-of-stay, as seen in the negative sign of SDU admission coefficient. We also
present the predicted patient outcomes under two extreme scenarios: (i) the SDU is never busy
(P̂SDU Busy=0 ) and (ii) the SDU is always busy (P̂SDU Busy=1 ). Our results indicate that, on average,
availability of SDU care is associated with a reduction in mortality by 3.2% and 29 minutes of
hospital remaining length-of-stay. We note that the estimated marginal effects are quite small as
there is a substantial proportion (83%) of low-severity patients who will not be admitted to the SDU
even when the SDU is not busy. As such, the outcomes for these patients will be agnostic to whether
the SDU is busy, since they will be admitted to the ward either way. Thus, our estimates are only
for the remaining 17% of low-severity patients whose routing from the ED is dictated by the state of
the SDU. We do not find a statistically significant relationship between SDU care and the likelihood
of hospital readmission within 2 weeks. Based on the size of the low severity cohort, we estimate
eliminating SDU busy-ness would translate into annual savings of 34 lives and 979 hospital days
(weekly savings of 0.65 lives and 18.8 hospital days) aggregated across the 10 hospitals.
1.6.2. High Severity
We find that a busy SDU is associated with a decrease in likelihood of SDU admission for
high-severity patients, while a busy ICU is associated with an increase in likelihood of SDU
admission. For the mortality model, the coefficient on SDU Busyi is −0.6325 with standard
error 0.1043 and p-value < 0.1%; for ICU Busyi , the coefficient is 0.4072 with standard error
0.1352 and p-value < 0.1%. The results are similar for the other patient outcome models. Table
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Table 11: Estimated Effect of SDU Admission Following the ED (γ) on Patient Outcomes for
Low-Severity Patients and Correlation Between Error Terms (ρ) for the Admission Decision and
Patient Outcomes: N = 42, 385

Outcome

γ (SE)

M ortality
log(HospRemLOS)
HospReadm2w

-0.55∗∗ (0.28)
-0.20∗∗∗ (0.04)
-0.13 (0.12)

With IV
Predicted Outcome
P̂SDU Busy=0 P̂SDU Busy=1
2.16%
2.23%
2.92
2.94
-

Without IV
ρ (SE)
0.33+ (0.17)
0.18∗∗∗ (0.03)
0.09 (0.07)

Test
ρ=0
0.07
0.00
0.21

γ (SE)
0.06 (0.06)
0.03∗ (0.01)
0.02 (0.03)

Notes: Standard error in parentheses. + (p < 10%),∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
∗
Low severity threshold, t1 , defined by 60th percentile of Tcxi .
Predicted outcome: P̂SDU Busy=0 - Average predicted outcome if the SDU was never busy
P̂SDU Busy=1 - Average predicted outcome if the SDU was always busy.
Predicted HospRemLOS (days) is shown instead of log(HospRemLOS)

12 summarizes the impact of SDU admission after ED transfer on the various patient outcomes for
these patients.
For high-severity patients, being admitted to the SDU appears to be associated with worse outcomes,
as seen in the sign of SDU admission coefficient, which is positive and statistically significant in
all outcome measures. We again use our estimation results to predict the patients outcomes under
two cases: (i) the SDU is never busy and (ii) the SDU is always busy. Our results suggest that
being admitted to the hospital when the SDU is busy is associated with substantial degradation in
patient outcomes. SDU bed availability is, on average, associated with an increase of 12.1% in
in-hospital deaths, a 50.8% increase in hospital readmissions within 2 weeks, and .35 additional
days in the hospital. As with the ICU cohort, the marginal effects estimates are based on the
estimated treatment effect, which is averaged across all patients who comply with the instruments.
Thus, one should interpret our results as demonstrating substantive and rigorous evidence to the
statistical significance and direction of the treatment effect. Again, we see evidence of a correlation
between the SDU admission decision and patient outcomes with the estimated correlation coefficient
ρ being statistically different than 0. Based on the size of this cohort, we estimate eliminating SDU
busy-ness would translate into annual increases of 71 deaths, 981 more hospital days, and 173
additional hospital readmissions within 2 weeks (weekly increases of 1.37 deaths, 18.9 hospital
days, and 3.33 readmissions) aggregated across the 10 hospitals.
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The results for LOS and hospital readmissions are consistent with Kim et al. (2015). Interestingly,
we find that being admitted to the SDU is associated with an increase in mortality risk, while Kim
et al. (2015) did not find an impact of non-ICU care on mortality. One potential explanation is
that Kim et al. (2015) considered all patients admitted from the ED to a medical service, while we
stratify our analysis to focus on only the high-severity patients. As such, the results of Kim et al.
(2015) may be distorted as SDU care may improve mortality risk for some patients within their
cohort while also degrading mortality risk for other patients, thereby cancelling each other out. In
contrast, since we focus on patients who are more likely to be admitted to the ICU (i.e., 54.90%
compared to 11% in Kim et al. 2015), we are able to provide a cleaner estimate.
Table 12: Estimated Effect of SDU Admission Following the ED (γ) on Patient Outcomes for
High-Severity Patients and Correlation Between Error Terms (ρ) for the Admission Decision and
Patient Outcomes: N = 2, 803

Outcome

γ (SE)

M ortality
log(HospRemLOS)
HospReadm2w

0.75∗ (0.33)
0.45∗∗∗ (0.12)
1.27∗∗ (0.40)

With IV
Predicted Outcome
P̂SDU Busy=0 P̂SDU Busy=1
23.64%
21.09%
6.22
5.87
18.28%
12.12%

Without IV
ρ (SE)
-0.48∗ (0.18)
-0.57∗∗∗ (0.07)
-0.78∗ (0.20)

Test
ρ=0
0.03
0.00
0.04

γ (SE)
-0.05 (0.07)
-0.32∗∗∗ (0.04)
-0.08 (0.08)

Notes: Standard error in parentheses. + (p < 10%),∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
∗
High severity thresholds, t2 , defined by 95th percentile of Tcxi .
Predicted outcome: P̂SDU Busy=0 - Average predicted outcome if the SDU was never busy
P̂SDU Busy=1 - Average predicted outcome if the SDU was always busy.
Predicted HospRemLOS (days) is shown instead of log(HospRemLOS)

1.6.3. Medium Severity
We now consider the impact of SDU admission on medium-severity patients. For these patients, a
busy SDU is associated with a decrease in likelihood of SDU admission. For the mortality model
(when comparing admission to the SDU versus ICU or ward), the coefficient on SDU Busyi is
−0.5503 with standard error 0.0377 and p-value < 0.1%. The results are similar for the other
patient outcome models.
Because of the aforementioned substantial heterogeneity within the medium severity cohort, when
we run our models on this population, the results are not statistically significant and our instruments
do not seem to be able to address potential endogeneity biases (see Table 13). The only result that is
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statistically significant is the remaining hospital LOS when considering whether a patient is admitted
to the SDU versus ICU or ward. We’re not sure what to make of this result due to the substantial
heterogeneity of this group, as discussed before. We find that when the SDU is busy, patients are
more likely to be rerouted – lower severity patients tend to go to the ward, while higher severity
patients tend to go to the ICU. One possible explanation for the statistically significant effect on
hospital LOS is that the high-severity patients who are admitted to the SDU are less sick that those
who are not (and instead are sent to the ICU). Combining this with the lower severity patients
who benefit from SDU care results in a statistically significant effect. Unfortunately, because of
limitations in our data and the presence of unobservable factors, it is difficult to accurately assess
the severity of the patients in this particular cohort, so we cannot be sure what is driving this result.
Table 13: Estimated Effect of SDU Admission Following the ED (γ) on Patient Outcomes for
Medium-Severity Patients and Correlation Between Error Terms (ρ) for the Admission Decision
and Patient Outcomes
With IV
Outcome
γ (SE)
ρ (SE)
Test ρ = 0
SDU vs. Ward: N = 21, 399
M ortality
-0.19 (0.25)
0.13 (0.15)
0.38
log(HospRemLOS)
-0.02 (0.13)
0.10 (0.07)
0.14
HospReadm2w
0.32 (0.25)
-0.16 (0.15)
0.28
SDU vs. ICU: N = 12, 043
M ortality
0.07 (0.20)
-0.18 (0.13)
0.15
log(HospRemLOS)
-0.26 (0.08)
0.10 (0.06)
0.11
HospReadm2w
-0.15 (0.19)
0.09 (0.12)
0.46
SDU vs. ICU or Ward: N = 25, 928
M ortality
-0.23 (0.19)
0.10 (0.11)
0.37
log(HospRemLOS) -0.21∗∗ (0.07) 0.17∗∗ (0.05)
0.01
HospReadm2w
-0.01 (0.25)
0.03 (0.15)
0.86

Without IV
γ (SE)
0.02 (0.04)
0.08∗∗∗ (0.01)
0.05+ (0.03)
-0.22∗∗ (0.07)
-0.18∗∗ (0.03)
-0.01 (0.04)
-0.06+ (0.04)
0.00 (0.01)
0.03 (0.03)

Notes: Standard error in parentheses. + (p < 10%),∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
∗
Medium severity thresholds, t1 and t2 , defined by 95th and 60th percentiles of Tcxi .

While it is challenging to consider this medium-severity group and to interpret the results of our
estimations for these patients, we highlight that this does not change the fundamental result of our
work. In particular, we find that sending high-severity patients from the ED to the SDU when the
ICU is busy can have substantial adverse consequences. On the other hand, for some low-severity
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patients care in the SDU may be beneficial with regard to some patient outcomes. These results
indicate the need for further study of the use of the SDU for patients originating in the ED.
1.6.4. Robustness Checks
We now describe a number of robustness checks for our ED cohort. Due to the challenges associated
with the medium-severity patients, we focus our attention on the robustness of our results for the
low- and high-severity patients. Our initial robustness checks are very similar to those we did with
the ICU cohort. We tried different specifications of control variables, different time-lines for hospital
readmission (within 1 week, 2 weeks, and 30 days after a patient is discharged from the hospital),
and different ways to control for congestion during a patient’s stay (max occupancy and no control).
We also varied the definition of our instrument(s) by varying the number of available beds from one
to four, using indicator variables for whether the percentile occupancy level was above a threshold, a
spline variable for the percentile occupancy level, as well as a time-varying capacity measure based
on three 4-month periods. For our LOS models, we also considered specifications including patients
with in-hospital death.

Low-Severity Patients
For the low-severity patients, we found the results for LOS were very robust in sign, magnitude and
statistical significance for all of these different specifications, including when we include patients
with in-hospital death. The sign and magnitude for the in-hospital mortality results were also very
robust. When the IV of SDU busy was based on very limited bed availability (i.e., ≤ 1 free beds
or occupancy above the 95th percentile), the coefficient estimates were not statistically significant.
In these instances, we cannot reject the null hypothesis that the correlation between the two error
terms in our model is 0, i.e., ρ = 0. This suggests that in these instances, the instrument is not
able to adequately address the endogeneity biases in our data. We consistently found no statistically
significant association between SDU admission and hospital readmissions within 1 week, 2 weeks,
or 30 days.
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High-Severity Patients
For the high-severity patients, we found the results for HospRemLOS were very robust in sign,
magnitude and statistical significance for all of these different specifications. The mortality results
were also quite robust. However, when defining ICU Busy or SDU Busy with a relatively low
occupancy level (e.g., 80th percentile), the statistical significance of the coefficients can drop to
p-value < 10% or in some rare instances, is no longer statistically significant even at the 10% level.
In these instances, we cannot reject the null hypothesis that the correlation between the two error
terms in our model is 0, i.e., ρ = 0. This suggests that in these instances, the instrument is not able to
adequately address the endogeneity biases in our data. Similarly, the hospital readmission results are
always consistent in terms of sign and magnitude for these different specification. However, there
are some instances when the results are not statistically significant. These instances correspond
to when we cannot reject the null hypothesis that ρ = 0. This happens most frequently with
the 1 week time to hospital readmission. We also found that all of our results were robust to
including an additional instrumental variable based on the number of recent admissions to the ICU
(RecentAdmissionICU
).
i
For the LOS models, we also considered the robustness of our results to including patients with
in-hospital death. When including patients with in-hospital mortality in the high-severity ED
Cohort, the sign of γ is negative (−1.83) and statistically significant at the p-value < .01 level.
This raises questions as to the robustness of our LOS results for the high-severity group. However,
we believe the main results as reported are more likely to be aligned with the true effect direction and
size of SDU admission as it has been well established in the medical literature to exclude patients
with in-hospital death for LOS models (e.g., Rapoport et al. 1996, Norton et al. 2007).

Severity categorizations
In our severity categorizations for the ED Cohort, we took a data-driven approach and used
∗
thresholds on Tcxi to partition the patients into low- and high-severity groups. We varied the

thresholds for these categorizations from the 45th to 85th percentile for low-severity patients and
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from the 90th to 97th percentile for high-severity patients. We then examined the robustness of our
estimation results to these different thresholds.

Low-Severity Patients
As with our main specification, we do not find statistically significant results for the hospital
readmission models. We find that the results for HospRemLOS is very robust in magnitude and
statistical significance to all of the different specifications of the low severity threshold. While
the mortality results are robust to lowering the threshold, which reduces the sample size, we lose
statistical significance when increasing the threshold above the 60th percentile. This may be because
as the sample size is increased, there are (moderately) high-severity patients whose mortality risk
may suffer with SDU admission are included in the cohort. When examining the LOS results
more closely, we see that as the threshold is increased, the magnitude of the coefficient decreases,
suggesting that the low severity cohort is including more patients for which SDU care is detrimental.
Moreover, we cannot reject the null hypothesis that the correlation between our error terms is 0
(ρ = 0), which suggests that as the threshold increases, there are more non-compliers included in
the cohort, making the instrument ineffective to address the endogeneity issues.

High-Severity Patients
In our readmission models, increasing the threshold for high-severity patients above the 95th
percentile results in the regressions not converging. This is likely because the size of the cohort is
being made smaller and smaller, and there are not enough samples to solve the FMLE optimization.
These results suggest that the hospital readmission results are not very robust.
On the other hand, the HospRemLOS results are quite robust to changes in the threshold. Similar
to our observations for the low-severity patients, we see that as the threshold decreases, the
magnitude of the coefficient decreases. This may be because low-severity patients who benefit from
SDU care are entering into the high severity cohort as the threshold is decreased. A similar argument
can be made for the mortality results. We find that when the threshold for high-severity patients is
less than the 93rd percentile, the mortality and LOS results are no longer statistically significant.
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About 10% of the ED-medical patients are admitted to the ICU from the ED. Additionally, our
admission model in Equation (1.6) incorporates an unobservable term ξi , such that if the observed
∗
latent variable Tcxi plus ξi is above the threshold, the patient will be routed to the ICU. As the

threshold gets closer to the 90th percentile, there will be more spill over of patients for which SDU
care is beneficial (instead of detrimental).

1.7. Conclusions and Managerial Insights
This paper studies the role of different levels of service for customers with uncertain needs. We
examine this in a hospital setting where step-down units (SDUs) can be used to treat a variety of
patients with very different repercussions. We consider fundamental questions regarding the SDU:
Does admitting a patient to the SDU improve or degrade patient outcomes? What is the magnitude
of these effects? And, how does it vary across different types of patients? Our work represents an
important first step towards answering these questions. We find that while the answer for patients
discharged from the ICU (it’s original purpose) is fairly clear, for those admitted from the ED, it is
quite nuanced – some patients will benefit, while others will not. Moreover, the impact of SDU care
can be substantial, so it is essential to be able to carefully identify which patients are appropriate
for SDU care. These findings suggest that while different levels of service may be used to serve
multiple customer types, the costs and benefits associated with each level of service can be highly
heterogeneous due to the different and sometimes uncertain needs of customers.
There are a number of opportunities for future work. Our empirical analysis relies on the variation
in patient routings following ICU discharge or following admission from the ED due to SDU and/or
ICU capacity constraints. Consequently, our estimates fundamentally apply to patients whose
SDU admission comply with our instrumental variables. As such, it is not possible to make any
statements about the impact of SDU care for patients whose care pathway is invariant to SDU (or
ICU) bed availability. While it is difficult to extrapolate our results to make inferences on the precise
magnitude of the effect of the SDU on individual patients, our results demonstrate strong evidence
as to the directional impact of an SDU. Because SDUs go in and out of favor at individual hospitals,
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there may be opportunities for natural experiments to make such inferences without requiring an
instrumental variable analysis. Alternatively, at a hospital system such as Kaiser Permanente, it
might be possible to conduct a controlled randomized trial by randomizing which hospitals have
SDUs. Of course, such a study would require substantial buy-in from hospital administrators and
staff. Our empirical setting focuses on patients admitted to the hospital via the ED to a medical
service. A number of studies in the medical literature consider the impact of SDUs on surgical
patients (e.g., Eachempati et al. 2004). The impact of SDU congestion is likely very different for
surgical patients, where surgical procedures and schedules often dictate the precise care pathway for
these patients. Hence, an alternative identification strategy is likely needed. In other service settings
where experimentation is less costly (e.g., call-centers), randomized experiments may be a feasible
approach to providing unbiased estimates of costs and benefits for different customers. That said, as
routing of customers to servers in call-centers is often done by computers, the likelihood of biases
due to unobservable factors may be lower, so an IV approach or randomized experiment may not be
necessary in these settings.
Our approach to classifying patients could be used in other service settings where customers’ needs
are uncertain. For instance, in an increasing number of healthcare settings–including EDs, critical
care, primary care and oncology, among others–Physician Assistants (PAs) and Nurse Practitioners
(NPs) are used as lower cost alternatives to physicians (e.g., Hooker and McCaig 2001, Naylor and
Kurtzman 2010, Hinkel et al. 2010, Doan et al. 2011, Gershengorn et al. 2011, Green et al. 2013,
Gershengorn et al. 2016). PAs and NPs are trained in some, but not all, of the skills of physicians,
raising important questions as to which patient types and tasks can be safely and effectively handled
by these healthcare professionals rather than by a physician. In such instances, a data-driven
approach, such as the one taken in this paper, could be utilized to classify patients. It could also
be useful in other service settings in which servers have different skill levels, such as call-centers
or repair facilities, where customers are heterogeneous, but their needs are not known a priori.
With the growing availability of customer information (e.g., demographics, spending habits, etc.), a
data-driven approach to customer segmentation may be useful.
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From a stochastic modeling point of view, there are a number of directions that could build upon
this work. From the healthcare operations management standpoint, it would be interesting to study
optimal control policies regarding where to transfer patients from the ED or following ICU discharge
in the presence of an SDU. This would provide a system-level view that would capture the potential
benefits of an SDU, including externalities on other patients, beyond the estimates of individual
patients estimated in this work. This would complement the growing body of work which examines
how to make patient transfer decisions from the ED as well as inpatient units (e.g., Mandelbaum
et al. 2012, Barz and Rajaram 2015, Samiedaluie et al. 2017, Dai and Shi 2017, Kilinc et al. 2016).
Additionally, one could consider how to determine the capacity of the SDU relative to the ICU and
general ward given patient mix and arrival rates. One factor which would significantly impact this
decision is whether to restrict use of the SDU to be a true step-down versus allowing admission of
patients from non-ICU units, such as the ED. This work quantifies the impact of lack of access to
care for various patient types and could be used to set performance benchmarks or to calibrate a cost
minimization framework when determining bed capacity (e.g., Yankovic and Green 2011, Yom-Tov
and Mandelbaum 2014, Best et al. 2015, Armony et al. 2018). Analysis of these questions can also
provide insights into how to utilize nested levels of service and routing policies in other types of
service settings with heterogeneous customers (e.g., call-centers (Gans et al. 2003), retail stores,
restaurants, etc.). For instance, it would be interesting to understand what factors such as number
of customer types, differences in customer demand, service times, and costs impact the optimal
number of levels of service and the optimal capacity to allocate to each level.
In understanding the benefits of the nested structure, an interesting tradeoff arises where increasing
the number of levels reduces pooling benefits and may increase delays or reroutings. On the other
hand, increasing the number of levels of care allows for more specialization that may result in
efficiencies that reduce service times and improve outcomes. In many nested service systems,
including the hospital situation studied here, it would be interesting to examine the potential
tradeoffs between pooling and efficiency, similar in spirit to the work in Song et al. (2015) and
how this would impact the allocation of servers (e.g., beds) to different levels of care (e.g., Best
et al. 2015).
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1.8. Appendix: Supplementary Tables
Table 14: Control Variables for Patient Characteristics and Hospital Care
Variable
Gender
Age

LAPS2

COPS2

SAPS3

Admitting
diagnosis

Seasonality

Previous
unit
LOS
before
ICU

ICU LOS

ED LOS

Description
Dummy variable: male = 1; female = 0
Continuous variable: coded as piecewise linear spline
variables with knots at its 50th and 80th percentiles (65 and
81)
Laboratory-based Acute Physiology Score: measures
physiologic derangement at admission and is mapped from
14 laboratory test results such as arterial pH and white blood
cell count obtained 72 hours preceding hospitalization to
an integer value that ranges from 0 to 262 in our data
set (higher scores indicate poorer condition); coded as
piecewise linear spline variables with knots at its 50th and
80th percentiles (94 and 134)
Comorbidity Point Score: measures the chronic illness
burden and is based on 41 comorbidities, such as diabetes,
to which patients are categorized using outpatient and
inpatient data from the 12 months preceding hospitalization;
ranges from 0 to 267 in our data set, a higher score indicates
a higher comorbid illness burden; coded as piecewise linear
spline variables with knots at its 50th and 80th percentiles
(33 and 87)
Simplified Acute Physiology Score: measures the severity
of illness and predict vital status at hospital discharge
based on ICU admission data. SAPS3 score is associated
with each ICU admission and is calculated based on data
obtained within one hour of ICU admission; ranges from
14 to 100 in our data set; coded as piecewise linear spline
variables with knots at its 50th and 80th percentiles (52 and
61)
A way of classifying ICD9 codes: this clinical classification
system was developed by HCUP and buckets ICD9’s into
about 200 groups. A further grouping of the variable HCUP
developed by Gabriel Escobar to condense the HCUP
grouping into 38 groups so it could be used in a similar
fashion as PRIMCOND3.
Month/day-of-week/time-of-day: category variable for each
month and day-of-week. For time-of-day, we use category
variables for nurse shifts happening three times a day at
7am, 3pm, and 11pm.
Category variable to track inpatient unit a patient is admitted
to immediately before ICU admission.
Continuous variable that is the total length-of-stay (hours)
prior to the ICU admission; measures how long a patient has
been in hospital before being admitted to the ICU; coded as
piecewise linear spline variables with knots at its 50th and
80th percentiles (2 and 31).
Continuous variable that is the length-of-stay (hours) at the
first ICU: measures how long a patient has been in the ICU;
coded as piecewise linear spline variables with knots at its
50th and 80th percentiles (38 and 83).
Continuous variable that is the length-of-stay (hours) at the
first ED: measures how long a patient has been in the ED.

ICU Cohort
X
X

ED Cohort
X
X

X

X

X

X

X

X

X

X

X

X
X

X

X

Notes: To account for potential non-linear effects of some of the variables used to control for patient severity,
we code them as piecewise linear spline variables.
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Table 15: ICU Cohort: Percentage of Patients Who Are Discharged from ICU When SDU Is Busy

Hosp
1
2
3
4
5
6
7
8
9
10
All hosp

SDU Size
24
25
14
19
24
19
20
27
11
32

% When Number of Available SDU Beds
≤1
≤2
≤3
≤4
0.93 3.57
7.80
12.17
0.66 2.95
7.54
12.46
0.56 7.94 24.29
45.63
3.17 12.68 27.07
41.59
0.28 1.54
3.93
7.87
0.82 3.34
6.76
15.37
0.00 2.84 16.74
36.77
2.81 9.34 18.80
31.74
9.76 37.72 63.94
80.34
0.34 2.66
6.19
12.71
2.52 10.64 21.70
34.00

Table 16: Post-ICU Location
Unit
Ward
SDU
Death in ICU
Out of hospital (alive)
Total

Frequency
7,226
3,832
985
1,150
13,193

Percent
54.77
29.05
7.47
8.72
100

Table 17: Effect of SDU Admission Following the ED (γ) on HospRemLOS When Including
Patients with In-Hospital Death
Cohort

γ (SE)

ED Cohort - High Severity
ED Cohort - Low Severity

-1.83∗∗ (0.07)
-0.20∗∗∗ (0.04)

Predicted Outcome
P̂SDU
P̂ICU /P̂W ard
1.33% 8.31% (P̂ICU )
2.38
2.92 (P̂W ard )

ρ (SE)
0.81∗∗∗ (0.02)
0.18∗∗∗ (0.03)

Notes: Standard error in parentheses. + (p < 10%),∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
Predicted outcome: P̂SDU - Average predicted outcome if all patients could be routed to the SDU
and P̂ICU (P̂W ard ) if no SDU and everyone is routed to the ICU (Ward).
Predicted HospRemLOS (days) is shown instead of log(HospRemLOS)
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Test
ρ=0
0.00
0.00

CHAPTER 2 : Evaluating the Efficacy of Connected Healthcare: An Empirical
Examination of Patient Engagement Systems and Their Impact on
Readmission
Joint work with Christian Terwiesch, David A. Asch, and Kevin G. Volpp

2.1. Introduction
More than ever, technology is bringing businesses and customers closer together. In the past,
consumers and their banks would interact only sporadically in a retail branch. Now, online and
mobile banking connect the two parties almost seamlessly, creating a delivery model known as
connected banking. Similarly, automotive insurance companies used to interact with the drivers
they insured only at predefined touch points, such as policy renewals or claims events. Now, sensors
and mobile apps continuously monitor driving behavior. Such data enable a connected insurance
business model by providing safety feedback to drivers (and parents) as well as informing future
underwriting decisions.
The domain that we study in this paper is healthcare. In the past, before the possibility of being
connected technologically to the healthcare system, patients made decisions related to diet, exercise
regimen, or medication adherence without the involvement of care providers (Asch et al. 2012).
Now, connected health devices, such as smart pill bottles, connected scales, and wearable health
trackers, are capable of transmitting clinically relevant data to information systems that can then
relay this information to patients and providers. The promise of connected healthcare is that
such information allows healthcare providers to monitor health-related behavior and to proactively
intervene rather than waiting for an adverse event. Moreover, it has been suggested that patients
adjust their behavior in response to feedback, becoming more adherent in taking their medication
and more active in their lifestyle.
Active patient engagement and feedback systems have the potential to reduce the number of
preventable readmissions and ultimately reduce healthcare costs (Chouvarda et al. 2015). Despite
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this enormous upside, however, there is limited evidence for the effectiveness of connected
healthcare and little guidance on how to effectively implement it (Caulfield and Donnelly 2013).
One of the crucial health behaviors that may affect the readmission risk and have been the target
for improvement is medication adherence. Although the costs of implementation are usually
straightforward to estimate, the benefits of engagement systems to improve medication adherence
and the impact of higher adherence on readmission are oftentimes ambiguous. Moreover, it is
unclear how to effectively engage with non-adherent patients in order to minimize the number of
readmissions given limited resources.
The aims of our research are to (1) investigate the efficacy of connected feedback systems in
promoting medication adherence among patients, (2) examine the relationship between patient
medication adherence and readmission, and (3) develop a readmission risk-scoring model that
takes into account medication adherence and use the model to better target non-adherent patients.
Establishing how connected health systems causally affect clinical outcomes can be done only in a
large-scale randomized controlled trial. Running such an intervention requires overcoming multiple
challenges. First, one needs to recruit a large cohort of patients, equip them with connected devices,
and train them how to use the devices. Second, for patients to benefit from connected healthcare,
new delivery processes have to be designed and implemented. Third, one has to track patients in the
study not only during their usage of the connected healthcare devices, but also for a long period so
that the full scope of the clinical outcomes can be observed.
Our study is part of a larger research project that overcame these challenges by implementing one
of the largest clinical interventions related to connected healthcare that has been conducted so far.
This study, known as the HeartStrong study, enrolled 1,453 patients for a two-arm randomized
clinical trial with a year-long intervention that aimed to improve medication adherence and reduce
the number of readmissions after myocardial infarction. The 1,000 patients in the intervention
group received a compound intervention integrating wireless pill bottles that can electronically
track openings and transmit them to the care team, lottery-based incentives, and social support
that involved feedback systems such as automated messaging, manual messaging, and phone calls,
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delivered to either the patients themselves or their enlisted partner at increasing levels of escalation.
Patients were then tracked for 12 months, capturing any future hospital readmissions.
The results of the study were published in one of the leading medical journals (Volpp et al. 2017) and
did not show a statistically significant difference in readmission between the control group and the
intervention group. The lack of statistically significant difference begs the question of why patients
who were better connected to the healthcare system did not benefit in the form of better outcomes.
Did the various reminder and feedback interventions improve medication adherence? Did higher
rates of adherence reduce the likelihood of readmission? Did we sufficiently allocate our capacity
to the patients who were at high risk of readmission? Without a more micro-level theory, one can
only speculate.
The contribution of this study is to present such a micro-level operational model. To evaluate
the effectiveness of the connected health system, the HeartStrong study focused on the variation
between the control group and the intervention group and did not use any data related to behavioral
interventions and daily medication adherence. In contrast, the present study exploits variation within
the intervention group, leveraging the micro-level data capturing patient behavior and provider
actions at the patient-day level. At this micro level, hundreds of observations per patient (did patient
i receive an intervention j on day t?) were analyzed and linked with adherence behavior (did patient
i take medication k on day t?) and clinical outcomes (was patient i readmitted on day t?). This
allowed us to establish the following novel contributions:
1. Showing the impact of escalation strategies on medication adherence: By studying the
effect of different levels and dynamics of intervention escalation, we show that patients are
significantly more likely to become adherent when (a) they or their partners receive high levels
of intervention that involve personalized feedback like phone calls and manual messages
and (b) the intervention is escalated quickly and consistently. Our results imply that, in
order to effectively make a previously non-adherent patient adherent again, one should start
calling the patient as soon as he or she becomes non-adherent. Receiving a personal phone
call immediately after the first day of non-adherence more than doubles the probability of
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becoming adherent again. Then, if non-adherence continues, one should escalate to manual
messages and calls to the patient’s partner successively on the following days.
2. Showing the impact of medication adherence on readmission: We explore how consistency
in medication use in the past affects the readmission probability in the present. Specifically,
we show that, for patients with cardiovascular disease, long-term adherence to statins and
β-blockers is associated with a 51% reduction in the odds of being readmitted on any given
day, thus better medication adherence is strongly associated with reduced risk of readmission.
3. Developing a dynamic readmission risk-scoring model and using it to better target
non-adherent patients: Using multi-layer perceptron, we develop a dynamic readmission
risk-scoring model that includes patient-day level medication adherence as predictors. We
evaluate the model primarily using the area under the ROC curve and find that (a) the model
outperforms a baseline model that does not include medication adherence and (b) the model
outperforms other models developed using different machine learning methods. Moreover,
using counterfactual analysis, we apply the dynamic readmission risk-scoring model to our
setting and show that, when using an intervention strategy that prioritizes patient-days with
highest readmission risks, we obtain 10% fewer readmissions than we would obtain without
considering readmission risk while maintaining the same level of effort.
Our connected healthcare setting holds great significance because reducing readmission rates of
patients with heart failure is a national priority (Bradley et al. 2013). Nearly 20% of Medicare
beneficiaries discharged from the hospital are readmitted within 30 days, and these readmissions
have been estimated to cost the country more than $24 billion (Agency for Healthcare Research and
Quality 2014). Since a significant part of the readmission risk can be attributed to patients’ lack of
adherence to their prescribed medications, real-time adherence monitoring and reminder systems
hold particular promise.
The rest of the paper is organized as follows. We provide a brief summary of related papers in the
literature in Section 2.2. In Section 2.3, we introduce our study setting. We present the study on
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the impact of escalation strategies on adherence behavior and its estimation results in Section 2.4.
The study on the impact of medication adherence on readmission is presented in Section 2.5. We
develop a dynamic readmission-risk scoring model and apply it to our setting in Section 2.6. Section
2.7 provides concluding remarks as well as discussions for future research.

2.2. Literature Review
The adoption of remote monitoring and feedback has long been prevalent outside of the healthcare
industry.

Researchers in operations management have been interested in examining remote

monitoring, diagnosis, and feedback in manufacturing and other service settings. In manufacturing,
the focus is usually on monitoring people, processes, and machines. Information technology is often
adopted to reduce the cost of capturing, storing, and transmitting data to all members of the supply
chain as well as to enable useful feedback functions such as fault notification, remote counseling,
and real-time online help and process intervention. In service industries, remote monitoring and
feedback became popular thanks to the call for digitalization in services (Tan and Netessine 2019)
and the rapid growth of teleservices, which allow customers to receive service virtually at their
convenience and, at the same time, allow behavioral data to be collected and shared with service
providers. An increasing number of studies explore the prospects of utilizing such technologies
in popular service domains such as retail and banking, through the use of e-commerce and online
banking (e.g., Campbell and Frei 2010, Moon et al. 2018). In these service settings, real-time
information sharing and customer interaction can benefit service providers by helping them target
customers with specific price promotions, detect fraudulent activities, improve customer retention,
and increase market share. This leads to “connected strategies” that allow firms to build continuous
relationships with customers by having frequent, low-friction interactions with them and to address
their needs as or even before those needs arise (Siggelkow and Terwiesch 2019). Apart from
their use with customers, remote monitoring and feedback are also increasingly utilized to oversee
internal service operations such as monitoring employee theft and productivity (e.g., Pierce et al.
2015).
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More recently, the applications of remote monitoring and feedback have expanded into the
healthcare community. For healthcare workers, remote electronic monitoring can be put in place
to help increase workers’ behavioral compliance, such as hand hygiene (Staats et al. 2017). For
patients, telehealth practices have been increasingly adopted to facilitate efficient management of
health and wellness, allowing health personnel to proactively connect with patients through health
IT and provide patients with real-time health and behavioral assessment, diagnosis, interventions,
and consultation (Kvedar et al. 2014). As more researchers and practitioners are interested in
learning how health IT may transform healthcare practices, we see a growing body of operations
management literature that explores the impact of various long-standing forms of health IT and
telehealth, such as home monitoring and e-visits (e.g., Rajan et al. 2019, Bavafa et al. 2018, Angst
et al. 2011, Devaraj et al. 2013).
In our study, we focus on connected healthcare that provides remote monitoring and feedback
for patients with heart disease. A number of past studies investigate the benefits of connected
health, or more broadly, telemonitoring, in patients with chronic conditions (e.g., Watson et al.
2009, Trappenburg et al. 2008), with many focusing on heart conditions (e.g., Chaudhry et al. 2010,
Cleland et al. 2005, Maeng et al. 2014). Although past studies, which primarily rely on small- to
medium-scale randomized and non-randomized control trials, suggest that telemonitoring may be an
effective strategy for disease management in heart failure patients, the evidence base is inconclusive
and quite limited (Chaudhry et al. 2007). Moreover, there exists little guidance on how to effectively
implement such a system.
Our study aims to (1) examine the efficacy of connected health systems in improving medication
adherence, (2) examine the relationship between medication adherence and readmission, and (3)
develop a dynamic readmission risk-scoring model that takes medication adherence as input and
use it to better target non-adherent patients. As shown in Figure 5, we address our first two aims in
two studies, Study A and Study B. To address the third aim, we use machine learning to develop a
dynamic risk-scoring model and investigate the benefit of utilizing the model in our intervention
delivery through counterfactual simulations, which link intervention to readmission by treating
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medication adherence as a mediator. Our work joins an increasing number of studies in operations
that focus on remote monitoring and compliance (e.g., Staats et al. 2017, Jonasson et al. 2020),
applications of data analytics in healthcare (e.g., Wang et al. 2019a), chronic disease management
(e.g., Jonasson et al. 2017), and behavioral healthcare analysis (e.g., Ibanez et al. 2018), particularly
analysis of patient behavior (e.g., Liu et al. 2018).

Real-time adherence information

Active feedback
systems

Study A

Medication
adherence behavior

Study B

Readmission

Counterfactual analysis

Figure 5: Analysis Outline
In the first study (Study A), we investigate the effectiveness of different escalation strategies in
promoting medication adherence behavior. The lack of medication adherence has been a serious
problem in managing chronic diseases around the world. Numerous studies have shown that
patients with chronic illnesses adhere to their prescribed medications only 50% to 60% of the
time, and the total direct and indirect cost estimates for non-adherence range from $100 billion
to $300 billion each year (Bosworth et al. 2011). Until now, traditional behavioral interventions
targeting medication adherence have produced only modest success (e.g., Ho et al. 2009, Nieuwlaat
et al. 2014). Furthermore, the evidence regarding the effectiveness of health IT interventions
to improve adherence is fairly thin (Bosworth et al. 2011). Bosworth et al. (2011) has found
that almost all of the interventions that were effective were complex, including combinations
of convenient care, information, reminders, self-monitoring, reinforcement, counseling, family
therapy, and crisis intervention. The finding is in line with Ho et al. (2009), which concludes
that multimodal interventions have been more successful than unimodal interventions, which rely
on methods like reducing the number of daily doses of medications or packaging medications into
special containers. These findings consistently suggest that connected healthcare, which can deliver
multimodal interventions at reasonable cost, is a promising care model.
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To the best of our knowledge, no one has attempted to study how patients’ medication adherence
behavior changes in response to different escalation strategies. Prior studies that study the impact of
adherence intervention on medication adherence primarily rely on randomized controlled trials and
before-and-after comparisons. They work with macro-level intervention information (e.g., always
receiving reminders vs. never receiving reminders) and approximate aggregate adherence data (e.g.,
self-reported adherence or prescription fill rates in the past three months). These studies do not
have the granularity of data that we have available and therefore do not examine directly how
patients respond to different escalation levels and dynamics. In contrast, we conduct our analysis
at the patient-day level by utilizing micro-level intervention and adherence data, which allow us to
examine the relationship between different escalation strategies and patients’ immediate changes in
behavior (or lack thereof). Micro-level data recorded over time are commonly used in healthcare
operations studies, especially to analyze workers’ behavior and performance (e.g., Gurvich et al.
2019, Berry Jaeker and Tucker 2017).
In the second study (Study B), we examine the impact of adherence to two crucial medications,
statins (a class of lipid-lowering medications; also known as HMG-CoA reductase inhibitors) and
β-blockers (a class of medications that are particularly used to manage cardiac arrhythmias; also
written as beta-blocker) on the risk of readmission. We focus on readmission as the outcome variable
for two main reasons (Kansagara et al. 2013). First, the ability to assess the readmission risk helps
physicians target the delivery of care, especially resource-intensive interventions, to patients who
are at highest risk for readmission. Second, readmission rates are often used as a care quality
measure (e.g., Kim et al. 2015, Chan et al. 2019) and a quality metric for healthcare providers.
Being able to identify drivers of readmission is important for hospitals. Since 2012, the Centers
for Medicare and Medicaid Services (CMS) has publicly reported readmission rates and planned to
lower reimbursement to hospitals with high risk-standardized readmission rates.
The relationship between adherence and health outcomes is recognized but understudied. DiMatteo
et al. (2002) conducted a meta-analysis and proposed that the relationship was under-investigated
because the effect of adherence on outcomes was often taken for granted. Nevertheless, several
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studies have attempted to determine the impact of medication adherence on health outcomes such
as rehospitalization and mortality for patients with chronic diseases such as coronary heart disease,
diabetes, and AIDS (e.g., McDermott et al. 1997, Yu et al. 2010, Han et al. 2014). However,
the difficulties of coming up with effective experimental study designs and having an accurate
measure of adherence have made it difficult for researchers to establish a clear causal relationship
between medication adherence and outcomes. Most previous studies rely on traditional measures
of adherence such as self-reports, physician reports, and prescription fill rates. They cannot
accurately measure medication adherence (Lam and Fresco 2015) and obtain medication adherence
information directly prior to each readmission. In contrast, our study utilizes medication adherence
data from electronic pill bottles. This allows us to analyze the probability of readmission at the
patient-day level using reliable adherence information leading up to each day using an econometric
approach, as opposed to traditional cross-sectional comparisons.
Finally, in our third analysis, we develop a dynamic readmission risk-scoring model that includes
medication adherence as predictors and use counterfactual simulations to examine the benefit of
using the model in our intervention delivery. Instead of alerting every patient at pre-specified
moments of non-adherence, our new strategy directly targets the patients (and the patient-days) with
highest readmission risks. Many researchers have explored various ways data analytics can improve
healthcare delivery (e.g., Raghupathi and Raghupathi 2014, Wang et al. 2019a). However, to the
best of our knowledge, none of them has studied the application of predictive analytics in connected
health delivery. Moreover, although many studies attempt to develop readmission prediction models
(e.g., Min et al. 2019, Shulan et al. 2013), they mostly aim to predict the probability of readmission
within a fixed period after hospital discharge (e.g., probability of readmission within 30 days).
Unlike our study, most prior studies do not have post-discharge patient-day level covariates, barring
them from obtaining patient-day level readmission risk.
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2.3. Study Setting
This study builds on a national two-arm randomized controlled trial program we conducted from
2013 to 2016. We collected data from 1,000 patients who enrolled in the program and received
a 12-month connected healthcare intervention that aimed to reduce repeated cardiovascular events
through improved medication adherence. Our original study was one of the first studies to deploy
connected health devices on a large scale. The study aimed to improve upon earlier intensive case
management efforts, which were mostly unwieldy and expensive, by using a simpler, cheaper,
and more scalable approach. By leveraging more connected technology, we were able to deploy
a novel, proactive model of chronic disease management. We also created new workforce roles and
shifted some intensive case management roles from physicians to non-physician providers, which
can benefit both physicians and the hospital (Powell et al. 2012).
Our study was approved by the Institutional Review Board of the University of Pennsylvania. Prior
to the study, patients were recruited by University of Pennsylvania research staff from 2013 through
2015 and observed for one year. Eligible patients were:
(a) 18 to 80 years old.
(b) Admitted as hospital inpatients for one to 180 days.
(c) Discharged home with a primary diagnosis code of acute myocardial infarction (AMI).
(d) Not suffering from dementia.
(e) Not enrolled in other research studies incorporating wireless pill bottles.
Patients could enroll up to 60 days after discharge. To recruit patients, we initially contacted them
through letters and phone calls. Of 19,678 potentially eligible patients contacted, 18,169 declined,
could not be reached, or were ineligible upon further inspection, leaving an enrolled sample of
1,509. The most common reasons cited by the patients who declined were: (a) not being interested,
(b) not wanting to change the current system, and (c) having privacy concerns. All enrolled patients
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received $25 for participation. Patients in our sample were insured with five large US insurers or
with Medicare fee-for-service at the University of Pennsylvania Health System.
We randomized patients in a 2:1 ratio of intervention:usual care using permuted block randomization
stratified by insurance provider to balance the allocation across provider groups. After excluding
patients who withdrew or did not have post-enrollment medical claims, 975 patients from the
intervention group remain in our final patient cohort. Patients in the intervention group received
an additional $25 for activating wireless pill bottles (Vitality GlowCaps), which electronically
monitored bottle openings with a small remote device that plugged into a wall outlet and transmitted
cellular signals to the care team, with no home wireless network, computer, or special setup
required. Adherence information transmitted from those pill bottles was recorded on an electronic
platform that we primarily utilized to facilitate real-time monitoring and feedback. Our connected
healthcare platform, which was developed with funding from the National Institutes of Health, is a
flexible and secure web-based infrastructure that consists of a portal that can be linked to various
peripheral connected health devices, such as scales, glucometer, and pill bottles. The platform is
capable of automating the delivery of feedback and communicating back to patients using email,
text messaging, and interactive voice recording.
Patients in the intervention group were assigned an engagement advisor (EA) for the duration of
their participation. The EAs assisted patients with pill bottle setup and troubleshooting, monitored
the patient’s daily medication adherence on the electronic platform, provided manual forms of
feedback, and served as a resource for patients struggling to stay adherent. All intervention patients
were asked to enlist a potential support partner, usually a friend or family member. The role of the
support partner was to receive information about the patient’s adherence through the platform and
EAs, and provide support and encouragement using their preferred format and content. Support
partners also had an account on the electronic platform, allowing them to automatically receive
alerts through email, text message, or automated phone call. We gave intervention patients access
to social work resources as well as five main forms of adherence feedback with increasing degrees
of intensity: (1) automated message to patient, (2) automated message to partner, (3) phone call to
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patient, (4) manual message to patient, and (5) phone call to partner. We discuss different forms of
intervention in further detail in Section 2.4.2 in conjunction with Study A. Patients in the control
group received usual care for the duration of the study and had no further contact with EAs or study
staff. The results of our randomized controlled analysis are described in Volpp et al. (2017). We did
not find statistically significant differences between study arms in time-to-first-rehospitalization for
a vascular event or death, or total number of repeated hospitalizations
To investigate further if and how the connected heath systems worked, this paper focuses on the
patients who received the intervention. These intervention patients had within-person variation in
their adherence behavior and variation in how the intervention was escalated. The data we use
for our micro-level analysis contains both operational and patient-level information. Operational
information includes daily data for each patient indicating whether:
(a) Each of the five forms of intervention was delivered.
(b) The patient opened each of his or her pill bottles.
(c) The patient was readmitted.
We also have information on the time between patients’ initial discharge and study enrollment
and on whether and when he or she was readmitted before enrollment. In addition to operational
information, our data set contains information about patient characteristics such as age, gender,
Medicare enrollment, Patient Health Questionnaire-2 (PHQ-2) score, and baseline Elixhauser
comorbidity score. The PHQ-2, which is used to screen depression, inquires about the frequency
of depressed mood and anhedonia over the past two weeks (McManus et al. 2005, Kroenke et al.
2003). A PHQ-2 score can range from 0 to 6, with higher scores translating to higher chances
of having depression. The second score, Elixhauser comorbidity score, is evaluated using up to
12 months of pre-enrollment data based on 31 individual conditions identified from diagnoses in
hospital and physician data and can take positive or negative values (van Walraven et al. 2009).
These scores were assigned once and not updated during the study period. Table 18 provides the
summary statistics of patient demographics for all patients in our cohort.
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Table 18: Summary Statistic for Patient Demographics
Patient characteristic
Age
Female
Medicare
PHQ-2 depression score
Baseline Elixhauser score
Time from discharge to enrollment (days)

Mean
61.26
0.34
0.44
1.26
6.46
40.52

SD
10.41
0.47
0.50
1.63
10.03
12.36

Min
23
0
0
0
-14
8

Max
80
1
1
6
44
60

We describe the data in more detail in Table 27 in the Appendix. Following the Management
Science policy for Data and Code Disclosure, we have made our code and data available on the
journal website to permit replication. Moreover, future research in connected healthcare can also
benefit from the data we provide.

2.4. Study A – Impact of Remote Monitoring and Feedback Systems on Medication
Adherence Behavior
We begin by examining the efficacy of the feedback systems. Specifically, we want to see how
effective different escalation strategies are in turning non-adherence into adherence. By answering
this question, we can develop insights into how feedback systems play a role in improving patient
behavior, and how best to engage with non-adherent patients in order to make them adherent again.
2.4.1. Data and Statistics
The data used in this analysis contains a series of non-adherence sequences for each patient. Each
non-adherence sequence begins on the first day without pill bottle use and lasts until the first day
the patient takes all of his or her medications again. One patient could have multiple non-adherence
sequences. Each entry in our data contains daily information on whether the patient opened all
the pill bottles and whether he or she received each type of intervention. On average, we observe
each patient for 318 days, including both adherence and non-adherence days. Our observation
period is slightly shorter than the intervention period because the wireless pill bottle activation was
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occasionally delayed, causing a lag time between the start of the intervention period and when the
bottles were functional.
Of 975 patients, approximately 3% were always adherent and are excluded from our analysis and 2%
of the patients had irregularly long periods of non-adherence. For these patients, the average number
of non-adherence days within each non-adherence sequence is greater than 15, and the maximum
number of non-adherence days within a sequence ranges from 68 to 334 days. We exclude these
patients from our main analysis because they may have intentionally not taken some or all of their
medications, or their pill bottles were not working properly. After those patients are excluded,
our data contain 930 patients who exhibit reasonable variability in their adherence pattern. Table
19 provides adherence statistics of the remaining patients and all patients. In our final cohort, on
average, each patient has 15.57 non-adherence sequences, each lasting a mean of 2.78 days.
Table 19: Summary of Medication Adherence Behavior
Adherence Characteristic
Number of non-adherence sequences per person
Number of non-adherence days within a sequence

Focus Cohort (N = 930)
mean
std
min max
15.57 12.39
1
73
2.78
3.05
1
122

All patients (N = 975)
mean
std
min max
14.94 12.77
0
73
3.86
6.10
1
334

2.4.2. Escalation of Feedback
We aimed to remind patients to take medications at increasing levels of escalation. Lower-level
interventions were delivered automatically through our electronic platform while higher-level
interventions were delivered manually by the engagement advisors who closely monitored
adherence behavior.

We usually provided lower-level interventions before we escalated to a

higher-level intervention and stopped delivering interventions once the patient became adherent
again. We illustrate the nature of escalation in Figure 6, which shows the distribution of each type
of intervention over different days within a non-adherence sequence. Each mark on the vertical
axis indicates the tth day of non-adherence. Each of the smaller plots corresponds to each form
of intervention and is displayed along with its total number of occurrences at the bottom. Each
plot illustrates the percent distribution of each form of intervention over day of non-adherence
and is compared across all forms of intervention, capturing the nature of escalation. For example,
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we delivered 122 manual messages to patients in total, 47% of which occurred on the sixth day
without pill bottle use. In contrast, we initiated automated messages to patients much earlier in the
non-adherence period, oftentimes in the first few days the non-adherence. Based on the escalation
pattern, we define five levels of escalation corresponding to five main forms of intervention, which
are described below in increasing order of escalation.
1. Escalation level 1 — Automated message to patient: In the lowest level of escalation, we
deliver a first automated message to tell the patient that he did not take his medications. These
non-personalized messages were mostly triggered via the electronic platform in the first two
days of non-adherence and were usually delivered through text message or email. We usually
sent automated non-adherence messages regularly until the patient became adherent again. In
total, 19,323 such messages were sent. These messages contained a standard text that wrote:
“You did not take all your meds yesterday.”
2. Escalation level 2 — Automated message to partner: In the next level of escalation, we
send an automated message to the patient’s partner. Most non-personalized automated
messages to support partners were initially triggered via the platform in the first four
days of non-adherence and mostly continued until non-adherence ended.

Like other

platform-triggered messages, they were mainly delivered through text message and email.
In total, 5,768 automated partner messages were sent. The standard message wrote: “Your
HeartStrong partner has missed some heart medications for the past few days and may need
your support.”
3. Escalation level 3 — Phone call to patient: In the third level of escalation, the EAs make
the first phone call to the patient after non-adherence starts. Telephone calls to patients were
mostly made after the fifth day of non-adherence. The EAs directly made these calls to tell
patients about their non-adherence and ask them about the reasons for why the pill bottles
were not opened. In total, the EAs made 305 calls that successfully reached the patients.
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4. Escalation level 4 — Manual message to patient: With the next escalation level, the EAs
sends the first manual message to the patient after non-adherence starts. Manual messages
were tailor-written and sent to the patients via the electronic platform, informing them of
their non-adherence and asking them to contact the care team. The EAs mostly sent these
messages after the sixth day without pill bottle use. In total, 122 manual messages were
sent. The content of these messages varied; for example, a manual message may write: “Our
system shows that you have not opened your GlowCaps for [number of non-adherence days]
days. We have been unsuccessful in [action] so we will be contacting [person we would
contact, e.g., support partner] if we do not hear back from you by the end of today. Please
call your HeartStrong Program Advisor, [EA name], at [EA’s phone number].”
5. Escalation level 5 — Phone call to partner: At the highest escalation level, the EAs first
call the patient’s partner after non-adherence starts. The EAs mostly made telephone calls to
patients’ support partners after the seventh day of non-adherence to inform support partners
of the adherence problems and enlist their support. In total, the EAs made 46 calls that
successfully reached the patients’ partners.
Although we did not deliver calls and manual messages regularly like automated messages, it was
not uncommon for the patients or the patients’ partners to receive them multiple times within a
non-adherence sequence. In our main analysis, we consider only the calls that successfully reached
the intended recipient. Apart from these five forms of intervention, the EAs also mailed letters
to patients in eight cases, and contacted the patient’s primary care provider’s office by telephone
to inform them of adherence problems in three cases. We exclude those interventions from our
analysis because they were very rare events and we do not know when the letters were delivered to
the patients and if they were received.
As Figure 6 shows, there exists considerable variation in when we delivered the intervention. We
did not deliver the intervention in a perfectly consistent manner for several reasons. For automated
messages, the inconsistency is primarily because (1) the patients were sometimes unable to receive
messages and (2) our electronic platform occasionally had errors that prevented it from successfully
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Figure 6: Feedback Distribution over Time
sending messages. For manual messages and phone calls, we observe considerable variation in
delivery timing due to operational constraints such as our care team having limited capacity, patients
not being reachable, and the intervention not being delivered on the weekends. Moreover, due to a
lack of a strict intervention protocol, we also sometimes delivered manual interventions relatively
early within a non-adherence period. These limitations result in varying escalation patterns, which
are illustrated in Figure 7. The figure shows six examples of the way the intervention was
escalated. In each plot, the marks on the vertical axis indicate current escalation levels, with level
0 meaning no intervention has been delivered. As we can see, there exists significant variation
in whether and when each escalation level was reached. Since the variation resulted mostly from
operational challenges on our end, we have no reason to believe that the variation is driven by
patient-specific factors. Thus, from a research design perspective, the operational challenges created
quasi-experiments that we can use to estimate the effect of escalation on adherence.
Since our goal is to estimate the effect of different escalation strategies on the probability of
becoming adherent again on a given non-adherence day, we first need to define what characterizes
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(a)

(b)

(c)

(d)

(e)

(f)

Notes: (a) No intervention was delivered, (b) Intervention was escalated to level 1 and stopped being escalated, (c)
Intervention was escalated to level 4 and stopped being escalated, (d) Intervention was consistently escalated to level 5,
(e) Intervention was escalated to 5, but was slowly escalated at the beginning, (f) Intervention was quickly escalated to
level 5, bypassing levels 3 and 4.

Figure 7: Examples of Escalation Patterns from Six Different Non-Adherence Sequences
the escalation leading up to that day. We denote the characteristics of escalation that patient i
receives on the tth day of non-adherence within the j th non-adherence sequence as Escalationijt .
For example, Escalation15,2,5 corresponds to the escalation that patient 15 in our sample receives
on the fifth day of non-adherence in his or her second non-adherence period. Based on the varying
escalation patterns we observe, we describe Escalationijt using two dimensions:
1. Current level of escalation (EscLevelijt ): This captures the intensity of escalation on
non-adherence day t. As defined above, levels of escalation range from 0 to 5 with increasing
degrees of intensity.

The escalation reaches level 1 when the patient first receives an

automated message and reaches level 5 when their partner first receives a phone call.
2. Dynamics of escalation:

This captures the dynamics of escalation leading up to

non-adherence day t. The escalation dynamics are further broken up into:
(a) Overall escalation dynamics (OverallEscijt ): OverallEscijt is observed from the
time non-adherence begins up to non-adherence day t. We quantify OverallEscijt
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as the overall rate of escalation, which is calculated by dividing EscLevelijt by t. This
captures the speed of escalation, which can also be interpreted graphically as the slope
of the escalation graph measured from the beginning of the non-adherence sequence to
non-adherence day t.
(b) Recent escalation dynamics (RecentEscijt ): Since OverallEscijt does not necessarily
capture recent escalation dynamics, we use RecentEscijt to indicate whether the
intervention has been escalated within the past three days. Specifically, we define
RecentEscijt as follows.

RecentEscijt =








1,






if







0,






if




EscLevel

ijt

− EscLevelij,t−2 > 0,



EscLevelijt > 0,



EscLevel − EscLevel
ijt



EscLevelijt = 0,

ij,t−2

t>3
t<3
(2.1)

= 0,

t>3
t<3

In the following section, we incorporate these escalation characteristics into the econometric model
that we present and explain how we identify the effect of different escalation strategies on the
probability of becoming adherent again.
2.4.3. Econometric Model
To study the effectiveness of the feedback, we conduct discrete-time survival analysis where we
view each non-adherence period as a spell that starts when the patient misses the medications and
ends when the patient resumes taking the medications again. Discrete-time survival models are
often used to model events that happen in truly discrete time and events that happen in continuous
time but are observed in discrete intervals, i.e., interval-censored events. In our case, we observe
whether the patient resumed taking the medications daily. Many researchers use continuous-time
survival models with discrete-time data and interval-censored data because continuous-time models
are easier to implement. In contrast, we use a discrete-time model for two reasons. First, we have
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many ties in the time when patients became adherent again, especially on the first few days of
non-adherence. According to Chalita et al. (2002), one should use a discrete-time model when the
proportion of ties is greater than 0.25, which is the case in our data. Second, discrete-time models
are less error-prone to implement since our data contain time-varying escalation characteristics that
change at high frequency.
To conduct discrete-time survival analysis, we use a complementary log-log (cloglog) model.
The cloglog model, which is also known as a discrete-time proportional hazards model, is a
mathematically exact time-aggregated version of the continuous-time Cox proportional hazards
model (Allison 1982, Prentice and Gloeckler 1978, Jenkins 1995). Like the Cox model, the
cloglog model makes no assumption regarding the nature of the hazard function, allowing
the baseline probability of becoming adherent on the tth day of non-adherence to take any
distributional form. We conduct our survival analysis at the patient-day level where the discrete-time
survival function, S(t|Escalationijt , Xijt ), is the probability that patient i remains non-adherent
for at least t days within non-adherence sequence j; and the discrete-time hazard function,
H(t|Escalationijt , Xijt ), is the probability that patient i becomes adherent again on non-adherence
day t within non-adherence sequence j given that he or she has been non-adherent up until that point.
Escalationijt and Xijt are a vector of escalation characteristics and a vector of control variables,
respectively.
Based on the proportional hazards framework, the survival function takes the following form:
S(t|Escalationijt , Xijt ) = S0 (t)exp(Escalationijt β+Xijt δ)νi

(2.2)

where S0 (t) the baseline survival function. Since each patient could have multiple non-adherence
sequences, we allow observations within each patient to be correlated by introducing a
patient-specific frailty, νi , which is an unobserved quantity that is log-normally distributed with
a mean of one and a variance of σν2 . A frailty, or a latent random effect, is the same for each patient
and is used to describe unobserved heterogeneity among patients (Meyer 1990). Our model is
known as a shared-frailty model, which is the survival-analysis analog to random-effects regression
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models. From Equation 2.2, we obtain a similar relationship for the complement of the hazard
function:
1 − H(t|Escalationijt , Xijt ) = (1 − H0 (t))exp(Escalationijt β+Xijt δ)νi

(2.3)

where H0 (t) the baseline hazard on non-adherence day t. We can rewrite Equation 2.3 in the form
of cloglog model as follows (Kalbfleisch and Prentice 2002, Allison 1982).
cloglog(H(t|Escalationijt , Xijt )) = ln(−ln(1 − H(t|Escalationijt , Xijt )))
(2.4)
= αt + Escalationijt β + Xijt δ + µi
where cloglog(·) is a complementary log-log link function, and αt is a constant for non-adherence
day t representing the baseline hazard and is equal to cloglog(H0 (t)). The log frailty µi , or ln(νi ),
is analogous to random effects in standard regression models and is assumed to be i.i.d., N (0, σµ2 ).
We can determine whether it is necessary to include the frailty by testing the hypothesis that the
proportion of total variance contributed by the patient-heterogeneity variance (σµ2 ) is equal to zero.
Similar to the Cox model, we can interpret the exponent of a coefficient as a hazard ratio, which
captures a proportional shift in the hazard due to a unit change in the associated covariate given all
other factors, including the frailty, being equal.
The main treatment variable in our model is Escalationijt , which consists of EscLevelijt ,
OverallEscijt , and RecentEscijt . We model EscLevelijt as a factor variable to allow for a
non-linear effect. Additionally, we include Xijt to control for seasonality and other factors that
potentially influence medication adherence. Specifically, Xijt consists of the following.
1. Seasonality: We control for two main seasonality factors: (1) weekends and holidays and (2)
days since enrollment. To control for weekends and holidays, we include a binary indicator
that equals one if the observation falls on a weekend or a federal holiday. Additionally,
since Staats et al. (2017) suggests that individuals’ compliance may vary by how long they
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have been monitored, we control for the number of days the patient had been enrolled in the
program.
2. Financial outcomes: Our original study used lottery-based incentives to promote medication
compliance in addition to providing real-time intervention. Each day, the electronic platform
randomly selected a lottery number, which was then compared with the patient’s assigned
lottery number. If the numbers matched under certain criteria and the patient was adherent
the previous day, the patient would receive a monetary prize. Adherent patients were told if
they won, and non-adherent patients were told if they would have won had they been adherent,
allowing us to leverage regret aversion and anticipated regret. To control for lottery outcomes,
we include Regretijt , which is a binary variable that equals 1 if the patient was eligible to
win but did not receive the prize due to non-adherence.
3. Patient characteristics: Random-effects models allow us to include time-invariant patient
characteristics. We include age, gender, PHQ-2 score, baseline Elixhauser score, and whether
or not the patient is enrolled in Medicare.
4. Variation in practices among EAs: Since the EAs possibly had varying intervention delivery
practices that may in turn affect patients’ adherence behavior, we include EA fixed effects to
control for this.
In our analysis, we aim to separately identify the effect of escalation level and the effect of escalation
dynamics. We are able to do so because the correlations among EscLevel, OverallEsc, and
RecentEsc are low. Specifically, we find that the magnitudes of correlation among them are
all below 0.5. Moreover, we also aim to disentangle the effect of escalation from the effect of
time. Although we control for the baseline hazard rate on non-adherence day t, high correlations
between escalation characteristics and non-adherence day may prevent us from reliably identifying
the underlying baseline hazard rates and the effect of escalation. To address this, we obtain the
correlation coefficients between (1) non-adherence day and each EscLevel, (2) non-adherence day
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and OverallEsc, and (3) non-adherence day and RecentEsc, and find that the magnitudes of the
correlation coefficients are below 0.62, with most being below 0.1.
Even though we do not have a high correlation problem, it is still possible that the effect of escalation
level depends on when the escalation level is reached. For example, patients may be less sensitive
to escalation level 4 that occurs on non-adherence day 6 than one that occurs on non-adherence day
3 because when patients reach the sixth day of non-adherence, they are naturally more non-adherent
and are less likely to respond to intervention. If this were to be true, the fact that higher levels of
escalation tend to occur later within a non-adherence sequence could lead to a downward bias in
the estimated effect of escalation level. This would also violate the proportionality assumption of
the discrete-time hazard model, which requires the effect of escalation level to be identical in every
non-adherence day t. To address this, we will test the proportionality hazard assumption by adding
the interaction terms between escalation levels and non-adherence day (Singer and Willett 2003,
Therneau and Grambsch 2000).
2.4.4. Results
Table 20 summarizes the relationship between escalation characteristics and the probability of
becoming adherent again in terms of hazard ratios. As we are primarily interested in estimating
the effect of feedback escalation, we only report the effects of EscLevel, OverallEsc, and
RecentEsc. We do not find a statistically significant relationship between the lowest escalation
levels that involve only automated messages and the probability of returning to adherence. However,
higher escalation levels that involve more customized feedback and a greater degree of personal
involvement were associated with greater patient responsiveness. Holding everything else constant,
the probability of becoming adherent increased by 28% when the patient started receiving personal
phone calls, and increased slightly higher when the patient started receiving manual messages. More
remarkably, when the patient’s partner started receiving phone calls, the probability of becoming
adherent again increased by more than 35%. Additionally, we find that patients were more likely
to become adherent again when the intervention was escalated quickly and when they received a
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recent escalation. When the patient received an escalation in the past three days, the probability of
becoming adherent again increased by 32%. To check for robustness, we also consider voicemails
in addition to calls that successfully reached the intended recipient. Although the estimated effects
of escalation level 3 (call to patient) and escalation level 5 (call to partner) are slightly smaller after
including voicemails, the findings are qualitatively similar.
To further investigate if the escalation levels that only involve automated messages are ineffective
in making the patients adherent again or if we simply do not find an effect because of a low
signal-to-noise ratio, we perform equivalence tests (Harms and Lakens 2018, Rogers et al. 1993).
The first step of the equivalence test is to specify the smallest effect size of interest (SESOI), which
is the effect size that we consider too small to be meaningful. To determine what the SESOI should
be, we first hypothetically assume that patients did not receive any intervention. Then, we determine
by what percentage, on average, the hazard rates would have to increase for the patients to be more
likely than not to become adherent when they were currently less likely than not to become adherent.
We find the average minimum increase to be 2.882%. Using 2.882% as the SESOI, we perform two
one-sided t-tests to determine if we can reject the hypothesis that the effect size is larger than or equal
to the SESOI. The test results suggest that we can reject the null hypothesis for both escalation level
1 (p-values < 0.001) and escalation level 2 (p-values < 0.05). Therefore, the effects of escalation
levels 1 and 2, if they exist, are likely to be of negligible significance.
Table 20: Estimated Effect of Escalation on the Probability of Becoming Adherent
Variable
EscLevel
Level 0 – Intervention not yet delivered
Level 1 – Automated message to patient
Level 2 – Automated message to partner
Level 3 – Phone call to patient
Level 4 – Manual message to patient
Level 5 – Phone call to partner
OverallEsc
RecentEsc

Hazard Ratio (SE)
(base case)
1.01 (0.00)
1.01 (0.01)
1.28∗∗∗ (0.05)
1.29∗∗ (0.10)
1.36∗∗ (0.16)
1.18∗ (0.09)
1.32∗∗∗ (0.12)

Notes: Standard error in parentheses. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
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To determine whether the effect of escalation level depends on non-adherence day, we compare a
model that includes interaction terms between escalation levels and non-adherence day to a model
that does not. We find that interaction coefficients are not statistically significant. Moreover, by
conducting a deviance goodness-of-fit test, we find that the model that allows for a time-dependent
effect does not provide a better fit than the proportional hazards model. This suggests that there is
insufficient evidence to indicate that the effect of escalation level depends on non-adherence day,
and, therefore, the fact that higher levels of escalation tended to occur later in a non-adherence
sequence should not bias the estimates. Furthermore, to determine whether patient-specific frailties
are necessary, we conduct a likelihood ratio test to evaluate the null hypothesis that the proportion
of the total variance contributed by the patient-heterogeneity variance (σµ2 ) is zero. The p-value for
the likelihood ratio test is less than 0.001. Thus, we can reject the null hypothesis and conclude that
patient-specific frailties are important.
Figure 8 shows the baseline hazard for each non-adherence day t, which translates to the probability
that the patient becomes adherent again on the tth day of non-adherence given that all covariates are
zero. As we can see, the baseline hazard tended to decrease over time, suggesting that patients
were less likely to become adherent again the longer they had been non-adherent. We report the
full estimation results except for the baseline hazards and patient-specific frailties in Table 28 in
the Appendix. In contrast to Staats et al. (2017), which finds that employees were less likely to
be compliant the longer they had been monitored, we do not find that the probability of becoming
adherent changed the longer the patient had been enrolled in the program. One possible reason for
this difference is that, in our study, we not only monitored patients’ adherence but also proactively
reminded patients to take medications and provided financial incentives to promote adherence
throughout the study period. Due to these constant stimulations, patients’ likelihood of becoming
adherent was likely unaffected by how long they had been in the program. This finding potentially
implies that compliance monitoring alone may not be enough to maintain compliance—one also
needs to consistently provide patients (or employees) with behavioral feedback and/or incentives to
promote compliance.
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Figure 8: Baseline Probability of Becoming Adherent Again (H0 (t))
The results from our study suggest that, in order to effectively make a previously non-adherent
patient adherent again, we should start providing personalized feedback as quickly and as
consistently as possible. Specifically, in our setting, we should start calling the patient immediately
after the first day of non-adherence and, if non-adherence continues, escalate to manual messages
and calls to the patient’s partner successively on the following days. When combining the effect of
escalation level and escalation dynamics, we find that receiving a personal phone call on the second
day of non-adherence, a manual message on the third day of non-adherence, and a partner call on
the fourth day of non-adherence more than doubled the probabilities of becoming adherent during
those days.

2.5. Study B – Impact of Medication Adherence on Readmission
To investigate how behavior change improved health outcomes, we explore the effect of medication
adherence on the likelihood of readmission. Specifically, we aim to examine how consistency in
medication use in the past affects the readmission probability in the present.
2.5.1. Data and Statistics
We utilize a panel data set that includes (1) daily data for each patient indicating whether he or
she opened each of the pill bottles and (2) daily data of patient readmissions. Consistent with most
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prior work, we consider as readmissions all-cause inpatient hospitalizations and observation stays,
but not emergency room visits. These criteria are also frequently used when hospital performance
is assessed. Table 21 provides the distribution of the number of readmissions between the initial
discharge and the end of the one-year study period. As the figure shows, approximately 36% of
the patients in our cohort were readmitted at least once between their initial hospital discharge and
the end of the study period. Apart from medication adherence, patient characteristics may also
contribute to the risk of readmission. Table 22 provides summary statistics of patient demographics
for all patients in our cohort along with a breakdown by whether or not the patients were readmitted
between their initial discharge and the end of the study period.
Table 21: Distribution of the Number of Readmissions between Initial Discharge and the End of
Study Period
Number of Readmissions
0
1
2
3
4
5 and above

Percentage
64.41%
20.00%
7.69%
3.49%
2.15%
2.26%

Table 22: Summary Statistics of Patient Demographics by Readmission Profile
Variable
Age
Female
Medicare
PHQ-2 depression score
Baseline Elixhauser score

Not Readmitted (N = 628)
mean
std
min max
61.03 10.35 23
80
0.31
0.46
0
1
0.39
0.49
0
1
1.10
1.53
0
6
5.11
9.12 -14
37

Readmitted (N = 347)
mean
std
min max
61.68 10.52 28
80
0.40
0.49
0
1
0.53
0.50
0
1
1.53
1.77
0
6
8.87 11.08 -13
44

mean
61.26
0.34
0.44
1.26
6.46

All (N = 975)
std
min
10.41 23
0.47
0
0.50
0
1.63
0
10.03 -14

max
80
1
1
6
44

In our study, we analyze the impact of adherence to two medications: statins (which lower
cholesterol) and β-blockers (which lower the heart rate). Each pill bottle the patients received
was dedicated to either one of the medications. Statins are a class of drugs that help lower
cholesterol levels in the blood. β-blockers are usually prescribed to patients with high blood
pressure. Statins and β-blockers are generally well-tolerated and nearly universally recommended
to patients following heart attack. Although we were able to track adherence to each of the two
medications separately, we consider adherence to statins and β-blockers combined because the
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correlation between adherence to the two medications is high. For these medications, we are
interested in studying the impact of short- and long-term adherence on readmission. We define
short-term adherence as adherence measured over the three days leading up to any given day, and
long-term adherence as adherence measured over the 120 days leading up to any given day. We
drop the first 120 days of the study for each patient because they do not have long-term adherence
information. The adherence measures are binary, taking the value of 1 when the average adherence
within a given time window is at least 80% and taking the value of 0 otherwise. The 80% cutoff is
widely used in medication adherence literature (Burnier 2019). Given that patients took one dosage
of each medication per day, this adherence cutoff implies that they had to take medications for three
out of three days to be adherent short-term.
Our main consideration in determining the appropriate lengths of short- and long-term adherence
windows was the correlation between short- and long-term adherence. We find that the larger
the difference between the lengths of short- and long-term adherence windows is, the lower the
correlation between short- and long-term adherence will be. We use three days for short-term
adherence and 120 days for long-term adherence because the correlation between 3-day and 120-day
adherence is only 0.398. Of course, the correlation would be even lower if we used a longer-length
long-term adherence window, e.g., 150 days. However, we would have to drop more observations
that do not have long-term adherence information. We believe that, by using three and 120 days,
we can balance the need to minimize the correlation with the preservation of information. Our
choices of adherence windows are also supported by the LASSO regression, which suggests that
3-day adherence and 120-day adherence are the most contributive adherence measures.
To ensure that dropping the first 120 days of the study does not cause a sample selection issue, we
examine whether adherence behavior varied with how long the patients had been in the program.
First, we consider the effect of the number of days since enrollment, which is a control variable in
Study A, on the probability of becoming adherent. The results indicate that the effect of the number
of days since enrollment is not statistically significant (p-value = 0.409). Second, we consider
the average adherence rates before and after day 120. We find that the average adherence rates
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before and after day 120 were 0.810 and 0.805, respectively. We also find that the difference is
not statistically significant (p-value = 0.102). These results suggest that there exists insufficient
evidence to indicate that patients’ adherence behavior was different in the first 120 days. Therefore,
dropping the first 120 days of the study should not cause a sample selection issue.
Table 23 shows average short- and long-term adherence to statins and β-blockers leading up to days
patients were readmitted and average adherence leading up to days patients were not readmitted.
We find that average short- and long-term adherence was lower leading up to days patients were
readmitted. For both adherence measures, we assume that patients were prescribed a medication
from the time of the first fill until the end of the study period. To reduce errors in measuring
adherence, we exclude patients whose communication history indicated that they had difficulties
setting up their pill bottles or that their pill bottles did not work as intended. We also remove days
that patients stayed in the hospital and assume that they were adherent on those days because they
were under hospital care.
Table 23: Average Short- and Long-Term Adherence to Statins and β-blockers
Variable
3-day statin and β-blocker adherence
120-day statin and β-blocker adherence

Prior to Day with No Readmission
0.885
0.880

Prior to Day with Readmission
0.802
0.746

2.5.2. Econometric Model
To study the effect of medication adherence on the risk of readmission, we conduct discrete-time
survival analysis where we view each healthy period as a spell that starts when the patient is
discharged from the hospital and ends when the patient is readmitted. Instead of using the cloglog
link function, we use the logit link function, which is another common link function for discrete-time
hazard models (Allison 1982, Cox 1972). The logit function allows us to incorporate patient
fixed effects, which account for all observable (both available and unavailable in our data) and
unobservable patient-specific factors that influence the patient’s likelihood of readmission and do
not vary over the span of the study period. Incorporating patient fixed effects ensures that our
estimates are immune to an omitted variable bias due to unobservable time-invariant factors that are
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correlated with both medication adherence and readmission. For example, patients who consistently
feel unwell may be more likely to adhere to their medications and, because they are likely in poorer
health, are also more likely to be readmitted. On the other hand, one can also argue that healthy
patients who are less likely to be readmitted tend to have higher motivation and thus are likely to be
more adherent. This is known in the literature as the healthy-user effect (Shrank et al. 2011). Patient
fixed effects adjust for these potential time-invariant attributes that are also confounding variables.
Although we do not have a high proportion of ties in the failure time and could potentially use
a continuous-time model for convenience, we use a discrete-time model because it allows us to
extend the model to account for time-varying confounders afterwards. We conduct our analysis
at the patient-day level where the discrete-time hazard function, H(t|Adherenceijt , Zijt ), is the
probability that patient i is readmitted on the tth day since last discharge within healthy period j.
We specify our model as follows:

logit(H(t|Adherenceijt , Zijt )) = αt + Adherenceijt β + Zijt δ + γi

(2.5)

where Adherenceijt is a vector of short- and long-term adherence measures; αt is the logit
transformation of the baseline hazard (logit(H0 (t))); and γi is patient i’s fixed effect. Zijt is a vector
of control variables, which include (1) a binary variable indicating whether the observation falls on
a weekend or a holiday, and (2) the number of previous readmissions, i.e., the number of times the
patient had been readmitted prior to the present day. Unlike our original randomized controlled
study, this model allows us to evaluate the probability of readmission by leveraging within-patient
intertemporal variation in medication adherence.
The fixed-effects logit model is a discrete-time equivalent of the stratified Cox model, i.e., Cox
model with each patient treated as a separate stratum (Allison 1996, Allison and Christakis 2006).
As opposed to the cloglog and Cox models where the exponent of a coefficient is simply a hazard
ratio, the exponent of a coefficient from the logit model is an odds ratio of hazard rates (Cox 1972).
However, this converges to a hazard ratio in our case because the probabilities of readmission are
generally very small.
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To fit the fixed-effects logit model, we use a conditional logistic approach where we group data
by patient and calculate the likelihood relative to each patient group, i.e., a conditional likelihood
is used (Chamberlain 1980). Through this approach, γi ’s are not directly estimated since the
conditional likelihood does not directly involve the patient fixed effects. We estimate the model
using robust-cluster standard errors, i.e., standard errors adjusted for clustering of observations
within patients, to allow a patient’s observations to be correlated. In all our analyses, we check for
robustness by varying the length of short-term and long-term adherence windows and by varying
the adherence threshold. Specifically, we consider 5 and 7 days as the short- adherence window, and
80 and 100 days as the long-term adherence window. For the adherence threshold, we also consider
using 60%, 70%, and 90%.
2.5.3. Results
Table 24 summarizes the relationship between short- and long-term medication adherence and
readmission. The odds ratio for long-term adherence is statistically significant and less than one,
suggesting that adhering to statins and β-blockers in the long term was associated with a reduced
likelihood of readmission. Specifically, we observe that taking statins and β-blockers at least 80%
of the required amount during the past 120 days was associated with a 51% reduction in the odds
of readmission. This translates to a similar-sized reduction in the risk of readmission since the
probability of readmission is generally very small. Given that patient fixed effects are zero, we
find that the average marginal effect of long-term adherence is -0.373%, which is quite significant
considering that the probability of readmission is usually lower than 1%.
Table 24: Estimated Effect of Medication Adherence on the Likelihood of Readmission
Adherence Measure
3-day statin and β-blocker adherence
120-day statin and β-blocker adherence

Odds Ratio (SE)
0.75 (0.29)
0.49∗∗ (0.12)

Notes: Standard error in parentheses. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).

We report the full estimation results in Table 29 in the Appendix and check for robustness when
using different specifications of adherence. As shown in Tables 30 and 31 in the Appendix, the
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results are robust when we vary the adherence threshold between 60% and 90% and when we
vary the short-term adherence window between 3 and 7 days, and the long-term adherence window
between 80 to 120 days.
In our analysis, we use patient fixed effects to account for time-invariant unobservable patient
attributes. However, there may also exist unobservable time-varying factors that influence both
readmission and adherence behavior. For example, patients may be more likely to be adherent
at times when they feel unwell or at times when they are healthier and have higher motivation.
Although researchers usually view the healthy-user effect as a person-specific time-invariant
phenomenon, we do not want to rule out the possibility that it varies with time. To address this,
we use an instrumental variable (IV) approach to control for potential endogeneity. As we discuss
in detail in the Appendix B, we use intervention as IVs for medication adherence and conduct
the analysis using a subset of patients who normally had relatively low adherence and needed
intervention to stay adherent. Using the IV approach, we find the results to be quite similar to what
we obtain using patient fixed effects. Specifically, we find that the effect of long-term adherence is
statistically significant while the effect of short-term adherence is not. For long-term adherence, we
find the average marginal effect on the probability of readmission to be -0.340%.

2.6. Readmission Risk Prediction and Its Application in Connected Healthcare
Being able to predict the risk of readmission can help health professionals to effectively intervene
with non-adherent patients. We aim to use machine learning to develop a model that predicts
readmission risk using recent medication adherence in addition to static risk factors. By utilizing
adherence information leading up to each day, one can obtain readmission risk at the patient-day
level and use this information when intervening with non-adherent patients. As a care team usually
handles a large number of patients and has a limited intervention capacity, it would be helpful for
them to be able to identify patients (and patient-days) that are at risk for an imminent readmission
and would therefore be prime candidates for the care team’s attention.
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In this section, we aim to (1) develop a dynamic readmission risk-scoring model that uses
medication adherence as predictors (Section 2.6.1) , (2) compare its performance to a baseline
model that excludes medication adherence and only contains baseline risk factors such as patient
characteristics (Section 2.6.2), and (3) apply the dynamic readmission risk-scoring model to our
connected health setting to better target non-adherent patients (Section 2.6.3).
2.6.1. Model Development
Most traditional readmission prediction models only predict the probability of readmission within
a fixed period after discharge using static predictors captured at discharge. Unlike previously
developed models, we want to develop a model that predicts patient-day level risk using recent
medication adherence in addition to static predictors and compare its performance to a baseline
model that excludes medication adherence. In particular, we consider the following models:
1. Baseline risk-scoring model: The baseline risk-scoring model only includes the following
baseline risk factors:
(a) Patient characteristics: These include age, gender, PHQ-2 score, baseline Elixhauser
score, and whether or not the patient is enrolled in Medicare.
(b) Seasonality: Seasonality factors include a categorical variable for month of the year and
a binary variable indicating whether the observations falls on a weekend or a holiday.
(c) Number of previous readmissions: This is the number of times the patient had been
readmitted prior to the present day.
(d) Day since last discharge: This is the number of days since the patient was last
discharged.
2. Dynamic risk-scoring model: The dynamic risk-scoring model includes the baseline risk
factors presented earlier as well as short- and long-term adherence to statins and β-blockers
as defined in Study B.
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To train our models, we consider five machine learning methods: (1) logistic regression, (2)
decision tree1 , (3) random forest1 , (4) support vector machine2 , and (5) multi-layer perceptron3 .
These classification methods are relatively well-known and are commonly used in the readmission
prediction literature. To prepare the data for model training, we standardize all continuous variables
to prevent some machine learning algorithms from putting excessive weight on features with
large values. Furthermore, we address class imbalance by using synthetic minority over-sampling
technique (SMOTE) (Chawla et al. 2002). Since there exist significantly more patient-days without
readmission than patient-days with readmission, the machine learning algorithms may bias toward
the majority class. To overcome this issue, SMOTE balances the data by creating synthetic
observations using k-nearest neighbors. In order to create a synthetic observation, SMOTE finds
the k nearest neighbors of each minority observation, selects one of them, and calculates linear
interpolations to create a new minority observation in the neighborhood. Research has shown
that SMOTE is superior to random oversampling, which is known to increase the likelihood of
overfitting.
In evaluating the models, we use a five-fold cross validation at the patient level instead of the
patient-day level in order to avoid label leaking, i.e., having observations with similar characteristics
in both training and validation sets. We use SMOTE within each cross-validation fold after removing
the validation sample so that we create synthetic data by interpolating only observations that will
not be used for validation.
2.6.2. Model Evaluation
As a main performance metric, we consider an average area under the ROC curve (AUC) across
all five cross-validation folds. Table 25 shows average AUCs along with their standard deviations
for the baseline risk models and dynamic risk models that we develop using different machine
learning methods. Based on the AUCs, we find that dynamic risk-scoring models outperform
baseline risk-scoring models for all classification methods. Furthermore, we find that multi-layer
1

With Gini impurity criterion.
With radial basis function (RBF) kernel.
3
With rectified linear unit activation function.
2
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perceptron, which is a class of artificial neural networks (ANN), outperforms non-ANN methods
that we consider. The average AUC for the dynamic multi-layer perceptron model is 0.941. This
means that, if we take two observations, one with readmission and one without readmission, the
model can correctly predict which observation is which 94.1% of the time. Using the dynamic
multi-layer perceptron model, we find that the predicted probabilities of readmission on a given
day range from 0.01% to 1.98%, with an average of 0.16%. This average is reasonable given that
readmission occurred on approximately 0.14% of all patient-days.
Table 25: Average Areas Under the ROC Curve (AUC) for All Models

Method
Logistic regression
Decision tree
Random forest
Support vector machine
Multi-layer perceptron

Average AUC (SD)
Baseline Model Dynamic Model
0.740 (0.015)
0.884 (0.036)
0.709 (0.051)
0.712 (0.073)
0.817 (0.020)
0.909 (0.022)
0.767 (0.074)
0.856 (0.082)
0.843 (0.017)
0.941 (0.021)

To further compare the baseline risk model and the dynamic risk model, we focus on the models
developed using multi-layer perceptron and consider a hypothetical scenario where the care team
has a limited capacity to intervene with patients to prevent hospital readmissions, e.g., sending
medical professionals to patients’ homes. We suppose that the care team can target only c% of all
patient-days using one of the three approaches: (1) using no information from a predictive model,
(2) using information from the baseline risk model, and (3) using information from the dynamic
risk model. If using the first approach, the care team will randomly target c% of patients each day.
If using the second or third approach, the care team will target the patient when his or her predicted
risk is higher than (100 − c)th percentile.
To evaluate the three approaches, we define patient-day at risk as patient-day with readmission
or prior to readmission, which accounts for 0.28% of all patient-days, and consider the following
performance measures:

Y ield =

Number of patient-days at risk we target
Number of all patient-days at risk
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(2.6)

P recision =

Number of patient-days at risk we target
Number of all patient-days we target

(2.7)

We calculate yield and precision using the validation sample across all cross-validation folds. As
seen in Figures 9 and 10, we obtain higher yield and precision when we use the dynamic risk model
as opposed to the baseline model, and when we use the baseline risk model as opposed to not using
a predictive model at all. Figure 9 shows that yield increases as capacity increases. We find that,
if we have the capacity to target 17% of patient-days using the dynamic model, we will be able
to successfully target all patient-days at risk. In contrast, if we use the baseline model or use no
information from a predictive model, we will be able to successfully target only 75.32% and 17% of
the patient-days at risk, respectively. Figure 10 shows that precision generally decreases as we target
more patient-days. If we have the capacity to target only 0.1% of patient-days using the dynamic
model, as many as 24.56% of the patient-days we target will be patient-days at risk. In contrast, if
we use the baseline model or use no information from a predictive model, only 7.02% and 0.28%
of the patient-days we target will be patient-days at risk, respectively. We also vary the definition of
patient-day at risk and show the results in Figures 13 and 14 in the Appendix. As expected, although
yield and precision vary according to the definition of patient-day at risk, we always obtain highest
yield and precision when using the dynamic risk model.
Our finding suggests that the variation in medication adherence over time provides useful
information about the readmission risk and enhances the quality of prediction in addition to baseline
risk factors. We note that the clinical value of adherence-based predictive models depends critically
on the real time availability of adherence data.
2.6.3. Application of Dynamic Readmission Risk-Scoring Model in Connected Healthcare
Predictive analytics can benefit connected healthcare by helping to identify patients who really need
to change their behavior to avoid adverse health outcomes. In our setting, the dynamic readmission
risk-scoring model can help identify patients who are at the highest risk of readmission and have
the greatest need to be adherent. We investigate the benefit of using the dynamic risk-scoring model
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Figure 9: Yield Obtained Using Different Readmission Intervention Approaches
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Figure 10: Precision Obtained Using Different Readmission Intervention Approaches
in our setting through counterfactual simulations, which link intervention to readmission by using
medication adherence as a mediator. We focus on the multi-layer perceptron model and numerically
examine the impact of different intervention strategies, which do and do not consider predicted
readmission risks when delivering adherence intervention. The strategies that we consider are as
follows.
1. Strategy A—Adherence-maximizing strategy: The adherence-maximizing strategy aims to
quickly make patients adherent again once they become non-adherent.

We define the

adherence-maximizing strategy based on the findings from Study A. The strategy involves
calling the patient on the second day of non-adherence, sending a manual message on the third
day of non-adherence, and calling the patient’s partner on the fourth day of non-adherence.
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2. Strategy B—Adherence-maximizing strategy with readmission risk prioritization: We use
the adherence-maximizing strategy, but the strategy is only triggered when the predicted
readmission risk is greater than or equal to the nth percentile. We consider four values of
n in our main analysis: 80, 85, 90, and 95.
3. Strategy C—No intervention: We do not deliver any intervention.
For each intervention strategy, we are interested in four outcome metrics: (1) total number of calls
and manual messages delivered, (2) average individual adherence rate, (3) number of patients who
are readmitted at least once, and (4) total number of readmissions. We use the empirical numbers
that we observe in our experiment as a baseline.
Our counterfactual simulations link intervention to medication adherence using the estimated
proportional hazards model from Study A, and link medication adherence to readmission using
the dynamic risk-scoring model. The unit of consideration in our simulation is patient i-day t. We
consider 930 patients in our focus cohort. For each patient, t starts from 120 until the patient’s
last day in the study. We illustrate a simulation flow for patient i in Figure 11 and present our
simulation parameters in Table 32 in the Appendix. In Figure 11, Adherentit is a binary variable
that equals one when patient i takes all of his or her medications on day t and, at the beginning of
the simulation, takes the actual observed value in the data. When the patient is non-adherent, we
calculate the probability that the patient will become adherent again using the proportional hazards
model from Study A, which takes into account the intervention the patient receives. Based on
that probability, we determine whether the patient becomes adherent again using random sampling.
P redictedReadmit is a binary variable that equals one when patient i is readmitted on day t.
We calculate the probability of readmission using the dynamic risk-scoring model and determine
whether the patient is readmitted using random sampling. If the patient is readmitted, he or she will
be in the hospital for LOS days, where LOS follows the empirical distribution shown in Table 32.
We replicate the simulation 1,000 times and obtain the averages for the four outcomes of interest.
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Unit of consideration:
patient i, day t

No

Yes
Adherentit = 1

Deliver intervention according to
the intervention policy

Calculate a readmission
probability and determine if
PredictedReadmit = 1

Calculate an adherence
probability and determine if the
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=1
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t=t+1
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Notes: (1) This chart depicts a simulation flow for patient i. (2) t starts from 120 until patient i’s last day in the study.

Figure 11: Simulation Flow
We report the simulation results for different intervention strategies in Table 26 and, to visualize
the results, plot the total number of readmissions against the number of calls and manual messages
delivered in Figure 12. We find that although Strategy A, which is the most aggressive strategy, can
increase adherence to as high as 98.36%, it may not be a practical way to reduce readmissions.
While it is true that high medication adherence leads to lower readmission risk, it may be
unnecessary to increase medication adherence among patients who already have relatively low
readmission risk and are unlikely to be readmitted. As Figure 12 shows, compared to Strategy
A, Strategy B leads to a significant decrease in the total number of calls and manual messages but
only a small increase in the total number of readmissions. When n equals to 80 (i.e., we intervene
with patients only when the predicted risk is greater than or equal to the 80th percentile), Strategy
B leads to a 70% decrease in the total number of calls and manual messages but only a 2% increase
in the total number of readmissions compared to Strategy A. Furthermore, we find that, compared
to the actual case we observe, Strategy B with n equal to 95 yields a comparable number of calls
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and manual messages but a significantly lower number of readmissions. Specifically, when using
the strategy, we deliver 3% fewer calls and manual messages and obtain 10% fewer readmissions
compared to what we empirically observe in the experiment. These results suggest that, by utilizing
predicted risk information, the care team can effectively allocate its capacity to the patient-days that
really need intervention.
Table 26: Simulation Results for Different Intervention Strategies
Outcome

Observed

Strategy A

327
210
83
34
85.50%
329
288

3453.9
3190.5
239.4
24.1
98.36%
281.9
259.8

Total number of manual interventions
Call to patient
Manual message to patient
Call to partner
Average individual adherence rate
Total number of readmissions
Number of patients readmitted at least once

Scenario
Strategy B
(n = 80)
1043.2
960.1
74.8
8.2
92.03%
286.3
261.2

Strategy B
(n = 95)
318.4
294.0
21.1
3.2
86.94%
297.3
266.2

Strategy C
0
0
0
0
81.43%
340.0
290.6

Notes: Results for Strategy B, n = 85 and 90, are show in Table 33 in the Appendix.
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Figure 12: Numbers of Manual Interventions and Readmissions for Different Intervention Strategies
Our simulation findings not only highlight the importance of predictive analytics in connected
healthcare but also provide a possible explanation for why we did not observe a significant reduction
in readmissions in our original randomized controlled trial. Since we could deliver only a limited
number of interventions and did not consider readmission risks, it is possible that we delivered many
interventions to low-risk patient-days and overlooked high-risk patient-days. As Figure 12 shows,
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we find that the observed number of readmissions is very close to the number of readmissions
we obtain in a simulated scenario where no intervention is delivered. To further investigate this,
we apply the readmission risk-scoring model to the observed data and find that more than half
of the patient-days that received manual messages or calls had readmission risks below the 59th
percentile. Moreover, only 11.42% of the patient-days that received manual messages or calls had
readmission risks above the 95th percentile. This evidence supports the explanation that we may
have not delivered enough interventions to patient-days with high readmission risk and that our
intervention would have been more effective if it had been based on dynamic risk scoring.

2.7. Conclusions and Managerial Insights
This paper studies the effectiveness of a connected health system that aimed to reduce the number of
readmissions through better medication adherence and examines the benefit of predictive analytics
in connected healthcare. By utilizing micro-level intervention and adherence data, we find that
patients are significantly more likely to become adherent again when they receive high levels of
intervention that involve personalized feedback and when the intervention is escalated quickly
and continuously.

Our findings highlight the importance of personal involvement and speed

when delivering connected health intervention, which has not been widely explored by healthcare
researchers. Although the marketing and psychology literature has documented the benefit of
personal involvement in changing customers’ behavior (e.g., Gordon et al. 1998), not much has
been studied in the context of healthcare.
To investigate the extent to which behavior change could improve patients’ health outcomes, we
explore the effect of short- and long-term medication adherence to two crucial medications on
readmission risk. We find that, for patients with cardiovascular disease, long-term adherence to
statins and β-blockers is associated with a 51% reduction in the odds of being readmitted on
any given day. Although we do not find a significant effect of short-term adherence, the lack of
significance does not suggest that short-term medication adherence is not important. Rather, our
finding implies that, in order to significantly benefit from adherence, patients need to consistently
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maintain their adherence over a long period. The benefit of long-term adherence is supported
by the view in the medical and behavioral compliance literature, which suggests that long-term
adherence to medications and treatments is crucial to maintaining good health (Sabate 2003). Most
importantly, our findings emphasize the importance of connected healthcare as a tool to improve
compliance in the long term by continuously connecting with patients over a long period, as opposed
to traditional care where such connectivity is not possible.
In addition to studying the impact of the intervention on medication adherence and the impact of
adherence on readmission, we develop a dynamic readmission-risk scoring model that considers
real-time medication adherence and find that the model outperforms a baseline risk model that does
not consider medication adherence. The results suggest that real-time behavior information can
be useful in predicting health outcomes. Although real-time behavior data were not extensively
available in the past, they are becoming more widely available thanks to an increasing availability
of connected health devices.
Lastly, we examine the benefit of using the dynamic risk model in connected healthcare when the
care team has a limited capacity. Using counterfactual simulations, we find that, when using an
intervention strategy that prioritizes patient-days with highest readmission risk, we can achieve a
significantly lower number of readmissions than we would obtain without considering readmission
risk while maintaining the same amount of effort. The dynamic risk model helps the care team
allocate their resources to high-risk patients who are non-adherent and have the greatest need to stay
adherent. Our findings underscore the value of predictive analytics in connected healthcare. Since
connected health technologies allow care providers to conveniently connect with patients, it also
enables them to oversee more patients than they traditionally could. With predictive analytics, care
providers can optimally allocate their limited resources to achieve the desired outcome. Predictive
analytics is not only useful for connected healthcare, but also for other industries that want to
implement a connected strategy and make the most out of their limited resources. For example,
in financial advising, instead of contacting consumer investors and asking them to rebalance their
account every time their asset allocation changes or their cash balance is low, investment firms can
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use predictive models to target only the investors whose portfolio health is more likely to be affected
if they do not rebalance their account.
There exist a number of opportunities for future work. To better understand the effectiveness of
connected healthcare, future research could explore whether and how different patient demographics
respond differently to intervention. Since it is possible that some patients are more sensitive
to certain types of intervention than others, understanding these differences can help health
professionals design an effective intervention strategy to target different demographics. We hope
that by providing the data that we obtained as part of a connected healthcare experiment to the
research community, future research can take advantage of the clinical interventions we performed.
Beyond using the data that we collected, we also believe that future research should conduct
a randomized controlled trial in which adherence behavior is tracked in both the control and
intervention groups, but feedback is delivered only to intervention patients. This would improve
our understanding on how exactly patients react to feedback and reminders. Moreover, future
connected healthcare studies could conduct a randomized controlled trial that utilizes a predictive
model similar to what we propose to better understand how predictive analytics can actually benefit
connected healthcare.

Acknowledgments: The randomized controlled trial was funded with a grant from Center for
Medicare & Medicaid Innovation (CMS), Health Care Innovation Award 1C1CMS331009.
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2.8. Appendix A: Supplementary Tables and Figures
Table 27: Data Description
Data
Adherence information
Intervention information

Financial incentive outcomes
Readmission

Age

Gender
Medicare enrollment

PHQ-2 depression score

Baseline Elixhauser score

Days since enrollment
Weekend and holiday

Description
Daily information on whether the patient opened each of the pill
bottles.
Daily information on whether our care team delivered each type
of intervention to the patient, the patient’s partner, or the patient’s
provider’s office.
Daily lottery results, indicating whether the patient was eligible
to win but did not receive the prize due to non-adherence.
Readmissions include all-cause inpatient hospitalizations and
observation stays, but not emergency room visits. It is a dummy
variable, coded 1 if readmission criteria are met and 0 otherwise.
Patient’s age. It is a continuous variable, coded as piecewise
linear spline variables with knots at its 50th and 80th percentiles
to account for potential nonlinear effects.
Patient’s gender. It is a dummy variable, coded as 1 if the patient
is female and 0 otherwise.
Information on whether the patient is enrolled in Medicare, a
national health insurance program in the United States. It is
a dummy variable, coded as 1 if the patient is enrolled and 0
otherwise.
Patient’s depression score from Patient Health Questionnaire-2
(PHQ-2), which inquires about the frequency of depressed mood
and anhedonia over the past two weeks. The score ranges from
0 to 6 with higher scores translating to higher chances of having
depression. We asked patients to complete PHQ-2 once at the
time of enrollment.
Patient’s Elixhauser comorbidity index, which measures
comorbidities of patients based on the International
Classification of Diseases (ICD) diagnosis code. We assigned
the score to patients once at the beginning of the study period
using pre-enrollment data. The score is a continuous variable,
coded as piecewise linear spline variables with knots at its 50th
and 80th percentiles to account for potential nonlinear effects.
The number of days since enrollment.
Indicator for weekend and holiday. It is a dummy variable, coded
as 1 if the day falls on a weekend or a federal holiday.
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Table 28: Full Estimation Results for Study A
Variable
EscLevel
Level 0 – Intervention not yet delivered
Level 1 – Automated message to patient
Level 2 – Automated message to partner
Level 3 – Phone call to patient
Level 4 – Manual message to patient
Level 5 – Phone call to partner
OverallEsc
RecentEsc
Regret
Days since enrollment
Weekend and holiday
EA 1
EA 2
EA 3
EA 4
Age [< 62]
Age [62-71]
Age [> 71]
Female
Baseline Elixhauser score [< 5]
Baseline Elixhauser score [5-15]
Baseline Elixhauser score [> 15]
PHQ-2 score
Medicare
Observations
Wald χ2185

Hazard Ratio (SE)
(base case)
1.01 (0.00)
1.01 (0.01)
1.28∗∗∗ (0.05)
1.29∗∗ (0.10)
1.36∗∗ (0.16)
1.18∗ (0.09)
1.32∗∗∗ (0.12)
1.04 (0.03)
1.00 (0.06)
0.91 (0.34)
(base case)
1.05 (0.07)
0.87 (0.32)
0.94 (0.35)
1.00 (0.00)
1.02 (0.01)
0.98∗∗ (0.00)
1.04∗ (0.01)
0.87 (0.33)
0.92 (0.34)
0.99∗ (0.00)
0.41∗ (0.19)
0.96 (0.04)
40,250
1319.14 (p < 0.1%)

Notes: Standard error in parentheses. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
αt ’s are not reported.
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Table 29: Full Estimation Results for Study B
Variable
3-day statin and β-blocker adherence
120-day statin and β-blocker adherence
Number of previous readmissions
Weekend and holiday
Number of observations
Pseudo R2

Odds Ratio (SE)
0.75 (0.29)
0.49∗∗ (0.12)
3.02∗∗∗ (0.61)
1.17 (0.93)
67,872
0.283

Notes: Standard error in parentheses. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
αt ’s are not reported.

Table 30: Robustness Test for Study B: Varying Adherence Threshold
Adherence threshold
60%
70%
80%
90%
60%
70%
80%
90%

Odds Ratio (SE)
Short-term statin and β-blocker adherence
0.81 (0.44)
0.75 (0.34)
0.75 (0.29)
0.73 (0.29)
Long-term statin and β-blocker adherence
0.54∗ (0.20)
0.48∗∗ (0.13)
0.49∗∗ (0.12)
0.46∗∗ (0.13)

Notes: Standard error in parentheses. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
We vary the threshold for short- and long-term adherence simultaneously.

Table 31: Robustness Test for Study B: Varying Short- and Long-Term Adherence Windows
Adherence window
3-day adherence
5-day adherence
7-day adherence
80-day adherence
100-day adherence
120-day adherence

Odds Ratio (SE)
Short-term statin and β-blocker adherence
0.75 (0.29)
0.72 (0.32)
0.80 (0.36)
Long-term statin and β-blocker adherence
0.53∗ (0.23)
0.50∗∗ (0.15)
0.49∗∗ (0.12)

Notes: Standard error in parentheses. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
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Table 32: Simulation Parameters
Parameter
Probability of becoming adherent again
Probability of readmission
Random effect distribution for adherence model
Readmission length-of-stay (LOS) distribution

Specification
Follows the proportional hazards model from Study A
Follows the dynamic readmission risk-scoring model
N(0,0.269)
P(LOS = 1 day) = 0.792, P(LOS = 2 days) = 0.105,
P(LOS = 3 days) = 0.065, P(LOS = 4 days) = 0.021,
P(LOS = 5 days) = 0.011, P(LOS = 6 days) = 0.006

Table 33: Simulation Results for Strategy B When n Is 85 and 90
Scenario
Strategy B (n = 85) Strategy B (n = 90)
831.3
607.3
766.7
559.3
58.5
42.9
6.2
5.1
90.11%
88.69%
289.0
295.7
262.9
265.7

Outcome
Total number of manual interventions
Call to patient
Manual message to patient
Call to partner
Average individual adherence rate
Total number of readmissions
Number of patients readmitted at least once
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30%
20%
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0%
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c%
Dynamic risk modeling

Baseline risk modeling

c%
No information

Dynamic risk model
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c%
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No information

(b)

Yield

Yield

(a)

Baseline risk model

c%
No information

Dynamic risk model

(c)

Baseline risk model

No information

(d)

Notes: The definition of patient-day at risk in each panel is: (a) patient-day with readmission, (b) patient-day with
readmission or prior to readmission (the default), (c) patient-day with readmission or up to two days prior to
readmission, and (d) patient-day with readmission or up to three days prior to readmission.

Figure 13: Yield Obtained Using Different Readmission Intervention Approaches: Varying the
Definition of Patient-Day at Risk
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(a)
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c%
No information

Dynamic risk model

(c)

Baseline risk model

No information
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Notes: The definition of patient-day at risk in each panel is: (a) patient-day with readmission, (b) patient-day with
readmission or prior to readmission (the default), (c) patient-day with readmission or up to two days prior to
readmission, and (d) patient-day with readmission or up to three days prior to readmission.

Figure 14: Precision Obtained Using Different Readmission Intervention Approaches: Varying the
Definition of Patient-Day at Risk
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2.9. Appendix B: Study B – Instrumental Variable Analysis
As we explain in Section 2.5.3, there may exist unobservable time-varying factors that influence
readmission and adherence behavior in addition to time-invariant factors. To address this, we
use the instrumental variable (IV) approach to control for both time-invariant and time-varying
unobservable factors that may be confounders.
There exist two groups of patients in our study: (1) patients who were usually able to maintain
relatively high adherence—they tended to receive few or no interventions when their adherence was
high and receive more interventions when their adherence was low; and (2) patients who normally
had relatively low adherence and needed intervention to stay adherent—they tended to have higher
adherence when they received more interventions and lower adherence when they received fewer
or no interventions. For the latter group, we see the possibility of using intervention as IVs for
medication adherence. The reasons why we may be able to use intervention as IVs for these patients
are because (1) intervention is positively correlated with medication adherence and (2) intervention
is likely uncorrelated with unobservable factors that affect readmission. Because of this observation,
we focus on this cohort of 115 patients in our IV analysis. Among these patients, the average shortand long- term adherence are 0.512 and 0.544, respectively.
There exist two potentially endogenous binary variables, short-term adherence and long-term
adherence. We need at least one IV for each endogenous variable. We want our IVs to be (1)
correlated with medication adherence (relevance condition) and (2) uncorrelated with unobservable
factors that affect readmission (exogeneity condition). We propose using the number of manual
interventions the patient received prior to the present day as IVs. Specifically, for short-term
adherence, the IVs that we propose are (1) the number of manual messages the patient received in
the past 8 days (i.e., length of adherence window plus five days), (2) the number of phone calls the
patient received in the past 8 days, and (3) the number of phone calls the patient’s partner received
in the past 8 days. For long-term adherence, the IVs that we propose are (1) the number of manual
messages the patient received in the past 125 days (i.e., length of adherence window plus five days),
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(2) the number of phone calls the patient received in the past 125 days, and (3) the number of phone
calls the patient’s partner received in the past 125 days. By using intervention as IVs, we obtain
the effect of medication adherence that varies depending only on how much intervention the patient
receives. We will also validate the relevance and exogeneity conditions for these IVs.
Since both readmission and medication adherence are binary variables, we use a bivariate probit
model jointly estimated via Full Maximum Likelihood Estimation (FMLE) (Cameron and Trivedi
1998, Greene 2012). We do not include patient fixed effects because patient fixed effects (or
individual fixed effects in general) in a two-stage binary response model may cause an incidental
parameter problem and biased estimates (Greene 2004). However, since the IV approach already
accounts for both time-invariant and time-varying unobservables that may be confounders, it is not
necessary to include patient fixed effects. We specify our model for patient i and day t as follows:
ShortT ermAdherence∗it = Zit ω + θ1 M anualM essages8Daysit + θ2 P atientCalls8Daysit
+θ3 P artnerCalls8Daysit + ε1it ,
ShortT ermAdherenceit = 1 {ShortT ermAdherence∗it > 0} ,
LongT ermAdherence∗it = Zit Ω + Θ1 M anualM essages125Daysit
+Θ2 P atientCalls125Daysit + Θ3 P artnerCalls125Daysit + ε2it ,
LongT ermAdherenceit = 1 {LongT ermAdherence∗it > 0} ,
Readmitted∗it = Zit δ + β1 ShortT ermAdherenceit + β2 LongT ermAdherenceit
+αt + ξit ,
Readmittedit = 1 {Readmitted∗it > 0}

(2.8)

where ShortT ermAdherenceit and LongT ermAdherenceit are short- and long-term adherence
as defined in Study A; readmittedit is a binary variable that equals one when readmission occurs;
αt is fixed effects of days since last discharge; and Zit is a vector of control variables, which include
(1) patient characteristics (age, gender, PHQ-2 score, Elixhauser score, and Medicare enrollment),
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(2) a binary variable indicating weekend and holiday, (3) the number of previous readmissions, (4)
days since enrollment, and (5) EA fixed effects.
In Equation 2.8, the error terms (ξit , ε1it ) may be correlated to model the endogeneity between
the short-term medication adherence and readmission. Similarly, the error terms (ξit , ε2it ) may be
correlated to model the endogeneity between the long-term medication adherence and readmission.
We assume that (ξit , ε1it ) and (ξit , ε2it ) follow a Standard Bivariate Normal distribution with
correlation coefficient ρ1 and ρ2 , respectively. We can conduct the likelihood ratio tests of null
ρ1 = 0 and null ρ2 = 0 to test the presence of endogeneity.
We report the first-stage results in Tables 34 and 35. We find that the effects of the numbers of
interventions received on short- and long-term medication adherence are positive and statistically
significant. One exception is the effect of the number of manual messages received in the past 8
days on short-term adherence, which is not significant at a 95% confidence level. However, the
insignificance is not an issue since we only need at least one IV to be “relevant” to each endogenous
variable. The first-stage results suggest that the relevance condition is satisfied.
Table 34: Estimated Effect of Instrumental Variables on Short-Term Medication Adherence
θ (SE)
0.22 (0.12)
0.26∗∗∗ (0.05)
0.75∗∗∗ (0.06)

Instrumental Variable
M anualM essages8Days
P atientCalls8Days
P artnerCalls8Days

Notes: Standard error in parentheses. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).

Table 35: Estimated Effect of Instrumental Variables on Long-Term Medication Adherence
Θ (SE)
0.11∗∗ (0.05)
0.12∗∗∗ (0.02)
0.44∗∗∗ (0.02)

Instrumental Variable
M anualM essages125Days
P atientCalls125Days
P artnerCalls125Days

Notes: Standard error in parentheses. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).

We show the second-stage results in the column titled “With IVs” in Table 36. Similar to the
results obtained from the fixed-effects logit model, we find that the effect of long-term adherence
is statistically significant while the effect of short-term adherence is not. For long-term adherence,
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the estimated coefficient of -0.24 translates to an average marginal effect of -0.34%. This marginal
effect is slightly smaller than the average marginal effect we obtain using the fixed-effects logit
model, which controls for only time-invariant confounders. Moreover, to determine what the results
will be if we ignore the potential endogeneity, we run only the second-stage model and report the
results in the column titled “Without IVs”. We find that the effects of adherence on readmission
are exaggerated when we do not account for either time-invariant or time-varying confounders. Our
findings suggest that patients who are healthier and are less likely to be readmitted are possibly
more adherent to their medications. Table 37 shows the results of endogeneity tests, which suggest
that the error terms in the first- and second-stage equations are negatively correlated. Therefore,
endogeneity is present.
Table 36: Estimated Effect of Medication Adherence on Readmission

Adherence Measure
ShortT ermAdherence
LongT ermAdherence

With IVs
-0.12 (0.09)
-0.24∗∗ (0.11)

β (SE)
Without IVs
-0.13 (0.10)
-0.33∗∗∗ (0.04)

Notes: Standard error in parentheses. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).

Table 37: Results of Endogeneity Tests
Parameter

Value (SE)

ρ1
ρ2

-0.16 (0.06)
-0.46 (0.09)

Test ρ = 0
p-value
0.04
0.00

Notes: Standard error in parentheses.

Although we cannot directly verify the exogeneity condition using the bivariate probit model, we
can verify the condition using a two-stage least squares (2SLS) model by conducting a Hansen
J test of overidenfying restrictions. Although the 2SLS model linearizes binary responses, many
economists including Angrist and Pischke (2013) have proposed using 2SLS for nonlinear models
with endogenous regressors. Many researchers also adopt a linearized two-stage model partly
because it can handle individual fixed effects (e.g., Bavafa et al. 2018). We conduct our analysis
using a 2SLS model and find that the results are consistent with those from the bivariate probit
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model. Using a Hausman’s specification test, we find that endogeneity is present. Moreover,
to verify the exogeneity condition, we conduct the test of overidentifying restrictions, which is
possible because the number of IVs exceeds the number of endogenous variables. Based on the
test, we find that the Hansen J statistic is 2.624 with a p-value of 0.623. This suggests that the IVs
are uncorrelated with unobservable factors that affect readmission and, therefore, the exogeneity
condition is satisfied.
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CHAPTER 3 : The Impact of Video Visit Availability on Care Utilization
Joint work with Hummy Song, Christian Terwiesch, and Krisda Chaiyachati

3.1. Introduction
Video visits are transforming the way patients are able to connect with providers—by providing
not only an additional pathway for patients to access care but also one that is more convenient and
available sooner. Traditionally, to see a primary care provider in person, patients in the US need to
wait 29 days on average for an available appointment (Merritt Hawkins 2017) and spend two hours
on average, including travel and wait time, for a visit that lasts an average of 20 minutes (Daschle
and Dorsey 2015, Ray et al. 2015). While it is well established that prompt access to care improves
both patient satisfaction and health outcomes (Reichert and Jacobs 2018), only 10% of new patients
are seen in person the same day (Hayhurst 2017). Video visits remove these geographical and
temporal barriers by allowing patients to remotely connect at any time of day or night with their
providers through electronic devices. With video visits, patients are able to see their providers not
just on the same day, but within minutes, from the comfort of where they are.
In recent years, researchers have been attempting to understand the impact of video visits on various
service outcomes, such as patient satisfaction, and examine why patients choose video visits over
in-person visits. Many studies go on further to examine how the use of video visits affects the use of
traditional in-person visits. However, these studies primarily rely on post-care surveys and simple
retrospective analysis and/or focus only on a specific patient demographic, such as the elderly or a
specific care specialty. There exists limited empirical research that utilizes large-scale, general care
utilization data and comprehensively examines how the availability of video visits impacts overall
care utilization and in-person care utilization. Moreover, to the best of our knowledge, no study has
utilized both in-system and out-of-system care utilization data to investigate how the availability
of video visits affects patients’ decisions regarding whether, how, and where to seek care. The
impact of video visit availability on patients’ patterns of care utilization is an important empirical
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question, the answer to which can help payors and providers decide whether and how to introduce
and promote video visits.
Our study investigates the impact of video visit availability at a large academic medical center, the
University of Pennsylvania Health System (UPHS), which has recently introduced video visits to a
subset of patients who are employees. Our overarching aims are to understand how the availability
of video visits for UPHS’s health system-insured employees impacts their care utilization and the
choices that they make when they are sick. As shown in Figure 15, prior to the introduction of
video visits, patients (employees) could choose to seek care in person, at UPHS or elsewhere, or
not seek care. After the introduction of video visits, their choice set expanded to also include the
option of seeking care via a video visit at UPHS. The higher convenience of video visits may make
patients who would have previously used an out-of-system provider more likely to seek their care
inside UPHS. It is also possible that the increased convenience leads to more care consumption as
patients who were previously deterred by the inconvenience might now see a provider via video
visit. Additionally, video visits may also act as a gateway leading to subsequent in-person care
consumption. Without a careful empirical analysis, one can only speculate.

In-person visit

In-person visit

UPHS

UPHS

Elsewhere

Elsewhere

Patient

No visit

Video visit at UPHS

No visit

(a) Before the Introduction of PMOD

(b) After the Introduction of PMOD

Figure 15: Patients’ Care Options Before and After Video Visits Were Introduced
Although we want to both determine the impact of video visit availability on care utilization and
explain the change in care utilization, this current study serves as a first step in our work and
focuses on the first question—that is, whether, and to what extent, the availability of video visits
impacts in-system care utilization. In particular, we investigate how the availability of video visits
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offered at UPHS impacts (1) overall care utilization at UPHS and (2) in-person care utilization at
UPHS. To examine these, we utilize a unique panel data set containing in-system patient encounters,
both from employees and non-employees. Our data contain over 1.5 million patient encounters
collected over the course of three and a half years. Visit types include primary care physician (PCP)
visits, emergency department (ED) visits, and video visits, the combination of which represents the
majority of visits that took place at UPHS.
Treating non-employees as a control group, we conduct difference-in-differences analyses and
find that the availability of video visits was associated with increased overall care utilization and
increased in-person care utilization at UPHS. Specifically, for patients who lived closer to their place
of care, video visit availability was associated with a 21% increase in overall care utilization and a
15% increase in-person care utilization. For patients who lived farther from their place of care, the
effects were more prominent. Specifically, we find that video visit availability was associated with a
34% increase in overall care utilization and a 25% increase in-person care utilization. Furthermore,
we see increases in both PCP utilization and ED utilization across both patient groups. These results
persist after we restrict to a sample of employees who are matched to non-employees based on key
patient characteristics.
The results from the current study lay the foundations for future analyses that could help us further
understand the impact of video visit availability on patients’ patterns of care utilization. Since
we now find that video visit availability was associated with increased overall care utilization and
in-person care utilization, the next important step is to understand the reasons for such increases.
This involves investigating whether patients who previously used an out-of-system provider or did
not seek care were more likely to seek care inside UPHS after video visits became available, as well
as whether the use of video visits generated subsequent in-person visits.
The rest of the paper is organized as follows. We provide a brief summary of related papers in the
literature in Section 3.2. In Section 3.3, we introduce our study setting and describe our data. We
present our empirical approach in Section 3.4 and report the results in Section 3.5. In Section 3.6,
we discuss the results and the next steps in our work as well as provide concluding remarks.
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3.2. Literature Review
Over the last decade, there has been a growing body of research that studies various aspects of
telehealth and remote care delivery. In the medical literature, the majority of research is descriptive
and conducted using post-care surveys. There exist many survey studies that evaluate patient
experience and satisfaction with telehealth (e.g., Slightam et al. 2020, Ramaswamy et al. 2020)
and examine why patients choose remote care over in-person care. The findings from these studies
are mostly consistent and suggest that leading reasons for choosing remote care are shorter wait
times and convenience (e.g., Health Industry Distributors Association 2017). To better understand
patients’ preferences, several studies examine patient characteristics associated with choosing
remote care and find that higher in-person care barriers are significantly associated with a higher
likelihood of choosing remote care (e.g., Reed et al. 2020).
Although the majority of past research focuses on patient perception and preferences regarding
telehealth, there exist an increasing number of studies that directly investigate its operational and
clinical impact. These studies are done in various settings such as telemonitoring for patients
with chronic conditions (Steventon et al. 2012), medication adherence monitoring and feedback
(Lekwijit et al. 2020), and remote doctor consultation in EDs (Sun et al. 2020). A small number
of studies focus specifically on the impact of remote care delivery on care utilization. Bavafa et al.
(2018) examine the impact of e-visits (i.e., secure messaging between patient and provider) on visit
frequencies and find that e-visit adoption leads to more in-person care consumption. This finding
challenges a number of medical studies that argue that e-visits could substitute in-person visits,
including Zhou et al. (2007) and Bergmo et al. (2005). In addition to e-visits, a small but increasing
number of studies focus on video visits, another common form of remote care that more resembles
in-person care, and their impact of care utilization. However, like studies on e-visits, the results have
been mixed. Delana et al. (2020) find that tele-ophthalmology generates an increase in the overall
visit rate, but a decrease in the in-person visit rate, suggesting that tele-ophthalmology can improve
overall care access and substitute in-person care. Shah et al. (2015) study video visit use among
older adults who live in a senior living community and find that video visit use is associated with a
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significant decrease in ED visits related to ambulatory-care-sensitive conditions. On the other hand,
Ashwood et al. (2017) examine how the use of Teladoc, a direct-to-consumer video visit platform,
affects care utilization among patients with acute respiratory illnesses and find that the magnitude of
video visit substitution for in-person visits is not significant. These studies do not only yield mixed
results and beg further studies—most of them also study only a specific patient demographic or care
specialty, or study third-party video visit platforms that are not specific to any healthcare system. To
the best of our knowledge, no one has studied how video visits offered within a healthcare system
impact overall and in-person care utilization within the system, without restricting to any specific
patient demographic or care needs.
Our study is related not only to the work on remote care delivery but also to several streams of
operations management literature beyond the context of telehealth. First, our work joins a growing
number of studies on multichannel healthcare, which broadly examine how improving access to
one channel of care affects care utilization in other channels. For example, Bavafa et al. (2021)
studies how an increase in PCP availability affects ED utilization, Ahuja et al. (2020) examines
how improved patient-provider interactions in primary care affects inpatient care utilization, and
Soltani et al. (2021) studies how ED physician workload impacts post-ED care utilization. Second,
since remote care delivery is an integral part of health information technology, our work is related to
studies on the impact of health information technology adoption, which consider various operational
outcomes such as provider productivity (e.g., Adler-Milstein and Huckman 2013) and hospital
performance (e.g., Angst et al. 2011). Finally, our study compliments operations management
studies that examine the impact of operational interventions in healthcare, especially the impact
of changes in provider flexibility (e.g., Balasubramanian et al. 2012) and work reallocation (e.g.,
Deo et al. 2013), on system outcomes.

3.3. Setting and Data
This study investigates the impact of video visit availability at the University of Pennsylvania Health
System (UPHS) and was deemed exempt by the Institutional Review Board of the University
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of Pennsylvania.

In July 2017, UPHS began to offer a video visit service known as Penn

Medicine OnDemand (PMOD) to approximately 50,000 UPHS-insured employees and their adult
dependents1 . PMOD is an on-demand, direct-to-consumer primary care service that is available
around the clock, every day of the year. PMOD providers are nurse practitioners who are stationed
at a centralized telemedicine center and are employed by UPHS. In addition to conducting live
video visit appointments, PMOD providers also provide short-term prescriptions, order lab tests,
and coordinate follow-up in-person care when necessary. To use PMOD, patients must have a
UPHS online account and have a video- and audio-enabled device, such as a smartphone, tablet,
or computer. If using a smartphone or tablet, patients need to download the myPennMedicine app,
which is available on both Apple App Store or Google Play Store. To see a provider, patients can
schedule a visit through either a desktop patient portal or the mobile app by selecting one of the
time slots, which are offered every 20 minutes throughout the day, and are able to request a specific
provider depending on the provider’s availability. Before the visit, patients have to check in and
verify their medications and allergies. PMOD is a covered benefit under employees’ insurance
plans and is therefore free for employees. There is no limit to the number of times one can use
PMOD.
The goals of this study are to investigate how the availability of PMOD impacts (1) overall care
utilization at UPHS and (2) in-person care utilization at UPHS, which is further broken down into
(2.1) PCP utilization and (2.2) ED utilization. Since UPHS is a self-insured health system, we
observe both in-system and out-of-system utilization for employees through their medical claims
but only observe in-system utilization for non-employees through the electronic health record. For
the purpose of this analysis, we utilize in-system, employees’ and non-employees’ visit data, which
are collected from July 2016, or one year prior to the introduction of PMOD, to December 2019.
Prior to our analysis, we restrict our sample based on two selection criteria. First, to ensure that we
can accurately track employees’ care consumption over time, we keep only employees who were
employed for the entire study period and assume that an employee was employed for the entire
period if (1) his or her first visit (based on the claims record) was in 2016 or earlier and (2) his or
1

For convenience, we refer to this group of patients simply as employees.
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her last visit was in 2019 or later. For consistency, we also apply these criteria to non-employees.
Second, to focus on patients who were active UPHS care users, we consider only those who had two
or more visits over the 42-month study period. After excluding patients who do not meet the criteria,
our final patient cohort contains 13,849 employees who had a total of 105,752 PCP, ED, urgent care,
and PMOD visits combined, and 213,347 non-employees who had a total of 1,434,940 PCP, ED,
and urgent care visits combined. Table 38 summarizes the distribution of visit types for employees
and non-employees. In both groups, over 80% of the visits were with a PCP and approximately 10%
were with an ED. For employees, while only 4.5% of all visits in the data were video visits, video
visits actually made up over 6% of the visits that happened after July 2017. Although there existed
a small number of urgent care visits, we exclude those visits from our study. Since UPHS opened
the first urgent care clinic in January 2018 after PMOD became available, we cannot identify the
effect of PMOD availability on urgent care utilization. Nevertheless, the opening and subsequent
expansion of urgent care clinics should not bias the estimated effects of PMOD availability on care
utilization of other types because urgent care was available to both employees and non-employees,
and our empirical specification, particularly time fixed effects, would be able to capture its impact
on care utilization.
Table 38: Distribution of Visit Types

Visit Type
PCP
ED
PMOD
Urgent Care
Total

Employees (N = 13,849)
Number of Visits Percentage
88,400
83.59%
11,191
10.58%
4,826
4.56%
1,335
1.26%
105,752
100.00%

Non-Employees (N = 213,347)
Number of Visits Percentage
1,280,746
89.25%
148,160
10.33%
N/A
6,034
0.42%
1,434,940
100.00%

For each visit in the data, we have both patient-level information and visit-level information.
Patient-level information, some of which can change over time, includes age, gender, patient’s zip
code, patient’s heath insurance plan, and Charlson Comorbidity Score, which is a weighted count of
specific chronic conditions in a patient’s diagnosis history at the time of visit. Visit-level information
includes visit date, visit type, service zip code, provider specialty, and primary diagnosis, which
we identify based on the International Classification of Diseases, Tenth Revision (ICD-10). For
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each in-person visit, we determine the distance the patient was from his or her place of care using
geographical distance between the centroid of patient’s zip code and the centroid of service zip
code. We observe that a patient’s distance from his or her place of care mostly stayed consistent
over time. Specifically, almost 80% of patients had no variation in distance over time, and over 99%
of patients had a within-person coefficient of variation in distance below 0.5. We report summary
statistics of distance from the place of care as well as patient demographics in Table 39. We find that
employees are statistically different from non-employees in all considered aspects. In particular, on
average, employees were younger, more female, had a lower comorbidity score, had higher UPHS
care utilization, and lived closer to the their place of care than non-employees. We note that, to
obtain these summary statistics, we use each patient’s age in July 2016, Charlson score averaged
across all visits, and distance from the place of care averaged across all patient-months.
Table 39: Demographics of Employees and Non-Employees

Variable
Monthly UPHS visits
Age (years)
Male
Charlson score
Distance from place of care (miles)

Employees
(N = 13,849)
Mean (SD)
0.18 (0.15)
43.24 (13.68)
0.33 (0.47)
0.70 (1.26)
16.56 (56.71)

Non-Employees
(N = 213,347)
Mean (SD)
0.16 (0.13)
50.61 (17.13)
0.39 (0.49)
1.11 (1.73)
8.35 (54.43)

t-test p-value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001

Note: The statistics are reported at the patient level.

3.4. Empirical Approach
We conduct difference-in-differences analyses at the patient-month level by treating employees as a
treatment group and non-employees as a control group. Since the impact of video visit availability
may depend on whether a patient lived closer to or farther from the place of care, we first stratify
patients into two groups based on each patient’s average distance from his or her place of care and
use a cutoff of seven miles, which is the median distance across all employees. Then, we estimate
the effect of video visit availability within each of the groups separately. For each group, we conduct
our analyses in two ways. First, we perform a standard difference-in-differences analysis using data
on all employees and non-employees in the group. Second, we match employees to non-employees
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within the group based on several key patient characteristics in order to obtain a better control group
and perform difference-in-differences analyses on this subset of patients.
Our dependent variable, M onthlyV isitsit , is the number of visits that patient i had during month
t, where t ranges from 1 to 42, representing July 2016 to December 2019. Since our dependent
variable is a count variable by nature and can only be a non-negative integer, we use a count
regression model to appropriately reflect its distribution and define λit as a rate parameter, i.e.,
the mean of the distribution of M onthlyV isitsit . To determine whether the distribution of
M onthlyV isitsit is Poisson or negative binomial, which are the two standard distributions for
count variables, we conduct a test of overdispersion and find that the dispersion parameter is
statistically different from zero (p-value < 0.001), suggesting that we should use a negative binomial
model rather than a Poisson model.
In addition to determining the count distribution, another important consideration is whether there
exists zero inflation in the count data. Given the nature of healthcare utlization where most patients
do not seek care very often, M onthlyV isitsit has a mean of only 0.16 and has a value of zero
on most months. The large number of zeros can likely be explained in one of the two ways. It is
possible that (1) there are two zero-generating processes—one generates only zeros (e.g., when the
patient is healthy) and the other generates counts, some of which may be zero (e.g., when the patient
is unhealthy); or (2) all zeros are generated from a single process, and we see a large number of zeros
because the rate parameter happens to be very small. To investigate this, we conduct a score test
where the null hypothesis is that there is no zero inflation, i.e., the latter case is true (van den Broek
1995, Deng and Paul 2005). The test suggests that the null hypothesis cannot be rejected (p-value
= 0.920). In other words, there exists insufficient evidence for zero inflation and, therefore, visit
counts can be modeled using a standard negative binomial distribution.
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3.4.1. Standard Difference-in-Differences
We specify our difference-in-differences model as:

ln(λit ) = ln(E(M onthlyV isitsit |Xit )) = β·V ideoV isitAvailableit +M ontht +Y eart +P atienti ,
(3.1)
where λit is the expected value of M onthlyV isitsit conditional on a vector of independent
variables, Xit , which consists of the following.
1. V ideoV isitAvailableit : This is our main independent variable that indicates whether
PMOD was available to patient i during month t. For employees, V ideoV isitAvailableit
is equal to zero prior to July 2017 and is equal to one afterwards. For non-employees,
V ideoV isitAvailableit always remains zero.
2. M ontht and Y eart : We include month fixed effects to control for seasonality and year fixed
effects to control for care utilization trends over time.
3. P atienti : Patient fixed effects account for all observable (both available and unavailable
in our data) and unobservable patient-specific factors that influence the patient’s care
consumption and do not vary over the span of the study period. In an alternative analysis,
we replace P atienti with patient characteristics, which include age, gender, and Charlson
score, and check for the results’ robustness.
Since we aim to examine the effect of PMOD availability on four types of care utilization,
i.e., overall, in-person, PCP, and ED utilization, we conduct four separate analyses, each with
M onthlyV isitsit modified to capture the corresponding type of care utilization.
illustrates the number monthly visits over time for employees and non-employees.
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Figure 16: Monthly Visit Frequency over Time

3.4.2. Difference-in-Differences on Matched Samples
One potential issue with the standard difference-in-differences analysis is that non-employees as a
whole may not be an appropriate control group for employees. As Table 39 shows, non-employees’
characteristics appear to be systematically different from employees’. To improve the comparison
between the two groups, we match each employee to a non-employee who is the nearest neighbor
based on age, gender, Charlson score, and distance from the place of care. Then, we perform
the difference-in-differences analysis in Equation 3.1 on this new cohort. Although it may seem
reasonable to improve the comparison by considering non-employees who had a care usage level
similar to that of employees, we do not match employees to non-employees based on average
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monthly visit frequency prior to the introduction of video visits because matching on outcomes
in the pre-treatment period could cause regression to the mean (Daw and Hatfield 2018). Tables 40
and 41 report the demographics of patients who lived within seven miles and farther than seven miles
from their place of care, before and after matching, respectively. We can see that, after matching,
employees and non-employees in both distance groups are no longer statistically different in the
dimensions we match on.
Since UPHS is a self-insured health system, another factor that differentiates employees from
non-employees and that possibly influences care utilization patterns is health insurance plans. To
obtain a better control group, we can consider only non-employees who had health plans that were
comparable to employees’ health plans. However, since only a small number of employees had
such health plans, we do not include this matching criterion in our main analysis but will discuss
the results from this extended analysis as we present the main results.
Table 40: Demographics of Employees and Non-Employees by Distance Group Before Matching

Variable
Monthly UPHS visits
Age (years)
Male
Charlson
Distance from place of care
(miles)

Distance 6 7 Miles
Employees Non-Employees
(N = 6,834) (N = 151,069)
Mean
Mean
(SD)
(SD)
0.17
0.16
(0.14)
(0.14)
42.59
50.80
(13.65)
(17.28)
0.34
0.39
(0.47)
(0.49)
0.65
1.11
(1.21)
(1.74)
3.59
2.77
(1.97)
(2.07)

t-test
p-value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001

Distance > 7 Miles
Employees Non-Employees
(N = 7,015)
(N= 62,278)
Mean
Mean
(SD)
(SD)
0.18
0.15
(0.16)
(0.12)
43.86
50.17
(13.68)
(16.76)
0.32
0.41
(0.47)
(0.49)
0.75
1.11
(1.29)
(1.71)
29.68
21.88
(78.23)
(99.40)

t-test
p-value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001

3.5. Results
Table 42 presents the estimated effects of video visit availability on overall, in-person, PCP, and ED
care utilization from the standard difference-in-differences model. We report the estimated effects in
terms of incidence rate ratios (IRRs), which are the ratios of expected monthly visit counts if video
visits were available to expected monthly visit counts if video visits were not available. For example,
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Table 41: Demographics of Employees and Non-Employees by Distance Group After Matching

Variable
Monthly UPHS visits
Age (years)
Male
Charlson
Distance from place of care
(miles)

Distance 6 7 Miles
Employees Non-Employees
(N = 6,830)
(N = 6,717)
Mean
Mean
(SD)
(SD)
0.17
0.16
(0.14)
(0.14)
42.59
42.73
(13.65)
(13.61)
0.34
0.34
(0.47)
(0.47)
0.65
0.62
(1.21)
(1.17)
3.59
3.58
(1.97)
(1.98)

t-test
p-value
< 0.001
0.549
0.620
0.142
0.768

Distance > 7 Miles
Employees Non-Employees
(N = 7,005)
(N= 6,870)
Mean
Mean
(SD)
(SD)
0.18
0.17
(0.16)
(0.16)
43.86
43.94
(13.68)
(13.77)
0.32
0.32
(0.47)
(0.47)
0.75
0.78
(1.29)
(1.21)
29.68
29.33
(78.23)
(76.81)

t-test
p-value
< 0.001
0.731
0.801
0.156
0.790

an IRR of 1.21 translates to a 21% increase in expected monthly visit counts, or equivalently, a 21%
increase in care utilization in general as a result of video visit availability. In addition to IRRs, we
also report average marginal effects (AMEs), which are average magnitudes of changes in monthly
visit counts as a result of video visit availability.
Using standard difference-in-differences, we find that the availability of video visits led to increases
in both overall utilization and in-person utilization and that the effects were larger for patients who
lived farther from their place of care. Specifically, for patients who lived closer to their place of
care, video visit availability was associated with a 21% increase in overall care utilization and a
15% increase in-person care utilization, which, on average, translates to 0.37 more visits per year in
total and 0.27 more in-person visits per year 2 . In addition, we break down in-person utilization and
find that video visit availability was associated with a 16% increase in PCP utilization and an 8%
increase in ED utilization. For patients who lived farther away, we find that video visit availability
was associated with a 34% increase in overall care utilization and a 25% increase in-person care
utilization, which translates to 0.54 more visits per year in total and 0.42 more in-person visits per
year on average3 . With regard to in-person utilization, video visit availability was associated with a
21% increase in PCP utilization and an 87% increase in ED utilization. For ease of understanding,
we visualize yearly average marginal effects in Figure 17. Although the average yearly marginal
2
3

Calculated as 0.031 × 12 and 0.023 × 12, respectively
Calculated as 0.045 × 12 and 0.035 × 12, respectively
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effects may not seem large for an individual patient, for our hospital system with approximately
230,000 active care users, these effects amount to over 90,000 additional visits and over 70,000
additional in-person visits each year if video visits were available to everyone. We find these results
to be robust when we replace the patient fixed effects with patient characteristics and when we use
a linear model instead of the negative binomial model.
Table 43 reports the results obtained using difference-in-differences on matched samples. Consistent
with our prior analysis, we find that video visit availability was associated with increases in both
overall and in-person utilization. However, the effect sizes are slightly larger with matched samples.
We find that video visit availability was associated with a 23% increase in overall utilization and
an 18% increase in in-person utilization for patients who lived closer to their place of care, and
a 38% increase in overall utilization and a 32% increase in in-person utilization for patients who
lived farther from their place of care. In addition to matching employees and non-employees on
patient characteristics, we also consider only non-employees who had health plans comparable to
employees’ and find the estimation results to be similar to what we obtain without considering health
plans. However, with this approach, the sample size decreases by approximately 70%.
Table 42: Effects of Video Visit Availability on Monthly Care Utilization Estimated Using
Standard Difference-in-Differences

Type of Utilization
(1) Overall utilization
(2) In-person utilization
(2.1) PCP utilization
(2.2) ED utilization

Distance 6 7 Miles
V ideoV isitAvailable
IRR
Mean of
(SE)
AME
Dependent Var.
1.21***
0.031
0.165
(0.01)
1.15***
0.023
0.163
(0.01)
1.16***
0.022
0.145
(0.01)
1.08**
0.002
0.019
(0.03)

Distance > 7 Miles
V ideoV isitAvailable
IRR
Mean of
(SE)
AME
Dependent Var.
1.34***
0.045
0.154
(0.01)
1.25***
0.035
0.153
(0.01)
1.21***
0.027
0.141
(0.01)
1.87***
0.007
0.012
(0.06)

Notes: Number of patient-months = 9,542,232. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
IRR = incidence rate ratio. SE = standard error. AME = average marginal effect.
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Table 43: Effects of Video Visit Availability on Monthly Care Utilization Estimated Using
Difference-in-Differences on Matched Samples

Type of Utilization
(1) Overall utilization
(2) In-person utilization
(2.1) PCP utilization
(2.2) ED utilization

Distance 6 7 Miles
V ideoV isitAvailable
IRR
Mean of
(SE)
AME
Dependent Var.
1.23***
0.040
0.175
(0.02)
1.18***
0.030
0.163
(0.02)
1.19***
0.028
0.145
(0.02)
1.15***
0.003
0.019
(0.02)

Distance > 7 Miles
V ideoV isitAvailable
IRR
Mean of
(SE)
AME
Dependent Var.
1.38***
0.063
0.164
(0.02)
1.32***
0.050
0.159
(0.02)
1.26***
0.036
0.141
(0.02)
1.88***
0.012
0.014
(0.07)

Notes: Number of patient-months = 1,151,724. ∗ (p < 5%),∗∗ (p < 1%),∗∗∗ (p < 0.1%).
IRR = incidence rate ratio. SE = standard error. AME = average marginal effect.

(b) Distance > 7 Miles

(a) Distance 6 7 Miles

Figure 17: Yearly Average Marginal Effects Estimated Using Standard Difference-in-Differences

3.6. Discussion and Conclusions
This study takes the first step towards understanding how video visit availability impacts the choices
that patients make when they are sick. Through difference-in-differences analyses, we investigate
the impact of video visit availability at the University of Pennsylvania Health System (UPHS) on
in-system care utilization and find that the availability of video visits was associated with increases
in overall and in-person care utilization within the system. These results lay an important foundation
for the next step in our work, which is to understand the reasons for the changes in care utilization.
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There are two main plausible explanations for the increases in care utilization that our future
research can investigate. The first explanation is the substitution effect. It is possible that, when
there was an option to see UPHS care providers quickly and conveniently, patients who previously
used out-of-system providers or who did not seek care were more likely to seek care inside UPHS
through video visits. Additionally, it is also possible that the convenience in accessing UPHS
care not only generated additional utilization through video visits but also directly led to increased
in-person utilization at UPHS. Since there existed an easy way to connect and communicate with
UPHS providers, patients may be more likely to seek in-person care inside UPHS rather than at
out-of-system hospitals that do not provide the same benefit. To investigate the substitution effect,
we can utilize employee claims data and use patient choice models to examine how the availability
of video visits impacts patients’ decisions regarding whether to seek care inside or outside of UPHS
when they decide to seek care. In addition, we can potentially examine patients’ decisions regarding
whether to seek care using sick days as a proxy for times when patients were sick but did not seek
care.
The second explanation for the increases in care utilization is known as the gateway effect. Our
preliminary analysis suggests that the use of video visits likely led to in-person visits shortly
afterwards. Based on our data, 18% of video visits were followed by an in-person visit within
seven days, while only 4% of PCP visits and 2% of ED visits were followed by another in-person
visit within seven days. There exist several reasons that can potentially explain the gateway effect.
It is possible that some video visits could not provide adequate care and therefore led to repetition
of care. It is, however, also possible that some patients used video visits in order to get an in-person
appointment with difficult-to-access specialties. In our future research, we can formally investigate
the presence of the gateway effect using hazard models where the hazard rate is time until the next
visit. Additionally, we can examine the causes of the effect (i.e., repetition of care vs. improvement
of care access) by incorporating visit-level information of video visits and subsequent visits, such
as the patient’s diagnosis and the type and specialty of the care provider.
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In addition to explaining the increases in care utilization, it is also important to understand the
impact of distance from the place of care on the sizes of the increases. Our future research can
examine whether and how the substitution effect and the gateway effect presented themselves
differently depending on how far a patient was from the hospital. Our preliminary analysis suggests
that the gateway effect may not differ between those who lived closer to the place of care and
those who lived farther from the place of care. Specifically, we find that the common reasons for
video visits and the rates of follow-up care after a video visit are consistent across both distance
groups. This implies that the larger increases in care utilization among patients who lived farther
away can possibly be explained primarily by the substitution effect. In other words, video visit
availability may have influenced care choices among patients who lived farther away more than it
did among patients who lived close by. To investigate this, we can incorporate distance into our
patient choice models and examine how distance changes the impact of video visit availability on
patients’ decisions regarding whether and where to seek care.
Lastly, since we find that in-person utilization increased as a result of video visit availability, our
future research can investigate how care providers were able to accommodate additional in-person
visits. There exist several possibilities that we can explore—for example, care providers may have
reduced the amount of time spent with each patient, admitted fewer new patients, or worked more
hours to provide additional visits.
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